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SUMMARY
1. A membranous sub-fraction has been prepared from locust 
(Schistocerca gregaria) muscle. The fraction shows some 
enrichment in the specific binding of L-glutamate compared with 
the total homogenate of the muscle. Electron microscopy and 
enzyme distribution studies suggest that the fraction is 
composed mainly of membrane and disrupted mitochondria.
Two methods have been used to measure the specific binding of
L-glutamate based on rapid filtration through Whatman GF/C
filters and a rapid centrifugation procedure using a Beckman
Airfuge. The latter method gave better reproducibility within
any one study but both assay methods showed great variation
between preparations. There appears to be no metabolism of
L-glutamate by the membrane fraction during the time over which
the binding studies were made. Preliminary experiments with
three marine toxins - suberitine and a and 3 cephalotoxin suggest
that these agents may prove to be useful in elucidating the nature
of the glutamate binding sites on the muscle membranes. The
variability of the binding activities of the muscle membranes
has so far precluded any unequivocal designation of the L-glutamate
binding sites as synaptic receptors.
1252, The specific binding of [ I]-a-bungarotoxin to a membrane fraction 
of locust (Schistocerca gregaria) supra-oesophageal ganglia showed 
the following characteristics:-
a) binding increased linearly with protein
125b) binding saturated at concentrations of [ I]-a-bungarotoxin 
greater than 2 nM
(ii)
125c) bound [ I]-a-bungarotoxin dissociated in a biphasic manner
d) binding was preferentially inhibited by nicotinic ligands.
When the membrane fraction was treated with the co-valent affinity
3label [ H]-MBTA and subjected to SDS-PAGE most of the radioactivity
was recovered as a single peak, corresponding to an of 58,000.
The binding characteristics (K^ and of the membrane fraction
did not change significantly on solubilisation in the non-ionic
detergent Triton X-100. Up to a 1000 fold purification of the
a-bungarotoxin binding component was achieved after affinity
chromatography on immobilised a-bungarotoxin. The of the
partially purified binding component was unchanged relative to
the membrane fraction, when measured from equilibrium binding
studies but determination of the k ^ showed dissociation of—  i
125[ I]-a-bungarotoxin to be monophasic. The partially purified 
a-bungarotoxin binding component sedimented as a single component 
after centrifugation in a sucrose density gradient (14.2s;
400,000 - 450,000) and SDS PAGE showed two major protein bands 
of M^'s 60,000 and 41,000. No acetylcholine esterase activity 
was detected in this partially purified binding component fraction.
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INTRODUCTION
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There are over 800,000 different species comprising the 
phylum Arthropoda, of which^ species of insects are by far the 
major constituents. A mere 47,000 different species belong to the 
phylum Chordata, which includes the whole spectrum of vertebrates.
If our understanding of nervous systems is classified into the 
respective phyla, and considered in relation to the above figures, 
then what is known of the nervous systems of the Arthropoda is 
insignificant compared to the knowledge accumulated from the con­
siderably fewer species of Chordata. This imbalance of knowledge 
is, however, rapidly changing as an economic interest, implemented 
in part by the insecticide industry, into insect neurochemistry and 
neurophysiology has shown a dramatic increase in the last twenty 
years.
In the past the insecticide industry has largely relied on 
random screening as a means of discovering new chemicals to use in 
pest control and, until quite recently, the belief was that this 
process would take care of our future requirements. At present, 
after screening tens of thousands of chemicals, insect control 
relies on only four major chemical classes : the organochlorines; 
the organophosphates; the carbamates; and the fast growing pyrethroid 
group. All four are classified as neuroactive but the fact remains 
that the precise mode of action of any one insecticide remains 
unknown. This lack of basic knowledge has only intensified the 
ever growing problem of insect resistance. Because the mechanism 
and exact site of action of these compounds is not known it is 
impossible to determine the precise reason for resistance and hence 
impossible to remedy it.
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Two general conclusions follow from the results of random 
screening: firstly that insects are still very difficult to control, 
as indicated by the availability of only a few effective compounds 
out of thousands tested; and secondly, it would be advantageous to 
know more about insect nervous systems. Such information would 
both add to our general knowledge within the field of investigative 
neurobiology and also facilitate a more rational and hopefully more 
successful development of toxicants. Conversely, the toxicants may 
prove to be valuable tools in neurobiological investigations.
The work described in this thesis has been done with tissues 
from the desert locust, Schistocera gregaria. The desert locust 
is an orthopteran, a group with the general characteristics as 
follows: the body is enclosed in an exoskeleton and is bilaterally 
symmetrical and segmented; one pair of jointed appendages may be 
present per body segment ; coelomic cavities are present in embryosi 
the blood system is of the "open" type; the gut has a mouth and an 
anus; and the life history is of many stages, separated by moulting 
of old exoskeleton.
The Locust Central Nervous System:
The locust central nervous system consists of a main ganglionic 
mass ("brain" or supra-oesophageal ganglion) and a ventral nerve 
cord (Fig. 1 ). The supra-oesohpageal ganglion lies above the 
oesophagus in the head and represents a number of fused ganglia 
which originate in different segments of the embryo and amalgamate 
during development. The supra-oesophageal ganglion acts as the 
receptor of excitatory impulses arising from the sense organs in 
the head region, as well as from ascending interneurones in the
Fig. 1 Diagram Showing the Head and Ventral Ganglia of the Locust
Supra-oesophageal
ganglion
Sub-oesophageal 
ganglion
1st thoracic ganglion
2nd thoracic ganglion
3rd thoracic ganglion 
fused with first 3 
ganglia of the abdomen
4th, 5th, 6th & 7th 
ganglia of the 
abdomen
8th-llth fused ganglia 
of the abdomen
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ventral nerve cord. It is thus the chief association centre as well 
as the seat of long-term organised behaviour patterns (Bullock and 
Horridge, 1965).
The ventral nerve cord runs the length of the thorax and 
abdomen of the insect and consists of a series of ganglia linked 
by paired interganglionic connectives. As in the supra-oesophageal 
ganglion, fusion between ganglia may occur during development, 
either during embryonic growth or at different times after hatching 
(Pipa, 1973). In the locust there are three thoracic ganglia, two 
of which are distinct and a third which is fused with the first three 
ganglia of the abdomen. The fourth, fifth, sixth and seventh ganglia 
of the abdomen are distinct and the eighth through to the eleventh 
are fused. The degree of fusion of ganglia varies from species to 
species, the extreme case being the dipterans (e.g. the housefly) 
which display fusion of all the ganglia of the ventral nerve cord 
into one large thoracic ganglion from which nerves emanate to all 
the other parts of the body (Bullock and Horridge, 1965).
Ganglia, in insects that have been studied to date, be they 
fused ganglia of the oesophagus or the ganglia of the ventral nerve 
cord, all have the following common structural details: they are 
surrounded by an acellular neural lamella beneath which lies a 
cellular perineurium. Under this are found nerve cell bodies 
enveloped by glial cells and a central neuropile within (Fig. 2).
The nerve cell bodies are situated in the cortical region, peri­
pheral to the central neuropile. The neuropile, therefore, lacks 
neurones and is transversed by axons of different diameters which 
may originate in nerve cell bodies within the same or a more distant 
ganglion or may come into the neuropilar mass from a peripheral nerve.
segmental
nerve sensory axon
motor axon
nerve cell layer
interneurone
connective
synapses in neuropile
ganglion
FIG 2 Diagram of an idealised insect ganglion to show 
arrangement of nerve cells and neuronal processes
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It is in this central neuropilar region that synaptic contacts 
between nerve cells take place. Because in insects the cell bodies 
are completely ensheathed by a glial investment, synapses between 
axon terminals and nerve cell bodies do not occur and in this 
respect insects differ from vertebrates.
The connectives of the ventral nerve cord consist of axonal 
processes only, invested by glial cells. The glial cells that 
surround the nerve cord are present in the so-called tunicated condition 
(Smith and Treherne, 1963), not in the myelinated form that occurs 
in vertebrates; that is to say attenuated glial cell processes 
spiral around the axons. Other glial cells also form the perineurium, 
invest the neuropile, and giant glial cells send invaginations into 
the peripheral cytoplasm of the large nerve cells (Wrigglesworth,
1959 b; Sohal et al , 1972).
The ventral nerve cord and the brain of insects have no 
vascular system, so that substances have access to the nervous 
system only by diffusion from the haemolymph through the various 
layers. This is a very important consideration with respect to how 
insecticides may reach their site of action.
Locust Muscle:
Morphologically, skeletal muscle of the locust and other insects 
closely resembles vertebrate striated muscle in that there are com­
parable striation patterns with A-, 1- and H-bands and Z- and M-lines 
(See, Elder, 1975; Piek and Njio, 1979). The presence of both thick 
and thin myofilaments (Huxley and Hanson, 1956 ) has been demonstrated. 
Basic biochemical similarities also occur in that the thick filaments 
are myosin-containing and thin filaments are actin-containing 
(Maruyama, 1965). This biochemical evidence in turn lent support
— 6 —
to the assumption (Hanson, 1956) that in insect, as in vertebrate 
striated muscle, active muscle shortening is achieved in the way 
proposed in the sliding filament theory of Huxley and Hanson (1954) 
and Huxley and Niedergerke (1954). Apart from a few cases which 
do not appear to conform (Gilmour and Robinson, 1964) the sliding 
filament theory is now generally accepted.
Large mitochondria (sarcosomes) are typically found in columns, 
longitudinally aligned between the fibrils. Usually there is no 
alignment with the striation pattern of the myofibrils.
In addition to the mitochondria and the contractile fibres, 
a system of tubules and vesicles can be discerned within the muscle 
fibre. As early as 1890 Ramon Y Cajal, using the light microscope 
and the Golgi-silver impregnation method, observed the presence of 
fine filaments forming longitudinal and transverse reticulae, in 
both vertebrate and arthropod skeletal muscle. Verratti (1902) 
noted that the arrangements of the internal reticular apparatus 
differed characteristically between different muscles. This sarco- 
tubular system is now defined as consisting of a transversely 
orientated tubular system (T-system) which is formed by invaginations 
of the plasma membrane and a longitudinally orientated sarcoplasmic 
reticulum (Anderson-Cedergren, 1959) which has no connection with 
the outer plasma membrane. These systems are involved in the 
generation of membrane potentials, and in the mechanism of muscle 
excitation, contraction and relaxation.
Insect muscle fibres are surrounded by a connective tissus 
sheath called the basement membrane, which has predominantly a sup­
portive role, binding fibres together. However, Clements and May 
(1974) have suggested that in intact locust muscle the basement
- 7 -
membrane could serve also as a barrier to the putative neuro­
transmitter, glutamate. They observed that in muscles fixed by 
perfusion, the basement membrane is more compact than in muscles 
that are dissected out and then fixed by immersion, indicating 
that this membrane is probably damaged by the dissection procedure 
and therefore may not demonstrate the same properties as the intact 
muscle that is fixed ^  vivo.
Light microscopy reveals three broad categories of insect 
flight muscle: tubular; close-packed; and fibrillar which 
functionally can be divided into two groups:
1. Synchronous muscle which is nonfibrillar and in 
which there is a 1:1 ratio of the frequency of motor 
nerve impulses and the frequency of the mechanical 
responses. There is also a correlation between the 
speed of contraction and the extent of sarcoplasmic 
reticulum (Cochrane et al., 1972).
2. Asynchronous muscle which is fibrillar and in 
which the frequency of contraction greatly exceeds and 
is relatively independent of the motor nerve impulse 
frequency (Pringle, 1967; 1972). In asynchronous 
muscle there is no correlation between the extent of 
sarcoplasmic reticulum, which is very much reduced 
(Smith, 1965; Smith and Sacktor, 1970) and the speed 
of contraction.
From these observations it can be said that the presence of 
a well developed sarcoplasmic reticulum (synchronous muscle) is 
associated with a high frequency excitation-contraction coupling 
system rather than with a high frequency oscillation (asynchronous
— 8 —
muscle) of the myofibrils. Locust flight muscle is synchronous 
and therefore has a well developed sarcoplasmic reticulum which 
presents many problems in fractionation procedures.
A major difference between vertebrate and invertebrate 
muscle is that the latter has a multiterminal and polyneuronal 
innervation (Hoyle, 1957; Edwards, 1959) i.e. a single muscle 
fibre can be innervated by more than one axon of different kinds 
(excitatory and inhibitory) and each axon makes multiple contacts 
with each fibre (Fig. 3). The axon can also make contact with the 
muscle in a number of ways; the axon may lie in a groove in the 
surface of the muscle fibre (Edwards et £l., 1958), or it may 
make contact with projections from the surface of the muscle which 
take the form of pillars or sheets as in the locust retractor 
unguis muscle, or finally, the axon can penetrate into the muscle 
where it is completely surrounded by the muscle cell (Shafiq, 1964; 
Smith, 1960). This last type of axonal contact usually has no 
glial investment (See, Osborne, 1970). Axon-muscle contacts are 
termed neuromuscular junctions and it is there that information is 
transmitted from axon to muscle.
Synaptic Transmission:
Where an axon makes contact with either another axon as in 
the neuropilar region of the ganglia, or with a muscle fibre at the 
neuromuscular junction, the axon terminal is called a synapse.
The word was coined by Sherrington (1925) whose eletrophysiological 
studies confirmed the earlier hypothesis of Raman Y Cajal (1888) 
that the nervous system was not a continuous network, as was the 
general opinion at that time, but consisted of a number of discrete 
cells or neurones, which only made contact at specialised areas.
MUSCLE
FIBRE
NERVE
ENDING
NERVE
FIG 3 Diagramatic representation of insect 
muscle showing multiple innervation
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It is at the synapse that information is transferred between 
cells. The synaptic area consists of a pre-synaptic membrane (the 
axon terminal), a post-synaptic membrane (either another axon or 
a muscle fibre) and a synpatic gap or cleft between (Fig. 4 ). The 
axon terminal is characterised by the presence of numerous synaptic 
vesicles about 20-40 nm in diameter. At the junction these vesicles 
are usually clustered in groups, lying close to the axon membrane.
It is generally accepted that the synaptic vesicles contain trans­
mitter substance.
As in vertebrates, at the insect neuromuscular junction, upon 
arrival of the nerve impulse at the synapse, an influx of Ca"*~̂  
occurs (Kerkut e^ al., 1965 b; Usherwood e^ ajL., 1968) whereupon 
the transmitter substance is released. It is now generally 
accepted that the neurotransmitter is released in discrete quanta 
and it has been suggested that each quantal package is the content 
of a synaptic vesicle (del Castillo and Katz, 1955). The release 
mechanism is thought to be by exocytosis and to involve the fusion 
of the membrane of the synaptic vesicles with the pre-synaptic 
membrane. The released neurotransmitter then diffuses across the 
synaptic gap and interacts with the post-synaptic membrane causing 
a permeability change to ions in that membrane. The specificity 
of the permeability change is dependent on the neurotransmitter 
released and on the resting state of the membrane; if an excitatory 
neurotransmitter is released a permeability change to Na"*” and K."*” 
ions (and possibly C a ^  and M g ^ )  is the result but if an inhibitory 
neurotransmitter is released then there is a permeability change
—  —j—to Cl and/or K ions. In general the release of an excitatory 
neurotransmitter causes a depolarisation of the post-synaptic
NERVE
TERMINAL
Mitochondr ia
SYNAPTIC
VESICLES
Presynaptic
Membrane
Postsynaptic
Thickening
FIG. 4 Diagramatic Representation of a Typical Synapse
— 10 —
membrane by decreasing the resting potential of the membrane, 
whereas release of an inhibitory neurotransmitter usually causes 
hyperpolarisation by increasing the membrane resting potential.
In the case of axonal-axonal contact the extent of depolarisa­
tion must reach a threshold value before an action potential is 
achieved and the impulse propagated along the post-synaptic axon. 
Hyperpolarisation acts to reduce the extent of depolarisation and 
so prevent the threshold depolarisation being reached. This can 
be achieved in one of two ways; firstly, an inhibitory axon may 
synapse pre-synaptically onto an excitatory axon and so inhibit 
the release of excitatory neurotransmitter, or secondly, if two axons, 
one excitatory and one inhibitory, synapse very close to each other 
onto a third axon, then the hyperpolarisation caused by the inhibi­
tory axon will diminish the depolarisation caused by the excitatory 
axon and threshold depolarisation will not be reached in the post­
synaptic axon.
With insect muscle, because innervation of each fibre is 
usually multiterminal, it is not necessary to generate a full action- 
potential, unlike vertebrate skeletal muscle. This is because in 
the insect, the muscle fibre is made to contract by excitation of 
a series of synapses. The post-synaptic depolarisation arising in 
each synapse spreads to give a local depolarisation in the immediate 
non-synaptic membranes (a graded response) as is the case with 
vertebrate muscle. However, in vertebrate muscle the graded depol­
arisation eventually reaches a threshold and a full action potential 
is generated. Insect muscle fibres, however, are affected directly 
by synaptic depolarisations generated at the many synaptic sites 
and it is the summation of these individual depolarisations which
— 1 1 —
causes contraction.
As stated previously, it is the interaction of the neuro­
transmitter with the post-synaptic membrane that, by opening specific 
ion channels, causes the ion permeability change. The point or 
points of interaction of the neurotransmitter on the post-synaptic 
membrane are called receptors and are envisaged as specific membrane 
proteins that combine with the transmitter in a highly specific 
manner.
The concept of receptors for specific ligands was first 
postulated by Langley (1905) when studying the paralysing effects 
of nicotine. He suggested that nicotine must combine with some, 
then unknown, constituent of the muscle cell, which he termed a 
"receptive substance". Dale (1914) extended these observations in 
physiological studies of a series of choline derivatives and showed 
the presence of two distinct types of activity - a "muscarinic" 
action essentially mimicking the effects of parasympathetic stimu­
lation and the alkaloid muscarine; and a "nicotinic" action 
possessed by nicotine and exerted at skeletal muscle and autonomic 
ganglia. Further study by Dale of the nicotine-responsive nerve- 
muscle junction showed that certain agents, "antagonists", reduced 
the response to acetylcholine whereas another group, "agonists", 
potentiated the response.
Today, although the exact mechanisms of receptor-ligand inter­
actions are not known,a model has been suggested by Changeux and 
his colleagues (Heidmann and Changeux, 1978; Changeux et al., 1976) 
for the neurotransmitter-receptor interaction based on the nicotinic 
cholinergic system. The model is based on the theory that the 
elementary membrane unit is composed of at least two distinct
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structural elements; the receptive unit and the biologically 
active unit or ionophore, which might be part of the same polypep­
tide chain or equally could be carried by distinct subunits. By 
analogy with the known behaviour of regulatory enzymes and in 
agreement with the Katz and Thesleff (1957) model for desensitiza­
tion, it was further postulated that the regulator may exist in 
at least three discrete and interconvertible conformational states 
(Fig. 5). These states, referred to as resting R, active A and 
desensitized D, would differ primarily in the affinity of the 
acetylcholine receptor site for cholinergic ligands. The affinity 
for agonists would increase from R (low affinity) to A (medium 
affinity) to D (high affinity); on the other hand the affinity for 
competitive antagonists would be lower in the A than in the R or 
D states. Postulated conformational states of the acetylcholine 
regulator may also differ in their affinity for non-competitive 
blocking agents; in the D and A states the affinity for these com­
pounds would be higher than the R state. Finally, the ion channel 
would be open only in the A state of the regulator.
Although evidence for this hypothetical model derives from 
studies on the nicotinic acetylcholine-receptor system of the 
electroplax and the skeletal neuromuscular junction of vertebrates, 
it is not unrealistic to suppose that the same or very similar 
interactions occur in other receptor-neurotransmitter systems in 
which the time taken to respond to neurotransmitter is very fast 
( 1 - 3  milliseconds). This would indicate that essentially the 
same events may be taking place; namely interaction of the neuro­
transmitter with the receptor which results directly in opening 
of an ion channel or channels, followed by desensitization after
RESTING STATE
Antagonists
Mini mill
mil l mill
ACTIVE STATE 
Agonists
Local anesthetics 
 likl ZL
DESENSITIZED STATE
FIG. 5 A Model of the Acetylcholine Regulator 
(after Changeux et a_l. , 1976)
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prolonged application of the transmitter. Clearly such receptor- 
ion channel systems differ fundamentally from those in which the 
response is mediated through second messengers such as cyclic AMP 
(Fain, 1978).
To date the most advanced work in elucidating the mechanism 
and consequences of receptor-neurotransmitter interaction has been 
carried out on the nAChR from the electroplax and vertebrate muscle. 
This situation has arisen for two reasons: firstly, the discovery 
of the snake venom a-neurotoxins and their high-affinity, specific 
binding to the nicotinic receptor (Lee and Chang, 1966); and 
secondly, the abundant source of nicotinic cholinergic receptor 
in the electric organ of the electric fishes (see, Changeux, 1975).
The a-toxins, because of their specificity and high affinity 
for the nicotinic acetylcholine receptor and also because they 
can be radiolabelled without loss of their biological activity 
(Miledi and Potter, 1971; Berg eit ^ . ,  1972; Biesecker, 1973;
Dolly and Barnard, 1974; Barnard ejt al., 1979), have been invaluable 
as tools in the identification and purification of the acetylcholine 
receptor protein and also in autoradiographical studies to examine 
the density and distribution of receptors in intact cell membranes 
(see Dolly, 1979).
Complementary to this use of the a-toxins was the rich source 
of nicotinic acetylcholine receptors in the electric organs of 
electric fishes. The electroplaque is a highly assymmetric cell 
which receives multiple innervation on only one of its faces. The 
extent of innervation is such that the subsynaptic areas occupy up 
to 50% of the total surface of the innervated membrane in Torpedo
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marmorata. In Electrophorus electricus the innervated face is much 
more convoluted and subsynaptic areas represent only 1.4 - 2% of 
the total surface. Nevertheless both fishes provide a rich source 
of nicotinic acetylcholine receptor (Changeux, 1975).
The combination of these two factors greatly facilitated the 
characterisation and purification of the nicotinic acetylcholine 
receptor from electroplaques. In denervated vertebrate skeletal 
muscle, acetylcholine receptors have been shown to proliferate over 
the whole muscle surface (Ginetzinsky and Sharmarina, 1942; Axelsson 
and Thesleff, 1959; Miledi, 1960). This phenomenon has been ex­
ploited in the purification of the muscle receptor using the procedures 
developed from studies on the electroplaque.
The identification, purification and characterization of 
putative acetylcholine receptors from other tissue and of other 
receptors have been greatly hindered by the lack of receptor enriched 
tissue and/or specific, high affinity ligands analagous to the 
a-toxins.
Numerous neurotransmitters have been suggested in insects 
(Table 1). The list ranges from the small peptide proctolin on 
which only limited electrophysiological work has been done (Miller, 
1980), and it is not known whether it has a true neurotransmitter 
role or is a neuromodulator at the visceral neuromuscular junction, 
to acetylcholine for which there is considerable biochemical and 
electrophysiological data to suggest it as an excitatory neurotrans­
mitter in the CNS (see Sattelle, 1980 a). It must be emphasised that 
the status of the compounds cited in Table 1 as neurotransmitters 
is, in some cases, still the subject of considerable speculation 
and controversy. A number of criteria must be fulfilled before a
TABLE 1 PUTATIVE NEUROTRANSMITTERS IN INSECTS
Neurotransmitter
Acetylcholine 
GABA 
Glycine
Site of Action
Central Nervous System 
Central Nervous System 
Central Nervous System
L-Glutamate
L-Aspartate
GABA
Neuromuscular Junction 
Neuromuscular Junction 
Neuromuscular Junction
5-Hydr oxytryptamine V isceral 6c Cardiac Neuromuscular Junctions
Dopamine 4 V isceral & Cardiac Neuromuscular Junctions
Octopamine 4 Visceral & Cardiac Neuromuscular Junctions
Proctolin 4 Visceral & Cardiac Neuromuscular Junctions
see Sattelle 1980 ou 
see UsWerwood 1978 
Irving & Miller 1980 
Miller 1980
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chemical can be termed a neurotransmitter and these are (Werman, 
1966):
1. That the transmitter candidate is synthesised and 
stored in the nerve terminals.
2. That it is released from the nerve terminals by 
neural stimulation.
3. That a specific mechanism for removing the trans­
mitter candidate from the synaptic cleft exists.
4. That it mimics the action of the natural trans­
mitter at the synapse and interacts with the receptor 
at the post-synaptic membrane in the same way as the 
receptor interacts with the natural transmitter.
Having established that a compound is a strong candidate for 
being a neurotransmitter through fulfillment of the above criteria, 
the next step is to isolate and characterise its site of interaction 
on the post-synaptic membrane, the receptor. However, to ensure 
that a true physiological receptor is being studied rather than 
some non-specific binding site, again a number of criteria must be 
satisfied (Birdsall and Hulme, 1976; Creese, 1978):
A. A component of specific binding should saturate 
with increasing concentrations of the ligand, indicating 
a finite number of sites.
B. Specific binding should increase linearly with 
increasing tissue concentrations.
C. Pharmacologically effective concentrations of 
receptor-active ligands should displace the saturable 
component of binding, whereas pharmacologically effective 
concentrations of drugs with different receptor speci­
ficity should be ineffective.
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D. The saturable component of binding should be localised 
to specific regions of tissues known from pharmacological 
and physiological experiments to contain the receptor.
E. The isolated receptor molecule, when incorporated 
into a model membrane, should endow the membrane with 
the property of chemical excitability.
Of these five criteria the last one is the most difficult to 
satisfy and it is only the nicotinic acetylcholine receptor from 
the electroplaque which has been reconstituted into a lipid vesicle, 
endowing it with the required chemical excitability (Sobel et ajL.,
1980; Heidmann £t 1980; Wu and Raftery, 1981; Anholt £t a^., 1980;
Lindstrom et al., 1980 c). Only this receptor satisfies all five of 
the above criteria and so can be termed, without reservation, a 
physiological receptor.
In insects putative neurotransmitter receptors are at various 
stages of identification and characterisation. Evidence is still 
accumulating for L-glutamate as a neurotransmitter and only limited 
study of the biochemical properties of the receptor has been carried 
out. The greatest advances have been in the isolation and character­
isation of putative acetylcholine receptors from insect CNS.
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ACETYLCHOLINE RECEPTORS IN INSECT CNS
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Few species of insects have been studied and in those that 
have there are rarely both biochemical and electrophysiological 
data for the same insect. This must be borne in mind when examining 
the evidence for acetylcholine being a neurotransmitter in insect 
CNS. Similar reservations must apply to the identification of the 
acetylcholine receptor because lack of complementary data for all 
species inevitably results in new information obtained from a 
particular species being taken as the general rule until proven 
otherwise.
Acetylcholine as a Neurotransmitter in Insect CNS:
Fig. 6 is a diagramatic representation of the chemical events 
which take place at the vertebrate neuromuscular junction. The 
high concentration of many of the components of the cholinergic 
system in insect CNS strongly suggests the existence of a similar 
functional system in this tissue.
Acetylcholine, choline acetyltranferase and acetylcholine 
esterase have been found, at high concentrations, in the CNS of 
various insects (see, Colhoun 1963; Pichon, 1974). The ability of 
insect central nervous tissue to synthesise acetylcholine vitro 
has been demonstrated (Tobias £t ad., 1946; Lewis, 1953; Smallman, 
1956, 1975; Frontali, 1958; Prescott et al., 1977). Acetylcholin­
esterase has been localised, cytochemically, in areas along the 
membranes of axon branches in the neuropile of Periplaneta 
americana (the cockroach) (Smith and Treherne, 1965; Frontali et 
al., 1971; Hess, 1972) and also in the neuropile of locust meta- 
thoracic ganglia (Mandelstom, 1967). These enzymic activities 
indicate that synthesis and breakdown of acetylcholine occurs in
Chemical Events at the Vertebrate NicotinicFIG. 6
Acetylcholine Synapse
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this tissue and so in part satisfy criteria 1 and 3 (p.'^)
The release of acetylcholine from insect ganglia by pre- 
synaptic nerve stimulation has not yet been demonstrated and early 
pharmacological work indicated an insensitivity of central neurones 
to acetylcholine even when desheathed, acetylcholine having no effect 
at concentrations lower than 1.0 x 10 ^ M (Pumphrey and Rawdon-Smith, 
1937; Roeder e^ al_., 1947; Roeder, 1948; Twarog and Roeder, 1956, 1957). 
The same authors, however, noted that upon addition of the acetyl­
cholinesterase inhibitor, eserine (1 x 10  ̂M) this threshold value was 
-4lowered to 1 x 10 M. It was not until the work of Shankland £t al. 
(1971) that a threshold value for acetylcholine sensitivity was obtained 
(1 X 10 ^ M) which was more representative of a physiological concen­
tration. The lower threshold value was obtained by the authors 
considering three factors which could affect acetylcholine reaching 
its site of action and then accounting for them. Firstly, they 
allowed for diffusion of acetylcholine into the ganglion; secondly, 
they considered the possibility that endogenous acetylcholine was 
interfering with the system and so inhibited its synthesis by pre­
treatment with hemicholinium-3 (an inhibitor of choline transport) 
and finally they prevented the rapid hydrolysis of acetylcholine 
before it reached the synaptic area by pre-treatment of the tissue 
with either dichlorvos or paraoxon (potent cholinesterase inhibitors).
Such preparations were found to be highly sensitive to acetylcholine.
—  6This same threshold value of 1 x 10 M has been obtained consis­
tently using the more sophisticated sucrose-gap recording technique, 
in the presence of eserine (1 x 10  ̂M) (Callec and Sattelle, 1973; 
Sattelle et al., 1976).
The results, both from studies of enzyme activities and
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electrophysiological recordings, lent support to the suggestion 
that acetylcholine is a neurotransmitter in insect CNS and 
although all four points on p. 15 have not been satisfied, the 
implication is strongly positive.
Putative Acetylcholine Receptors in the Insect CNS
Both the electroplaque of electric fish and the post-synaptic 
membrane of vertebrate skeletal neuromuscular junctions each 
possess a homologous population of acetylcholine receptors. The 
receptors have a high affinity for nicotinic agonists and antago­
nists and little or no affinity for muscarinic ligands. Such a 
well defined system is not apparent in insect CNS. Three types of 
putative acetylcholine receptor have been suggested on the basis 
of their pharmacological specificity. They are:
1. Receptors which have an affinity for both nicotinic 
and muscarinic ligands -the mixed receptor (nmAChR).
2. Receptors which have an affinity for only mus­
carinic ligands - the muscarinic receptor (luAChR).
3. Receptors which have an affinity for only nicotinic 
ligands -the nicotinic receptor (nAChR)
(See Sattelle, 1980 a)
Controversy surrounds the status of these three suggested 
receptors and it is not known whether they exist vivo as three 
distinct receptors or are all part of the same receptor system 
which has been disrupted during tissue fractionation and subsequent 
purification procedures. Most of the evidence for the possible 
existence of these putative acetylcholine receptors has accumulated 
from radiolabelled ligand binding studies and there are little or 
no complementary electrophysiological data for the same insect.
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1. Acetylcholine Receptors with Mixed Muscarinic-nicotinic
Properties :
Putative acetylcholine receptors of mixed muscarinic-nicotinic
specificity have been reported in extracts of housefly (Musca
domestica) heads (Eldefrawi and O'Brien, 1970; Eldefrawi et al.,
1970, 1971; Cattail and Donnellan, 1972; Donnellan et al., 1975;
Mansour et al., 1977). The earliest report of cholinergic ligand
binding to extracts of insect CNS was that of Eldefrawi and O'Brien
(1970) where they showed saturable binding of the cholinergic
ligand [^H] muscarone, (Kd 2.4 x 10  ̂M; Bmax 70 nmol/g head
protein) to a 100,000 x g supernatant of an aqueous homogenate of
housefly heads. This binding was inhibited by both nicotinic
(nicotine, curare and gallamine) and muscarinic (atropine and
pilocarpine) ligands (40 - 70% inhibition at 10 ^ - 10  ̂M) and
3it was therefore concluded that [ H] muscarone was binding to an 
acetylcholine receptor of mixed nicotinic-muscarinic affinity.
The same workers went on to complement this study, by demonstrating 
binding of several additional radiolabelled cholinergic ligands to 
a similar high speed fraction. Nicotine, décaméthonium, dimethyl-d- 
tubocurarine and atropine all had binding constants in the micro­
molar range (Eldefrawi et , 1971). Furthermore, they concluded
3 3that [ H] nicotine and [ H] muscarone were binding to the same
macromolecule on the basis of their having the same number of
binding sites, the inhibitory effects of six cholinergic ligands
were the same in each case and the binding molecules for both
radiolabelled ligands were sensitive to trypsin and chymotrypsin
but not to phospholipase C (Eldefrawi ejt al., 1970).
Initial studies of Cattell and Donnellan (1972) were concerned 
with the use of chloroform-methanol to extract proteolipids from
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flyhead homogenates. In later experiments by this same group 
(Donnellan et 1975) an aqueous extract of the same preparation
was shown to have the pharmacological characteristics of both their 
own proteolipid extract and the aqueous extract of the Eldefrawi 
group. Subsequently, the chloroform-methanol extraction method was 
abandoned because of the difficulties in the manipulation of 
proteolipids. Donnellan et al. (1975) also reported two apparent
3
binding constants for [ H] acetylcholine (0.15 and 8.3 yM), and
3[ H] decamethanium (0.52 and 6.7 yM) but a-bungarotoxin, the potent 
nicotinic antagonist at the vertebrate skeletal neuromuscular 
junction, had no effect (Clarke and Donnellan, 1974). A twenty- 
five fold purification of this putative receptor with respect to
3[ H] décaméthonium binding was achieved by gel-filtration on
Sephadex G-200 (Mansour e_t ab. , 1977). This partially purified
125preparation bound only 1 pmol C I]-a-bungarotoxin/mg. protein
3compared to 1000 pmol [ H]-decamethonium/mg. protein and acetyl-
3choline displaced [ H] décaméthonium binding with an inhibition 
constant (K^) of 1 x 10  ̂M. Further purification of this prepara­
tion proved difficult in that affinity chromatography resulted in 
a 90% loss of total binding activity accompanying any increased 
purity. Nevertheless, two fast migrating protein bands which 
apparently accounted for all the binding activity were detected 
by acrylamide gel electrophoresis (Mansour et ^ . , 1977).
Jewess et al. (1975) achieved an 800-fold purification of a 
décaméthonium-binding component from fly-heads by gel filtration 
through Sepharose 6B and Sephadex G-200 columns. Although previous 
work by this group (Donnellan et al., 1975) had found an enrichment 
of cholinergic ligand binding in an 80,000 x g supernatant fraction
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of flyheads homogenised in water, the purification mentioned above 
was carried out on a solubilised (0.12 M NaCl) 80,000 - 190,000 x g 
pellet fraction. The flyheads in this instance had been homogenised 
in 0.32 M sucrose as opposed to water which suggests that the cholin­
ergic binding component is readily soluble in water but not in an 
isotonic solution.
Polyacrylamide gel electrophoresis in the presence of SDS of 
this partially purified mixed receptor, revealed two major poly­
peptide bands of Mr 83,000 and 91,000. By isoelectrofocussing in 
polyacrylamide gels, two major protein bands were observed with 
pi values of 4.7 and 4.9 and gel permeation studies attributed an 
Mr of 360,000 to the native binding protein. The native receptor 
and subunits all stained as glycoproteins and gas-liquid-chromato- 
graphy of the alditol acetate derivatives of the native receptor's 
neutral sugars (3% W/W) has demonstrated that mannose, glucose and 
galactose are the major constituents (Donnellan and Harris, 1977;
Harris et al., (1980).
The same pharmacological specificities were reported for 
this purified preparation as for both the membrane bound and sol­
uble fractions. High and low affinity binding sites were attributed 
to radiolabelled acetylcholine, décaméthonium and nicotine. 
a-Bungarotoxin again had no inhibitory effects on binding of these 
ligands. The muscarinic antagonist quinuclidinyl benzilate (QNB) 
was also reported to bind to this purified preparation, but the 
binding did not saturate at concentrations as high as 1 yM. A 
dissociation constant (K^) of 0,689 yM was reported for binding of 
this ligand (Cattell , 1980 a).
Tripathi £t (1979) have also reported purification of a
putative mixed receptor. They determined a molecular weight of
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360.000 Mr for the native receptor protein which was composed of 
two subunits Mr 82,000 and 90,000. Only one major protein band 
of pi 4.8 was obtained after isoelectrofocussing. These results 
are in general agreement with those of the Donnellan and Cattell 
group although there is a discrepancy in the size of the subunits 
and in the number of bands observed upon isoelectrofocussing. 
Tripathi et al. (1979) also reported that a-bungarotoxin had no
3effect on [ H ] décaméthonium binding.
In summary, a cholinergic binding protein of mixed nicotinic- 
muscarinic pharmacology has been purified with an Mr of 340,000 -
360.000 and two subunits of Mr S3,000 and 91,000 or 82,000 and 
90,000. The native protein has an isoelectric point of 4.8, or 
possibly exists in a monomer and a dimer form pi 4.7 and 4.9, or 
alternatively as two distinct receptors, a-Bungarotoxin had no 
effect on the binding of any of the radiolabelled ligands tested 
to either the soluble, particulate or partially purified prepara­
tion. However, rarely, especially in the early reports, was
radiolabelled a-bungarotoxin binding measured in the fraction
3which was enriched in [ H] décaméthonium binding, neither were any 
other fractions assayed for specific a-bungarotoxin binding activity,
2. Acetylcholine Receptors with Muscarinic Properties:
The potent muscarinic antagonist QNB, when radiolabelled, has 
proved to be a useful receptor probe in studies on vertebrate brain 
tissue (Yamamura and Snyder, 1974 (a), (b), (c); Yamamura et al.,
1974 (a), (b); Snyder ^  al., 1975) and on isolated brain synapto- 
somes (Yamamura and Snyder, 1974 (a)).
3C H] Quinuclidinyl benzilate binding has been demonstrated 
in fractions of fruitfly (Drosophila melanogaster) heads (Dudai and
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Ben-Barak, 1977; Dudai, 1977; Haim e;t al. , 1979) housefly heads
(Jones and Sumikawa, 1981 b) and locust (Locusta migratoria) central
ganglia (Breer, 1981). In all cases binding increased with tissue
concentration, and saturated at higher (2 nM) concentrations of
[^H] QNB, giving s of 0.7 x 10  ̂M, 0.26 x 10  ̂M and 0.77 x 
-910 M for fruitfly, housefly and locust respectively. Dissocia­
tion constants calculated from on- and off- rate constants, ranged
-9 -9from 0.08 x 10 M - 0.7 x 10 M. All three preparations also
showed a pharmacological specificity for muscarinic ligands, of
which atropine, scopalamine, pilocarpine and dexetimide were the
3most effective inhibitors of [ H] QNB binding. Acetylcholine, in 
the presence of antiacetylcholinesterases, at a concentration of
_5approximately 10 M, inhibited binding by 50% in both housefly
-4and fruitfly preparations, and 10 M acetylcholine displaced more
3than 80% of [ H] QNB binding in the locust preparation. Jones and 
Sumikawa (1981) also reported an 80% inhibition of binding by 
benzoquinonium (10 ^ M), a potent vertebrate skeletal neuromuscular 
nicotinic antagonist and lobeline (10 ^) a vertebrate ganglionic 
blocker. No such inhibition by nicotinic ligands was reported by 
the other two groups but neither group reported testing these two 
particular ligands and Jones and Sumikawa (1981) found little 
inhibition with any of the other nicotinic ligands tested. It is
3possible therefore that inhibition of C H] QNB binding by benzo­
quinonium and lobeline is a peculiarity of these two particular 
ligands. The pharmacological binding specificities, with the ex­
ception of benzoquinonium and lobeline, are indicative of a 
classical muscarinic acetylcholine receptor.
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The QNB binding component was shown to sediment between 
500 X g and 20,000 x g regardless of whether homogenisation was 
in isotonic sucrose or in buffer of low ionic strength (Haim ^  
al., 1979). Solubilisation, the first step towards purification, 
of the QNB binding component proved difficult and to date 100% 
solubilisation of binding activity has not been reported. The 
putative receptor is unstable even in isotonic media at 4°C, 
losing binding activity with a half-life of 24 hours (Dudai,
1980). Triton X-100, the detergent used to solubilise the nico­
tinic acetylcholine receptor from both vertebrate muscle (Stephenson, 
1980) and invertebrate CNS (Hall, 1980), inactivated this putative 
muscarinic receptor (Haim et al̂ . , 1979). The same authors also 
reported that 2 M NaCl released less than 20% of the binding 
activity into the supernatant from a high-speed centrifugation.
When this apparently solubilised fraction was passed through a 
Sepharose 4B column, binding activity was eluted by 2 M NaCl in 
the void volume, indicating the presence of large aggregates or 
possibly small membrane fragments.
It would appear therefore that before the putative muscarinic 
acetylcholine receptor can be purified and fully characterised, 
further attention must be given to tissue solubilisation procedures
3that ensure retention of the [ H] QNB binding activity.
3. Acetylcholine Receptors with Nicotinic Properties:
As stated previously, early studies on the binding of radio­
labelled nicotinic cholinergic ligands to insect CNS preparations
showed no susceptibility to a-bungarotoxin. It was not until Hall
125and Teng (1975) demonstrated by autoradiography that [ I]-a-
bungarotoxin bound in a non-uniform way to frozen sections of
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fruitfly CNS, that the early reports that the a-bungarotoxin 
insensitive cholinergic binding component was the only acetyl­
choline receptor in insects, were reassessed.
Following the autoradiographical demonstration of
125[ l]-a-bungarotoxin binding, radiolabelled a-bungarotoxin was
shown to bind specifically and saturably to particulate fractions
from fruitfly heads (Schmidt-Nielsen et ^ . , 1977; Rudloff, 1978;
Dudai, 1977). Binding increased linearly with tissue concentration
-9 ,and saturated with a of 1.1 - 1.8 x 10 M. Dudai (1980) cal-
-9culated a of 0.6 x 10 M from measurements of the on- and off-
rate constants. The same author obtained a Hill coefficient of 
1250.96 for [ I]-a-bungarotoxin binding, indicating no coopérâtivity
and a Hill coefficient of 0.5 for acetylcholine binding which could
be an indication of either negative cooperativity or a heterogeneity
125of agonist binding sites. The concentration of [ I]-a-bungaro­
toxin binding sites (B ) ranged from 0.0075 to 0.8 pmol/mg.max
protein. Drug specificity was very similar to that of the classical
125nicotinic acetylcholine receptor in that [ I]-a-bungarotoxin 
specific binding was strongly inhibited by nicotinic ligands (nico­
tine and d-tubocurarine) and muscarinic ligands (atropine and 
pilocarpine) had little effect. Décaméthonium, which has been used 
in identification of the putative mixed receptor, had little effect.
Similar nicotinic acetylcholine receptor properties have been 
reported for fractions of housefly heads (Eldefrawi and Eldefrawi, 
1980; Harris e^ al., 1979; Cattell et al., 1980 a, b) and for 
locust central ganglia (Breer, 1981 ). However, Cattell et al.
(1980 b) reported that when housefly heads were homogenised in 
0.32 M sucrose the a “bungarotoxin binding component was enriched
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in the pellet fraction of an 80,000 x g centrifugation but the 
activity was found in the supernatant if the heads were homogenised 
in water. The same group (March e^ al. , 1980 ) have subsequently 
reported an enrichment of binding in the supernatant fraction from 
centrifugations at 20,000 x g and 150,000 x g, after homogenisa­
tion of heads in buffered sucrose. This work will be dealt with 
in more detail in the discussion (p.156).
In order to purify and further characterise the putative 
nicotinic receptor it must be obtained in a soluble form. The 
a-bungarotoxin binding component from housefly heads in the pre­
paration of March et £l. , (1980 ) seems to be unusual in this respect 
because all other workers in the field have had to solubilise the 
membrane-bound receptor with detergent. Schmidt-Nielsen et al. 
(1977) reported a preparation of fruitfly heads homogenised in 
buffer containing the non-ionic detergent Triton X-100 (1% ^/v). 
Binding to this detergent extract showed similar characteristics 
and pharmacological specificities to the membrane-bound receptor 
but no data for total binding activities were reported. On the 
other hand, Dudai (1978) reported difficulties in solubilising the 
a-bungarotoxin binding component with Triton X-100 (1% ^/v) and 
achieved only partial release of binding activity into a 100,000 x g 
supernatant after treatment with a combination of NaCl (0.12 M) in 
Triton X-100 (1% ^/v). Furthermore, this apparently solubilised 
Triton-NaCl extract sedimented after further centrifugation at
200,000 X g for 2 hours and Dudai concluded that most of the 
material may therefore, represent small membrane fragments or 
aggregates. Treatment of the particulate a-bungarotoxin binding 
component of fruitfly heads with the anionic detergent deoxycholate
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(1% ^/v) at a pH of 9.0 was reported to give a more efficient
extraction than Triton X-100 (1% ^/v) at the same pH (Jimenez
and Rudloff, 1980). The deoxycholate extract was included in a
Sepharose 6B column vÆiereas the Triton extract was excluded and
appeared in the void volume.
Despite the apparent difficulty in solubilisation of the
particulate binding component, a scheme has been proposed which
125gives up to a 1200 fold purification of [ I]-a-bungarotoxin 
binding activity (Gepner, 1979; Hall, 1980). Triton X-100 (1%) 
in combination with NaCl (O.l M) was employed in the solubilisa­
tion procedure but again no recovery of total binding activity 
is given and the criterion for solubility was release into a
30,000 X g supernatant. The "solubilised" fraction was then 
purified by adsorption onto an affinity column consisting of 
a-cobratoxin covalently linked to Sepharose 4B, followed by 
elution with carbamyl-choline (0.2 M). The specific binding
activity was 60-1100 pmol/mg protein and a dissociation constant 
-10of 1.5 X 10 M was calculated from the on- and off- rate constants. 
Pharmacological studies showed a specificity for nicotinic ligands 
similar to that of the membrane-bound receptor. Molecular weights 
estimated were 500,000 Mr for the receptor-toxin complex from gel 
filtration chromatography (without accounting for contribution of 
bound detergent to the Stokes' radius) and 300,000 from sedimentation 
in a discontinuous sucrose density gradient = 11.5).
125Localisation of [ I]-g-Bungarotoxin Binding:
For the three putative receptors, the nicotinic, the muscarinic 
and the mixed, results of binding studies satisfy the first three
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criteria (p. 15 ) for defining a physiological receptor, i.e. binding 
is saturable and specific, it increases linearly with tissue con­
centration and shows pharmacological specificity.
Localisation of binding activity by autoradiographic tech-
125niques so far has only been demonstrated for [ I]-a-bungarotoxin
binding to frozen sections of the central ganglia from fruitfly,
moth (Manduca sexta) and cockroach (Periplaneta americana).
Hall and Teng (1975) first demonstrated a non-uniform dis- 
125tribution of [ l]-a-bungarotoxin binding sites in frozen sections
of fruitfly. Binding was confined to neural tissue in the head
125and thorax. Attempts to introduce [ l]-a-bungarotoxin into whole 
brain tissue were unsuccessful (Rudloff, 1978), consequently all 
subsequent work has been carried out on frozen sections.
Three groups of workers independently concluded from auto- 
radiographical studies that toxin binding in fruitflies was confined 
to synaptic areas of the neuropile and was absent from nerve tracts 
and cell bodies in the CNS (Schmidt-Nielsen e^ ̂ . , 1977; Dudai and 
Amsterdam, 1977; Rudloff, 1978). This localisation of toxin 
binding to neuropile regions was later confirmed in the moth 
(Hildebrand ^  al., 1979). However, Sattelle ^  al•’ (1981) working 
on the 6th abdominal ganglion of the cockroach, observed not only 
dense binding in the neuropile region as expected but also densely 
concentrated toxin-binding sites in the periphery of the ganglion, 
a non-synaptic region occupied by glial cells and neuronal cell 
bodies.
125In all cases binding of [ I ]-a-bungarotoxin, as shown by 
autoradiographical studies, has proved to be pharmacologically 
specific. In the fruitfly, toxin binding was blocked by preincubation
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-7 -4with unlabelled toxin (1 x 10 M) or d-tubocurarine (1 x 10 M),
whereas atropine (1 x 10 ^ M) reduced but did not eliminate binding
(Schmidt-Nielsen et al., 1977; Rudloff, 1978). Toxin binding was
also blocked by nicotine (1 x 10  ̂M) (Dudai and Amsterdam, 1977).
In the moth (Hildebrand et al., 1979) binding was blocked by
"3 3acetylcholine (1 x 10 M; in the presence of 10 neostigmine),
d-tubocurarine (1 x 10 ^ M) but QNB (1 x 10  ̂M) reduced binding
only slightly.
All the data so far, with the exception of the report of 
Sattelle e^ aT. (1981) of binding to non-synaptic neural regions, 
provide evidence in support of a synaptic localisation of the 
a-bungarotoxin binding component.
The Physiological Role of the Putative Acetylcholine Receptors:
For a putative receptor to be assigned a physiological role, 
biochemical binding data need to be supported by electrophysio- 
logical studies in the same tissue, of the same species. Unfortu­
nately, in only one preparation have there been reports of both 
approaches. Most biochemical binding data have accumulated from 
studies on insect head ganglia, a tissue which has yet to be 
extensively investigated electrophysiologically. Conversely, 
detailed electrophysiological data have been presented from work 
carried out on cereal afferent neurones and giant interneurones 
in the sixth abdominal ganglion of the cockroach, for which there 
is only limited complementary ligand binding data. Results of 
binding experiments on preparations of cockroach abdominal nerve
cords are similar to those obtained for preparations of insect
125head ganglia, in that an [ I]-a-bungarotoxin binding component
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has been identified with the specificity expected of a nicotinic
-9acetylcholine receptor. A of 1.1 x 10 M was reported for the 
125saturable C I]-a-bungarotoxin binding, a value which compares 
favourably with the concentration of a-bungarotoxin (nanomolar 
range) which completely blocks transmission in this system 
(Sattelle, 1978, 1980 b; Sattelle al., 1980).
Furthermore, when the concentrations of various cholinergic ligands
125required to inhibit [ I]-a-bungarotoxin binding by 50% are 
compared to concentrations estimated to produce half-maximal 
physiological actions at cercal-afferent, giant interneurone 
synapses there is a close correspondence in pharmacological 
specificity, again suggesting the presence of a functional nico­
tinic acetylcholine receptor (Sattelle, 1978; 1980 a, b).
A physiological role for the other two putative acetyl­
choline receptors of insects has yet to be demonstrated. It seems 
unlikely that these putative receptors contribute substantially 
to acetylcholine-mediated transmission at cercal-afferent, giant 
interneurone synapses since both the muscarinic receptor and the 
mixed receptor are unaffected by a-bungarotoxin in the micromolar 
range. Nevertheless, some support for the existence of a-bungaro­
toxin- insensitive acetylcholine receptors on certain insect 
neurones has emerged from recent electrophysiological experiments. 
For example, dorsal unpaired median (DUM) neurone cell bodies of 
the grasshopper (Schistocerca nitens) and cockroach metathoracic
ganglia are sensitive to acetylcholine but the resulting depolarisa-
-6tion is not blocked by 1 x 10 M a-bungarotoxin (Goodman and 
Spitzer, 1979; Sattelle £t al., 1980). However, the pharmaco­
logical specificity of these acetylcholine responses has not been
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detailed and it should be noted that these experiments were carried 
out on cell bodies which, in insects, are devoid of synapses and 
hence the functional role of such receptors is unclear.
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L-GLUTAMATE RECEPTORS AT INSECT 
NEUROMUSCULAR JUNCTIONS
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In contrast to the putative cholinergic neurotransmission 
system in insect CNS, evidence for L-glutamate being a neuro­
transmitter at insect neuromuscular junctions and the characterisa­
tion of the putative receptors is derived almost entirely from 
electrophysiological studies. The electrophysiological techniques 
now used are so sophisticated that not only can the change in ion 
permeability and hence conductance of the post-synaptic membrane 
be measured, but also the change in conductance and the lifetime 
of a single open channel can be determined after either neural 
stimulation or addition of the putative transmitter or its agonists.
Evidence for L-Glutamate as a Neurotransmitter in Insects :
The first invertebrate muscle on which L-glutamate was shown 
to have an excitatory effect was that of the crayfish (Procambarus 
clarkii) (Robbins, 1959; Van Harreveld and Mendelson, 1959). 
Following these reports a similar effect was reported for muscles 
from the cockroach (Kerkut e_t ^ . ,  1965 a) and locust (Usherwood 
and Grundfest, 1965). These studies led to the tentative suggestion 
that L-glutamate was the excitatory neurotransmitter in these 
tissues. The suggestion was not readily accepted, one of the main 
objections being the central role of L-glutamate in intermediary 
metabolism and its apparent high concentration in insect haemolymph, 
which was believed to be in direct contact with neuromuscular 
synaptic receptors. A number of explanations have been proposed 
that argue against the elimination of L-glutamate as a neurotrans­
mitter candidate solely on these grounds.
The concentration of L-glutamate has been reported to be as 
high as millimolar in the haemolymph of some insects (Chen a_l., 
1968), a concentration at which an excitatory response and
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subsequent desensitisation would be expected if applied to a 
muscle preparation. A number of workers noticed no such effects 
following the application of fresh haemolymph to a muscle prepara­
tion (Usherwood and Machili, 1968; Miller et a^., 1973) but if the 
haemolymph was stored at room temperature it developed pharmaco­
logical activity equivalent to a solution of L-glutamate having
-4a concentration of 1 x 10 M (Miller et al., 1973). These 
authors suggested that L-glutamate was "bound" in some way in 
fresh haemolymph and on exposure of the haemolymph to air, was 
slowly released. This was confirmed by Clements and May (1974) 
when they reported that 25% of blood L-glutamate was bound to 
divalent cations, but unlike Miller £t al. (1973), they found an 
excitatory response in 50% of the cases tested with fresh haemo­
lymph . They suggested the presence of a physical barrier to the 
entry of haemolymph to the synapse. The barrier, which may be con­
stituted by the perineurium,was probably destroyed on dissection 
and hence isolated muscle would show a quite different response to 
exogenous glutamate from that seen with the muscle situ.
However, Irving and Osborne (1976), dismiss the problem of high 
L-glutamate in the haemolymph by suggesting that in fact all con­
centrations previously quoted were gross overestimates. Irving 
and co-workers claim that the techniques they employ represent a 
major improvement in the analysis of insect blood and that the data 
of previous investigators were greatly affected by the conversion, 
in vivo and vitro, of L-glutamine to L-glutamate. This would 
also account for the time-dependent gain in the ability of 
haemolymph to elicit a pharmacological response, an effect that 
Irving and Osborne (1976) also noted.
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If the criteria for defining a chemical as a neurotransmitter 
(p. 15) are considered, the evidence for synthesis, storage and 
release of L-glutamate in and from the nerve terminals is not 
conclusive. Similarly there is only little evidence for the presence 
of any removal mechanism in the region of the post-synaptic receptor.
Glutamate has a central role in many aspects of metabolism 
and is a significant constituent of most tissues, therefore the 
fact that it is present, along with many of its metabolising 
enzymes, in insect nervous tissue does not constitute strong evi­
dence for a potential transmitter role. Clarification of this 
point would be greatly assisted if isolated synaptosomes could be 
prepared from insect muscle.
Synaptosomes are isolated nerve-ending complexes and are 
readily prepared from mammalian CNS (Whittaker, 1965; Whittaker 
and Barker, 1972; De Robertis, 1967). Precise conditions of 
homogenisation of the nervous tissue appear to tear the pre-synap- 
tic apparatus together with the attached thickened post-synaptic 
membrane from the post-synaptic cell. The nerve terminal is broken 
from its axon and the membrane rapidly reseals resulting in a 
discrete osmotically sensitive entity which is the synaptosome. 
Electronmicroscopy shows synaptosomes to retain the morphologi­
cal components of the pre-synaptic terminal (Gray and Whittaker,
1962) and they exhibit the metabolic capabilities of more intact 
tissue preparations (see Bradford, 1972); synaptosomes respire 
linearly when incubated with an exogenous substrate, produce ATP, 
phosphocreatine and lactate and maintain ionic gradients across 
their membranes. These properties justify Whittaker's (1969) 
designation of synaptosomes as 'miniature non-nucleated cells' 
and provide evidence that synaptosomes behave as might be
— 39 —
expected for an intact nerve terminal. Therefore, in mammalian 
systems, synaptosomes have been invaluable tools in substantiating 
evidence for a particular ligand being a neurotransmitter; in 
studies on the uptake and the release of the putative neurotrans­
mitter and in characterising the pharmacology of these systems.
The enzymes responsible for synthesis and degradation of putative 
neurotransmitters have also been shown to be located in synapto­
some preparations. Indeed, most of our understanding of the bio­
chemical organisation of the nerve terminal has come from studies 
on synaptosomes. Moreover, synaptosomes can be osmotically dis­
rupted so that purified fragments of synaptic membranes are obtained, 
thus providing an ideal preparation for receptor-ligand binding 
studies without interference from the other components of the nerve 
terminal.
In reports which have attempted such an isolation of insect 
neuromuscular synaptosomes (Donnellan et al., 1974; Briley, 1981) 
problems of fragility and contamination with vesiculated sacroplasmic 
reticulum and with fragments of disrupted mitochondria have seemingly 
precluded the isolation of a pure synaptosomal fraction. Thus in 
these studies it has not been possible to assign a neurotransmitter 
role to the glutamate measured in any of the fractions prepared. The 
same problems apply to the enzymes responsible for the synthesis of 
L-glutamate, in that their presence in any fraction could equally 
imply synthesis of glutamate as a metabolite or as a neurotransmitter, 
If isolated insect neuromuscular synaptosomes were available, studies 
on the uptake, synthesis, storage and release of L-glutamate using 
such preparations would greatly clarify the neurotransmitter status 
of this amino acid.
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The release of L-glutamate from intact nerve-muscle prepara­
tions upon neural stimulation has not been conclusively demonstrated. 
Early studies (Kerkut et a^., 1965 (b); Usherwood et _al., 1968) 
were criticised mainly because of the large quantities of L-glutamate 
apparently released; values which were too high (>1% of the total 
weight of the muscle preparation) to be accounted for solely by 
release of a neurotransmitter. Nevertheless, Usherwood and his 
co-workers (1968), did demonstrate that this rather high release 
of L-glutamate from a locust retractor unguis nerve-muscle prepara­
tion was proportional to neural stimulation and was Ca"^ dependent; 
but in a later attempt to repeat this work Daoud and Miller (1976) 
could find no correlation between neural stimulation and release 
of L-glutamate. All of these studies measured release of L-glutamate 
into perfusates of whole muscle preparations and therefore it is 
possible that a proportion of the L-glutamate measured was due to 
leaching from non-synaptic regions which could mask any neurally- 
promoted release of the amino acid. Recently,Takeuchi et al.
(1980) demonstrated the release of picomolar amounts of L-glutamate 
from a thoroughly washed crayfish muscle preparation and the 
release was proportional to stimulation. The release was shown
CLonce ^
to drop significantly upon the reduction of Ca ^  in the bathing
medium. Briley (1981) has demonstrated a k"*” stimulated release 
3of H -L-glutamate from pre-loaded membrane vesicles prepared 
from locust muscle but the release was not Ca"^ dependent.
A mechanism for removal of L-glutamate from the synaptic 
cleft after interaction with the post-synaptic receptor has not 
yet been delineated. Unlike the enzymic inactivation of acetyl-
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choline by acetylcholinesterase in cholinergic systems (Rang, 1975) 
there is no evidence for enzymic removal of L-glutamate at the 
insect neuromuscular junction (McDonald, 1972; Dowson and Usherwood,
1973). Two possible alternatives have been suggested. The first, 
a rapid diffusion of the transmitter from the synaptic cleft, bas 
been shown to be adequate on theoretical grounds (Eccles and Jaeger, 
1958) but the suggestion has not been subjected to experimental 
verification. The second possibility is that there is a high- 
affinity uptake system for L-glutamate in the synaptic region. An 
enhanced uptake of labelled L-glutamate by a stimulated intact 
nerve muscle preparation has been demonstrated autoradiographically 
(Faeder and Salpeter, 1970; Faeder et al., 1974) at cockroach myo­
neural junctions. Uptake was into tracheole cells, sheath cells, 
(especially in the junctional region) and into the post-synaptic 
muscle region.
However, autoradiographical studies cannot be taken as con­
clusive. They need to be complemented by biochemical investigations 
on sub-cellular preparations to localise the sites of high affinity 
uptake systems for L-glutamate. Briley (1981) has demonstrated 
both high and low affinity uptake of L-glutamate into a vesi­
culated membrane preparation from locust muscle. The high affinity 
system showed a high Na"̂  dependence whereas the low affinity system 
was relatively independent of Na"*”.
The most convincing evidence for L-glutamate being the 
excitatory neurotransmitter at the insect neuromuscular junction 
lies in the numerous electrophysiological demonstrations that it 
interacts with and elicits the same response from the post-synaptic 
membrane as the natural transmitter (see Gerschenfeld, 1973;
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Usherwood and Cull-Candy, 1975; Anwyl, 1975; Usherwood, 1978 b).
The most recent and probably the most compelling evidence of this 
type comes from investigations of glutamate currents and excitatory 
post-synaptic currents (EPSCs) in voltage-clamped locust muscle 
fibres (Anwyl and Usherwood, 1974 a; b; Anwyl, 1977 a; b) and from 
measurements of membrane voltage and current noise generated by 
application of glutamate to locust muscle fibres (Anderson et al., 
1976; 1977).
When a neurotransmitter interacts with its receptor on the 
post-synaptic membrane the result is the opening of a channel or 
channels which allows the passage of particular ions down their 
electrochemical gradient. This conductance of ions gives rise to 
an electrical current which is dependent on the particular ion 
channels which have been opened and hence reflects the specificity 
of the neurotransmitter. That is, one neurotransmitter may open 
channels for Cl ions whereas another neurotransmitter opens 
channels for Na"̂  ions, the post-synaptic current measured in each 
case will be different and will be characteristic of the ion 
channels associated with the particular neurotransmitter.
Recent studies (Anwyl and Ushqrwood, 1974 a, b; 1975 a, b ; 
Anwyl, 1977 a, b) have shown that the EPSCs measured on application 
of glutamate to voltage-clamped locust muscle, are the same as the 
EPSCs measured after neural stimulation. This strongly suggests 
that glutamate and the natural transmitter are opening the same 
ion channels.
Further encouraging evidence supporting the suggestion that 
L-glutamate is the natural transmitter, derives from studies of 
transmitter noise, a phenomenon first described by Katz and Miledi 
(1972). When an agonist is applied to a synapse the primary event
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observed is a change of potential across the post-synaptic membrane 
Accompanying this change are minute fluctuations in conductance. 
These fluctuations form the basis of transmitter noise and arise 
from random variations in the collision rate between agonist and 
receptor molecules and hence in the opening and closing of the ion 
channels. Similarly, when a nerve is at rest spontaneous minia­
ture excitatory post-synaptic potentials (min EPSPs) are still 
produced by leakage of transmitter. The amplitude of the min 
EPSPs are seen to be discrete multiples of the smallest min EPSP 
recorded, which is taken to represent the opening of a single 
channel. Thus the larger min EPSPs correspond to two or more 
channels opening simultaneously. Measurement of transmitter noise 
can therefore quantify the number, lifetime and conductance of 
channels involved in a min EPSP.
Miniature EPSPs can be produced by iontophoretic application 
of agonists and the lifetime and conductance of a single channel 
are specific for the applied drug. Anderson £t £l. (1976; 1978) 
working with the extensor tibia muscle of the locust have reported 
similar results for the lifetime of channels opened by the natural 
transmitter and iontophoretically applied L-glutamate, a strong 
indication that the two are identical. Application of quisqualic 
acid, a glutamate agonist, gave a channel lifetime 2.2 times longer 
than that associated with L-glutamate (Anderson e£ al., 1978) thus 
exemplifying the dependence of the specificity of the open ion 
channel's characteristics on the ligand applied.
Junctional and Extrajunctional L-Glutamate Receptors:
Extrajunctional receptors for L-glutamate have been found on 
locust leg muscle fibres (Lea and Usherwood, 1973; Usherwood and
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Cull-Candy, 1975; Cull-Candy and Usherwood, 1973; Cull-Candy,
1976 a). Both junctional and extrajunctional receptors display 
heterogeneity in terms of their pharmacological properties and, 
to a lesser extent, in terms of the ionophores that they gate.
Recently, reports have suggested the co-existence of three 
pharmacologically distinct sub-populations of L-glutamate receptors 
on locust muscle post-synaptic membranes (Clark et aL., 1979 a; 
Oration £t al., 1979). This distinction results from their pre­
ference for either DL-ibotenate or L-aspartate or neither. The 
depolarisations arising from application of these two ligands 
cannot be accounted for by solely a pre-synaptic action because 
the same depolarisations were recorded on muscle which had been 
denervated for 18 days, after which time the axon terminal has 
degenerated (Usherwood, 1963; Rees and Usherwood, 1972;
Usherwood, 1973).
The first sub-population of junctional glutamate receptors 
is activated by DL-ibotenate and therefore is assumed to prefer 
L-glutamate in its fully extended form (Fig. 7). The second sub­
population has a high affinity for L-aspartate and therefore 
appears to prefer L-glutamate in its fully folded conformation. 
Finally, the last sub-population and the largest, is activated by 
neither DL-ibotenate nor L-aspartate and therefore seemingly 
prefers L-glutamate in its partially folded conformation.
Questions yet to be answered are whether or not all three sub­
populations co-exist at all insect excitatory neuromuscular 
junctions, whether they gate the same ionophores and whether all 
three contribute to the EPSC.
Extrajunctional L-glutamate receptors can be divided into
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two pharmacologically and physiologically distinct populations.
One population, D-receptors, is very similar to the glutamate
H“ “f"junctional receptor in that it gates ionophores for Na , K and 
possibly Ca"^ and the two receptors have identical reversal currents 
(Clark et a_l., 1979 b). It has not yet been established whether the 
D-receptor population is pharmacologically homogeneous, although 
a sensitivity to quisqualate and not to DL-ibotenate has been re­
ported (Usherwood, 1978). The second population of extrajunctional 
receptors, H-receptors (Mathers and Usherwood, 1978) gates for Cl 
ions and unlike D-receptors, the H-receptors are insensitive to 
quisqualate but sensitive to DL-ibotenate (Usherwood, 1978a). Both 
receptor population-densities are normally quite low, relative to 
the junctional receptors and upon denervation or local injury only 
the D-receptor population has been shown to proliferate (Cull- 
Candy, 1975; Usherwood, 1969; Mathers and Usherwood, 1978). A 
functional role has yet to be attributed to these extrajunctional 
receptors.
The Pharmacology of L-Glutamate Receptors:
To date no specific highly potent agonist or antagonist for 
L-glutamate has been reported. Kainate, quisqualate, DL-ibotenate 
and L-aspartate are only very weak agonists, in comparison to 
L-glutamate, in both vertebrate CNS and at the invertebrate neuro­
muscular junction. The search for potent antagonists of L-glutamate 
has been mainly concerned with the effects of analogues of glutamate 
and aspartate on mammalian CNS preparations.
From electrophysiological studies putative L-glutamate 
receptors in mammalian CNS have been divided into three receptor 
populations on the basis of the effects of selective antagonists
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on responses to a range of L-glutamate agonists (Figs. 8 and 9) (see, 
Davies e^ al̂ ., 1980). These three receptor populations are: 
firstly, those that are activated by N-methyl-D-aspartate (NMDA) 
and are selectively blocked by a variety of antagonists, the most 
potent of which is 2-amino-5-phosphonvalerate (2 APV); secondly, 
quisqualate-induced responses which are selectively blocked by 
L-glutamic acid diethyl ester (GDEE) and finally receptors which 
are activated by kainate. The latter receptor population is not 
selectively inhibited by any one antagonist but can be distinguished 
from quisqualate receptors by y-D-glutamylglycine (yDGG) but yDGG 
also inhibits NMDA responses. All of these antagonists together 
with 2-amino-5-phosphonobutyric acid (2 APB ) and cis-2,3-piperidine 
dicarboxcyclic acid (cis-2,3-PDA) (Fig. S ) block L-glutamate 
induced responses with varying degrees of discrimination. However, 
there is a poor correspondence between conclusions drawn from 
electrophysiological studies and conclusions drawn from binding 
studies and often the pharmacology deduced from binding studies
3is conflicting. [ H] Kainate has been shown to bind with high 
affinity to rat brain membrane fractions. Quisqualate and L-gluta- 
mate also bind with a high and a moderate affinity respectively 
but neither ibotenate nor NMDA bind at all (Simon et aL., 1976; 
Johnston et al., 1979). Conversely, Snodgrass (1979) has reported
3that [ H] NMDA binds with high affinity to cerebellar membranes 
of rat and mouse brain, with an inhibition pattern of binding con­
sistent with the results of electrophysiological studies. The
3number of [ H] L-glutamate binding sites exceeds those for kainate 
or NMDA by ten-fold or more (Simon ejt £l, 1976; Snodgrass, 1979; 
Foster and Roberts, 1978) and in general these sites appear to
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resemble those classified on the basis of electrophysiological 
experiments as quisqualate receptors, in that neither kainate nor
3NMDA inhibited [ HI L-glutamate binding to cerebellar membranes, 
whereas quisqualate was almost as effective as L-glutamate itself.
On the other hand, the potent quisqualate antagonist GDEE, as 
observed from electrophysiological studies, inhibited binding only 
weakly (Foster and Roberts, 1978).
The results from both electrophysiological studies and 
binding studies are interesting and encouraging in that further 
investigation of a wider range of glutamate analogues may bring 
to light a potent antagonist of this putative neurotransmitter, 
which may also be effective at the insect neuromuscular junction. 
Moreover, the interaction of the antagonists with various agonists 
of L-glutamate may enable distinctions to be made between different 
populations of L-glutamate receptors and may permit the elucidation 
of the physiological role of such receptors.
Very few of these putative antagonists have been examined in 
insect systems. Cull-Candy al. (1976) reported antagonism by 
iontophoretically applied DL-2 APB of an L-glutamate-induced response 
at the locust neuromuscular junction. However, when DL-2 APB was 
bath-applied it had no effect even at very high concentrations
-4(5 X 10 M). The authors proposed that these observed differences 
in effectiveness may be more apparent than real and may only reflect 
a difference in the concentration of drug reaching the post-synaptic 
receptors. In binding studies with proteolipids isolated from 
locust muscle (Cull-Candy e^ al., 1976) DL-2 APB was shown to 
inhibit L-glutamate binding although the inhibition constant 
(K^; 65 yM) indicates a relatively low affinity for the receptor.
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Unfortunately, no equivalent of the potent antagonist, 
a-bungarotoxin, at the vertebrate skeletal neuromuscular junction 
has yet been found for insect neuromuscular junctions. More effort 
is now being put into studies on the effect of natural toxins and 
venoms on insect nerve-muscle transmission (see, Leake and Walker,
1980).
The most interesting natural venom under investigation at 
the moment is that of the digger wasp, PhiIanthus triangulum. The 
female wasp lays its eggs on honeybee workers which it has para­
lysed by stinging. The venom causes paralysis apparently by 
blocking the neuromuscular system at the periphery (Rathmeyer,
1962) and subsequent experiments on the locust have yielded no 
evidence for any effects on axonal conduction or muscular contract­
ion (Piek £t a^., 1971). The venom appears to have a complex mode 
of action at the locust neuromuscular synapse and has been shown 
to contain at least three active compounds of low molecular weight 
(Piek and Spanjer, 1978). At least one pre-synaptic action has 
been attributed to the venom, as judged by its effect on the fre­
quency of miniature EPSPs, at relatively low concentrations (Piek 
and Spanjer, 1978). A post-synaptic action of the venom is also 
suggested by the reduction in glutamate-induced and neurally-evoked 
contractions when applied to the retractor unguis muscle of the 
locust (May and Piek, 1979). The authors propose that the venom 
binds to the glutamate ion-channel in the open conformation, as 
bath-applied glutamate potentials are blocked non-competitively, 
indicating a site of action that is different from the receptor 
site. The complexity of the mode of action of the digger wasp 
venom may be elucidated by analysis of the specific actions of
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the three active components (Piek and Spanjer, 1978) and thus dis­
tinction between the relative contributions of pre- and post- 
synaptic action to the neuromuscular block may ensue.
Biochemistry of L-Glutamate Receptors
Biochemical studies on L-glutamate receptors on insect muscle 
lie far behind electrophysiological studies. Biochemical identifi­
cation and characterisation of a putative receptor usually involve 
radiolabelled-ligand binding studies, using a ligand which has a 
high affinity and specificity for the receptor. No such ligand is 
available for the putative L-glutamate receptor and workers have 
had to resort to using the radiolabelled putative transmitter in 
such studies. This poses problems in that the off-rate is likely 
to be quite high and more importantly the assessment of the speci­
ficity of binding may be difficult (See discussion p.104).
First reports of specific L-glutamate binding receptorswere 
made adopting the procedures of De Robertis (1975) for extracting 
putative receptors as proteolipids. Two of the isolated proteo­
lipids exhibited specific binding of L-glutamate with 's of 
8 yM and 50 yM (Lunt, 1973; James ejt al., 1977). Binding was also 
shown to increase with tissue concentration and the proteolipid 
with the higher affinity for L-glutamate also showed the pharmaco­
logical specificity expected for an L-glutamate receptor (James e_t 
al.., 1977).
However, as stated previously, working with proteolipids 
presents many problems, not only in the measurement of binding but 
also in the further characterisation of the binding macromolecule. 
In general the techniques that are used for the physiochemical 
characterisation of proteins are applicable only to those proteins
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that are readily soluble in aqueous systems. Therefore, as proteo­
lipids are, by definition, soluble only in chloroform-methanol 
mixtures the conventional techniques cannot easily be used to 
determine the physical parameters of the proteolipid receptors. 
Because of these considerations, attention has turned to measure­
ment of glutamate binding to intact membrane fragments prepared 
from insect muscle.
Specific binding of L-glutamate to a single set of binding 
sites, with a of 0.5 yM, was reported for a whole muscle pre­
paration from locust solubilised in deoxycholate (Lunt, 1973).
Later studies were carried out on a sub-fraction of locust muscle, 
using ultrafiltration (Donnellan et al., 1975) to separate bound 
from free L-glutamate. As with the isolated proteolipids (James 
^  a^. , 1977) two populations of specific binding sites were rep­
orted which differed in their dependence on Na^ (James e^ a^., 1977) 
One site was Na"*” independent, had a of 0.53 yM and a B max of 
25 pmol/mg of protein. The other site was dependent on Na^ and 
had a lower affinity for L-glutamate, with a of 21.6 yM and 
a B max of 175 pmol/mg of protein. Pharmacological specificity 
of these two sites, using putative agonists and antagonists sug­
gested a receptor-like function for the binding site of higher 
affinity whereas the Na^ independent lower affinity binding site 
showed some characteristics of an uptake system. However, these 
early membrane-fragment binding studies are open to criticism in 
that only D-glutamate was used to account for non-specific binding.
In an impure preparation it is inevitable that a proportion 
of the L-glutamate binding measured will be to non-neuroreceptor 
binding sites (see discussion, p.105). D-Glutamate, in excess.
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was used on the premise that as it is physiologically inactive but
has the same structure as the L-isomer, it will occupy only the
non-specific glutamate binding sites. However, as very little is
known about the specific interactions of L-glutamate with its
receptor at the molecular level, it is questionable whether or not
D-glutamate occupies all of the non-specific binding sites or if
indeed it is totally inert with respect to L-glutamate specific
binding (see Discussion, p. 77). In studies on mammalian brain
the method of "unlabelled ligand excess" is now widely used in the
determination of the specific L-glutamate binding component. The
method is based on the assumption that if the specific radioactivity
of the radiolabelled ligand is reduced by addition of a large excess
of unlabelled ligand, then specific binding will become insignificant
whereas non-specific binding will be essentially unchanged. The
assumption is rationalised algebraically by Turner (1980) and 
3specific [ H] L-glutamate binding is defined as the total binding 
minus the amount bound in an excess of unlabelled L-glutamate (see. 
Discussion, p.104).
Using this method to account for non-specific binding,
Cleworth e£ al. (1980) reported two specific binding sites for 
L-glutamate in a subfraction of locust femur muscle. One saturated 
rapidly in 15 minutes and was independent of Na^ and the binding 
to the other was linear over a period of one hour and was dependent 
on the presence of Na"*". The data presented in this report were in­
sufficient to estimate 's or B max's for either binding site.
There has been a considerable amount of work done on the 
binding of L-glutamate to putative receptors in mammalian brain 
and rather more progress has been made in this area than in the
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insect studies. However, the same problems of lack of a diagnostic 
glutamatergic ligand and the ubiquitous distribution of the amino 
acid are pertinent. Furthermore, early binding studies to mammalian 
brain were limited with respect to the concentration range of ligand 
which could be investigated because only low specific activity 
[ -L-glutamate was available.
Bearing these considerations in mind, first reported binding 
sites for L-glutamate in this tissue were of rather low affinities 
with 's in the micromolar range (Roberts, 1974; Michaelis et al.,
1974). Roberts also noted a marked difference in glutamate binding 
in the presence and absence of Na^. De Robertis et al. (1976) had 
similar problems of a restricted concentration range but demonstrated 
binding to three proteolipids isolated from whole rat brain with 
Kjj's of 0.3 yM, 5 yM and 55 yM and corresponding B max's of 0.53,
32 and 166 nmol/mg protein. The Na"̂  dependence of binding to 
these three sites was not investigated so it is not possible to 
attribute them with either receptor binding or an uptake function.
It would seem unlikely that the two binding sites of lower affinity 
are neuroreceptors because the reported concentration of these 
sites is so high as to render a synaptic origin improbable.
More recent studies have utilised radiolabelled L-glutamate 
of a much higher specific activity. Consequently, the ability to 
accurately measure binding at lower concentrations of L-glutamate 
has revealed binding sites of much higher affinity than was pre­
viously reported. A single population of L-glutamate binding sites 
has been demonstrated on freshly-prepared cerebellar synaptic mem­
branes with a Kp of 744 nM and a B max of 73 pmol/mg protein (Foster 
and Roberts, 1978). The pharmacology of this binding site was in
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keeping with the characteristics expected for a post-synaptic 
glutamate receptor. However, a later study by the same workers 
(Sharif and Roberts, 1980 a) estimated a of 300 nM and a B max 
of 117 pmol/mg protein. The reasons for the increased affinity 
and increased concentration of binding sites appear to be changes 
in the preparation procedure, namely, increased periods of ultra- 
sonication and more extensive washing of the fractions. On
3investigation of even lower concentrations of [ H]-L-glutamate, 
binding sites with s in the low nanomolar region were obtained. 
Biziere al. (1980) reported two binding sites of 's 11 nM 
and 80 nM for homogenates of whole rat brain and Roberts (1981) 
detected multiple binding sites to rat striated synaptic membranes
3when a [ H]-L-glutamate range of 0.05 - 25 nM was examined. One 
of these binding sites had a of 16.6 nM and a B max of 400 
fmol/mg protein and thus corresponds with the high affinity 
(K^ = 11 nM) binding site reported by Biziere al_ (1980). As 
yet, no pharmacological data are available for these very high 
affinity binding sites and indeed, as the authors themselves point 
out, their physiological significance is far from clear.
The majority of binding studies outlined above were carried out 
in an Na^-free medium with the intention of minimising possible 
binding to a high affinity glutamate uptake site. A number of
3
workers have subsequently investigated the dependence of [ H]-L- 
glutamate binding on Na"*” concentration with a view to revealing 
such an uptake system. Baudry and Lynch (1981) demonstrated in 
rat hippocampal membranes that low concentrations of Na"*" (0.5 - 
5 mM) inhibited L-glutamate binding whereas higher concentrations 
(10 - 150 mM) stimulated it. Two binding sites were thus revealed.
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one high affinity, Na"^-independent site, 750 nM, and another of 
lower affinity, 2.4 yM, which was dependent on the presence of 
sodium. The authors attribute a high affinity glutamate uptake 
system to the Na -dependent binding site, as its regional distri­
bution compares favourably with that of glutamate uptake into brain 
homogenates. On the other hand, the regional distribution of the 
high affinity Na^-independent binding site is markedly different. 
Vincent and McGeer. (1980) also compared Na^-dependent glutamate 
binding with high-affinity glutamate uptake in rat striatum but
3unlike the majority of other workers, they could not detect [ H]- 
L-glutamate binding in the absence of sodium. Nevertheless, the 
authors concluded from pharmacological studies and from lesion 
studies that about half of the Na^-dependent glutamate binding 
sites in rat striatum represent high-affinity uptake sites on the 
corticostriatal terminals. The remainder of the sites are located 
on striatal neurones and may also be uptake sites. Apart from 
these two studies (Baudry and Lynch, 1981; Vincent and Me Geer, 
(l980)little attention has been given to the putative L-glutamate 
uptake system. More detailed studies of L-glutamate binding to 
mammalian brain have been mainly concerned with the Na"^-independent 
component - the putative neuroreceptor.
Sodium independent L-glutamate binding appears to be very 
sensitive to low temperatures (Foster and Roberts, 1978). Specific
3[ H >L-glutamate binding to cerebellar synaptic membranes was 
almost abolished by freezing in liquid nitrogen or storage at -30°C 
and was undetectable after storage at 4°C for 20 hours. Non-specific 
binding was unaffected by any of these procedures. The addition of 
cryoprotectants such as glycerol afforded no protection to the
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specific binding component. Two storage procedures have been
suggested which do not have a detrimental effect on binding. The
first method involves lyophilisation of the membranes immediately
after preparation and not only confers stability to the preparation
but also enhances binding as demonstrated by an increase in B° max
from 117 pmol/mg protein to 227 pmol/mg protein (Sharif and Roberts, 
1980 a). The second storage procedure in which the specific binding 
capacity of synaptic membranes is preserved was reported by Chang 
and Michaelis (1980) and requires rapid freezing of the tissue at 
-80°C followed by thawing in a controlled manner according to the 
method of Rudnick (1977) for platelet membrane vesicles. Both of 
the procedures enable storage of synaptic membranes for at least 
one month without loss of binding activity.
Preliminary studies by Sharif and Roberts (1980 a) and Michaelis 
et al. (1980) have suggested the presence of an endogenous glutamate 
inhibitor in synaptic membrane preparations. Either incubation of 
the tissue at 37°C for 30 minutes followed by extensive washing 
(Sharif and Roberts, 1980 a) or treatment of brain synaptic membranes 
with 1% or 0.5% cholate buffer solutions (Michaelis £t al̂ ., 1980) 
apparently resulted in the release of the proposed endogenous inhibitor 
into a 50,000 x g supernatant. Binding was enhanced in both cases 
and cholate treatment resulted in the appearance of a set of high- 
affinity (K^ =3.2 nM) low capacity (B max = 24 pmol/mg protein) 
binding sites, not seen in untreated membranes. Readdition of the 
supernatant (found to contain no glutamate or any other detectable 
amino acids) to the washed, incubated membranes resulted in a 
potent inhibition of specific L-glutamate binding (Sharif and Roberts, 
1980 a). Michaelis e^ (1980) have tentatively suggested
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that this endogenous inhibitor is a brain ganglioside for two 
reasons; firstly, cholate treatment of the membranes extracted 
N-acetyl neuraminic acid, a marker for gangliosides and secondly, 
addition of a mixture of bovine brain gangliosides to the assay 
media produced a dose-dependent inhibition of binding. This effect 
has been interpreted as a reflection of the possible functional 
importance of glycosyl residues on the glutamate receptor (Roberts,
1981).
To date little is known of the functional groupings involved 
in the receptor-lipid interactions occurring in mammalian brain 
synaptic membranes. A very preliminary report by Sharif and 
Roberts (1980 b) suggests firstly that a membrane glycoprotein 
could be involved , as indicated by decreased specific binding in 
the presence of trypsin and the inhibition of binding by concanav- 
alin A. The authors also suggest that membrane lipids are crucially 
involved in the maintenance of the glutamate receptor conformation, 
as judged by the decrease in binding after treatment with phospho- 
lipase, polyene antibiotics or extraction of membrane lipid with 
a 50% acetone :watar mixture or treatment with 0.5% Triton X-100. 
Finally, it has been suggested (Michaelis, 1979; Michaelis et al., 
1980) that the glutamate binding site may be a metallo-protein 
(glycoprotein) with an centre at the glutamate receptor, as
azide and strong field iron ligands have been shown to inhibit 
binding.
Regulation of the glutamate binding site is also unclear, but 
recently a series of experiments carried out by Baudry and Lynch, 
(1979; 1980; Baudry £t al., 1980) provides evidence for an involve­
ment of cations in the regulatory process. Monovalent cations
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such as Li^, Cs^, Ru^, and Na^ in the low millimolar range all 
show significant inhibition of Na"*”-independent binding in hippo­
campal synaptic membrane preparations, vÆiereas low micromolar 
concentrations of Ca^, M g ^  and M n ^  effectively enhance the 
binding (Baudry e£ al., 1980). In these studies the number of 
sites rather than their affinity is changed and the authors suggest 
involvement of a C a ^  regulated thiol-protease that regulates the 
number of glutamate receptor sites in hippocampal synaptic mem­
branes (Baudry and Lynch, 1980).
In several other systems guanine nucleotides have been shown 
to regulate receptor sensitivity. Such a regulation may also apply 
to glutamate receptors as Sharif and Roberts (1980 c) have demon­
strated substantial inhibition by these nucleotides, especially
3GTP, at mircomolar concentrations, of [ H]-L-glutamate binding to 
cerebellar synaptic membranes, an effect not observed with adenine 
nucleotides.
Solubilisation of rat brain synaptic membranes has been 
achieved using Triton X-100 (Michaelis, 1975; Sharif and Roberts, 
1980 a). Michaelis (1975) then went on to partially purify a 
glutamate binding glycoprotein by affinity chromatography on con- 
canavalin A. Gel electrophoresis revealed a small acidic protein 
of 13,800 Mr which was not related to the enzymes involved in gluta­
mate metabolism. Binding was inhibited by concanavalin A and iron 
ligands thus providing further evidence for the suggested metallo- 
glycoprotein nature of the receptor. Furthermore, gangliosides, 
the proposed endogenous inhibitor, also inhibited binding.
In fulfilling the criteria for defining a physiological 
neuroreceptor (p. 15) point E, incorporation of the isolated
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receptor molecule into a model membrane and thus endowing the 
membrane with the property of chemical excitability, is probably 
the definitive test. A very preliminary report has been made of 
the incorporation of the metallo-glycoprotein of Michaelis into 
a variety of membrane preparations and some binding activity was 
retained (Grubbs and Michaelis, 1979). In similar experiments, 
Kusnetsov and coworkers solubilised the hippocampal glutamate binding 
site with Triton X-100 and then achieved partial purification by 
chromatography on Sepharose 4B. Incorporation of both the detergent 
extract and the partially purified protein into lipid films pre­
pared from whole brain phospholipids, was then attempted. Glutamate- 
induced permeability changes were observed but spontaneous permeabi­
lity changes, of equal magnitude, also occurred in aged preparations 
(Kuznetsov and Mogilyanskii, 1975). A more recent study by the 
same workers described the incorporation of "Triton X-100 solubilised 
membrane fragments" into a planar lipid bilayer (Kolomytkin e£ a^., 
1979 a, b). Glutamate-induced permeability changes were again noted 
but only if incorporation was into both sides of the lipid membrane. 
This latter observation implies that some sort of interaction between 
components in the two halves of the bilayer is necessary for the 
formation of functional channels. The authors conclude that these 
glutamate induced permeability changes, especially for Na"̂ , are 
consistent with those of the synaptic glutamate receptor. However, 
a great deal more work is necessary before the above system can be 
termed a reconstituted functional glutamate receptor.
The initial part of the work described in this thesis was an 
attempt to further characterise this putative L-glutamate receptor 
in subfractions from the locust, Schistocerca gregaria, interthoracic
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muscle, using the method of "unlabelled ligand excess" to account 
for non-specific binding. As will be seen, many problems were 
encountered both in obtaining a suitable membranous subfraction 
with minimal non-specific binding and in the binding assay itself.
In contrast, the second part of this thesis is devoted to character­
isation of the a-bungarotoxin binding component, a putative nicotinic 
acetylcholine receptor, from the same insect's supra-oesophageal 
ganglia. The problems were minimal relative to the glutamate study 
and characterisation of a membranous, solubilised and consequently 
partially purified binding component was achieved. Both studies 
sought to provide basic knowledge about the neurotransmitter 
receptors of the insect nervous system that would permit comparisons 
to be made with their better characterised mammalian counterparts. 
Such receptor sites, once characterised, would constitute attactive 
targets for novel insecticides.
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SECTION 1 : STUDIES ON PUTATIVE L-GLUTAMATE RECEPTORS AT THE LOCUST
NEUROMUSCULAR JUNCTION
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MATERIALS
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Locusts, (Schistocerca gregaria), were supplied by Larujohn,
Colwyn Bay, U.K.
Enzymes, substrates and co-factors were obtained from BoeVdnger- 
Mannheim, West Germany, or Sigma Chemical Company Ltd., London,
U.K.
General reagents were obtained from B.D.H. Chemicals, Poole, Dorset, 
U.K.
3L-[G- H]-glutamate C35Ci/mmol) was obtained from the Radiochemical 
Centre, Amersham, Bucks., U.K.
Centrifugation procedures were carried out using an MSE model 18, 
Beckman L5 50B Ultracentrifuge, Beckman Airfuge and Beckman Microfuge B 
Spectrophotometric assays were performed on an Aminco-Bowman 
spectrofluorometer or a Cecil CE 212 UV spectrophotometer coupled 
to a Heathkit model 1R-18M multispeed chart recorder.
Radioactivity was determined by liquid scintillation spectrometry 
using a Packard Tricarb model 3385.
— 63 —
METHODS
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1, Tissue Preparation;
All experiments were carried out using the total intrathoracic 
musculature from two-week old adult locusts (Schistocerca gregaria). 
As a routine, the head, abdomen and legs of the locust were cut off; 
the thorax was then cut ventrally and gently pulled open to reveal 
the muscles. Most of the fat body was removed by blotting with 
tissue papers and the entire thoracic muscle was dissected out and 
stored on ice. The muscle (approx. 3 g from 20 locusts) was homo­
genised (2% w/v) in a solution of locust saline (Table 2 ) pH
7.0,in a Potter-Elvejham homogeniser with a motor driven pestle 
(speed, 500 rpm; radial clearance 0.15 ram). The homogenate was 
then filtered through nylon bolting cloth (159 yM mesh) and the 
filtrate subjected to the fractionation scheme shown in Fig.10.
2. Electron Microscopy:
The morphology of the P^ fraction was examined by electron- 
microscopy. Table 3 outlines the technique used to prepare tissue.
Fractions were fixed as suspensions by dropwise addition of 
an equal volume of 6% glutaraldehyde in O.IM cacodylate buffer, 
pH 7.1, containing 0.2M sucrose (final concentration of 3% glutar­
aldehyde) . Samples were post-fixed in 1% osmium tetroxide in the 
same buffer after washing of the fixed suspensions by centrifugation, 
Pellets were dehydrated through a series of alcohols and embedded 
in Spurr's resin. Ultrathin sections were cut (LKB microtome) and 
stained with uranyl acetate and Reynold’s lead citrate. Grids were 
viewed in a Jeol 100 x c electron microscope equipped with a camera.
TABLE 2
Locust Saline (Hoyle, 1953)
Choline chloride (or sodium chloride for Na rich saline) 
10 mM Potassium chloride 
Calcium chloride 
Magnesium chloride 
Potassium hydrogen carbonate 
Potassium dihydrogen phosphate
pH 7.0
0 .15 M
2 mM
5 mM
4 mM
6 mM
FIGURE 10
Fractionation Scheme for Locust Muscle
Filtrate (50 ml/g original tissue)
Centrifuged 3,000 x g for 10 min.
Pellet Supernatant S
Centrifuged 30,000 x g for 1 h.
Pellet Supernatant S
X 2 washes in 20 ml locust saline 
Centrifuged 30,000 x g for 10 min.
Final pellet resuspend in 5 ml locust saline/3g original 
starting material
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3. Measurement of Enzyme Activities;
Assay procedures were those of Donnellan e^ a]̂ , (1974) unless 
otherwise stated. Spectrophotometric assays were performed at 
30°C using silica cuvettes of 1 cm light path. Reaction volumes 
were 3.0 ml.
a) L“Aspaifate;2 Oxoglutarate Aminotransferase;
(E.G. 2.6.1.1.; GOT)
Glutamate oxaloacetate transaminase activity was measured by 
coupling oxaloacetate production to the oxidation of NADE by malate 
dehydrogenase.
GOT
L-asp + aKG — ^ O A A  + L-Glu
+ +OAA + NADH + H — ^-L-malate + NAD
Extracts were added to reaction mixtures containing 50 mM 
KH2P0^, pH 7.9, 0.1% w/v Triton X-100, 40 mM L-aspadhte, 0.22 mM 
NADH and 5 U malate dehydrogenase (MDH, Boehringer pig heart, 
mitochondrial, 5 mg/ml in 5% glycerol) NADH oxidation was monitored 
at 340 nm after the addition of 5mM a-ketoglutarate,
b) L-Glutamate;NAD(F) Oxidoreductase; (E.G. 1.4.1.3.; GDH) 
Glutamate dehydrogenase activity was assayed by the reductive
amination of a-ketoglutarate and followed by monitoring the decrease 
in absorbance of NADH at 340 nm.
+ gdh
aKG + NADH + H — ^  L-glu + NAD + H^O
Extracts were added to reaction mixtures containing 50 mM Tris- 
HGl, pH 7.9, 0.1 % w/v Triton X-100, 100 mM ammonium acetate, ImM 
ADP and 0.22 mM NADH. The reaction was started by the addition of 
5mM a-ketoglutarate.
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c) L-Alanine;2-oxoglutarate Aminotransferase;
(E.G. 2.6 .1.2.; GPT)
Glutamate-pyruvate transaminase activity was assayed by coupling
pyruvate production to the oxidation of NADH by lactate dehydrogenase.
GPT
L-ala + aKG ■ ►  pyruvate + L-glu
+ ldh
pyruvate + NADH + H L-lactate + NAD
Extracts were added to reaction mixtures containing 50 mM 
KH2P0^, pH 6.9, 0.1 % w/v Triton X-100, 40 mM alanine, 0.22 mM 
NADH and 10 U lactate dehydrogenase (Boehringer, pig heart, 5 mg/ml 
in 2.2 M (NH^)2S0^). NADH oxidation was monitored at 340 nm after 
addition of 5 mM a-ketoglutarate.
d) L-Glutamate 1-Garboxy-Lyase;
(E.G. 4.1.1.15.; GAD)
Glutamate decarboxylase activity was assayed by measuring the 
production of [^^G]G02 from L-[^^G]glutamate (Langeake and Glements, 
1974).
J U. GAD . / -I /
U r C glutamate — ^  U- [ G ]gaba + [ G] -GO2
0.8 ml samples were added to 25 ml conical flasks containing
1.0 ml imidazole acetate buffer (0.2 M imidazole corrected to pH 6.5 
with acetic acid) and containing 10 mM mercaptoethanol and ImM 
pydridoxal phosphate. To these flasks was added 200pl of 0.54 M 
L-glutamate which included 1 yGi of L-U-[^^G]-glutamate. The flasks 
were sealed immediately with air-tight^rubber seals and were Incubated 
for 1 h at 37°G. The reaction was terminated by injection of 0.8 ml 
2N H2S0  ̂followed by 0.2 ml 0.5 M Na2C0  ̂to flush out the GO^.
Labelled GO2 was absorbed by 200 yl hyamine hydroxide on filter paper
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wicks in plastic centre wells. Flasks were left overnight to ensure 
complete absorption of Centre wells were placed directly
into vials containing 10 ml toluene: PPO (100%:0.5%; v/v: w/v). 
Activity was calculated from the specific activity of the labelled 
glutamate which gave rise to stoichiometric amounts of labelled COg.
e) Sn-Glycerol-3-phosphate:(acceptor) Oxidoreductase:
(E.G. 1.1.9.9.5.; GPox or glycerol 3 P DHase)
Glycerolphosphate oxidase activity was monitored by coupling 
the oxidation of L-glycerol-3-phospha^te to the reduction of 
ferricyanide to ferrocyanide.
glycerol-3-phosphate + acceptor = dihydroxyacetone phosphate
+ reduced acceptor 
Extracts were added to reaction mixtures containing 130 mM 
KGl, 10 mM KH^PO^ ImM EGTA (pH 7.1), 1 mM KGN and ImM potassium 
ferricyanide. The decrease in absorbance at 425 nm due to ferri­
cyanide reduction was followed after the addition of 66.7 mM 
D, L-glycerol-3-phosphate.
f) Adenosine triphosphatase:
Total ATPase activity was followed at 340 nm using a coupled
enzyme assay involving lactate dehydrogenase and pyruvate kinase CPK)
(Balerna et al., 1975).
ATPase
ATP + H^O — ^  ADP + Pi
PK
ADP + PEP — ATP + pyruvate
+pyruvate + NADH + H L-actate + NAD
The reaction mixture contained 50 mM Tris-HGl, pH 7.5, 100 mM 
NaGl, 5 mM MgGl2, 10 mM KGl, 2 mM ATP, 0.15 mM NADH, 2 mM phosphoenol
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pyruvate (PEP), LDH (Boehringer, pig heart 5 mg/ml in 2.2 M 
(NH^)2S0^, 3 units/assay) and PK (Boehringer, rabbit muscle,
10 mg/ml in 50% glycerol, 9 units/assay). The assay was repeated 
in the presence of 1 mM ouabain.
4. The Binding Assay;
Membranes (P^) were suspended (2-4 mg protein/ml) in either
sodium rich or sodium free locust saline pH 7.0 (Table 2 ). Membrane
samples 200 yg protein) were incubated at 23°C for 15 min in the 
3presence of [ H ]-L-glutamate (0.002 - 200 yM final cone; 29 Ci/mm). 
Non-specific binding was accounted for by incubation in the presence 
of either 1 mM D—glutamate or 0.5-2C)mM L-glutamate* Bound pH] -
3L-glutamate was separated from free [ H]-L-glutamate by one of the 
following methods:
a) The Filtration Assay:
Samples were incubated in a final volume of 500 yl, Aliquots 
were removed (150 yl) and filtered through Whatman 2,5 cm GF/C 
filters. Filters were washed with 2 x 2 ml ice cold locust saline. 
Total filtration time (i.e. of sample plus washes) was 3 - 3 0  sec. 
Filters were dried at room temperature and either placed immediately 
in 5 ml scintillation fluid (70:30:0.5% toluene: Triton X-100: PPO 
v/v/w) or trimmed to the exact size of the millipore tower using a 
1 cm diameter bore cutter and then placed in the above scintillant. 
Filters, either cut or uncut were left for 12 hours at room 
temperature and then counted in Packard Scintillation counter. Filter 
blanks were in the absence of membranes.
“ 69 —
b) The Microfuge Assay:
Samples were incubated in a final volume of 500 yl. Aliquots 
were removed (150 yl) and centrifuged at 2,000 x g for 10 min in 
a Beckman microfuge (Model B). The supernatant was removed using 
a pasteur pipette and the pellet superfically washed with 2 x 0.5 ml 
ice cold locust saline. 50 yl of soluene - 350 were added to the
pellet and left to solubilise for 6 hours. The solubilised pellet
was then transferred using a pasteur/to a scintillation vial 
containing 5 ml of the above scintillant. The centrifuge tube was rinsed 
with 100 yl scintillant and the wash also was placed in the vial.
Samples were left in scintillant for 12 hours before counting to allow 
chemiluminescence to subside.
c) The Microairfuge Centrifugation Assay:
Samples were incubated in a final volume of either 500 yl or
150 yl directly in the centrifuge tube. If incubated in a final
volume of 500 yl, aliquots (150 yl) were taken and centrifuged for 
1 min at 100,000 x g in a Beckman airfuge. Samples incubated directly 
in the centrifuge tubes were also centrifuged for 1 min at 100,000 x g . 
The supernatant was removed and the pellet washed with 2 x 200 yl of 
ice cold locust saline, after which 50 yl of Soluene 350 were added 
and the pellet was left to solubilise for at least 6 hours. The 
end of the centrifuge tube containing the solubilised pellet was then 
cut off into a scintillation vial containing 5 ml of scintillant 
(70: 30: 0.5% toluene: Triton X-100: PPO (v/v/w)) plus 0.5 ml distilled 
water. The scintillation vial was then mixed for 30s on a 
whirlimixer and left to stand for 12 hours to allow chemiluminescence
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to subside. Samples were then counted for radioactivity in a Packard 
scintillation counter, of counting efficiency 30%. Quenching was accounted
3for by an external standard* Results were expressed as pmol [ H]-L- 
glutamate bound/mg protein.
5. Thin Layer Chromatography to Check for Metabolism of [^H]-L- 
Glutamate;
10 X 10 cm plates of Baker-Flex F cellulose (prewashed in 2 M
3NaCl) were used to check for metabolism of [ H]-L-glutamate during 
the binding assay.
Solvent system: propanr2-ol/formic acid/water 40/2/10v/v/v.
Plates were run in two dimensions at right angles in the same 
solvent, and the amino acid spots visualised with ninhydrin,marked,
Spots were bleached by spraying the plates with 1% H^O^. Plates 
were cut into 1 cm squares and the squares counted in 5 ml Triton/ 
toluene/PPO 70/30/0.5 v/v/w to check for other radioactive spots 
not ninhydrin positive. P^ was incubated at 25°C with labelled 
L-glutamate and samples taken at 0, 15, 30 and 60 mins. Protein 
was precipitated with an equal volume of ice cold ethanol and the 
supernatants dried under a stream of nitrogen. Aliquots were applied 
to TLC plates, together with standards.
a-ketoglutarate was visualised under U.V. by spraying the 
plates with 0.1% semicarbazide in 0.15% sodium acetate, prior to 
ninhydrin.
6 . Protein Determination:
Proteins were determined by the method of Lowry et al (1951)
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RESULTS AND DISCUSSION
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1. The Choice of the Subcellular Fraction for Further Study
The fractionation scheme outlined in Fig.10 , is a modification 
of that reported by James (1977) (Fig. 11). It was my experience
'a.
that the yiel(^/from the latter method was very low. In an attempt 
to improve this position, the modified fractionation scheme outlined 
in Fig.10 was adopted; this eliminates the centrifugation steps A 
and B (Fig.10 ) and substitutes one centrifugation at 3,000 x g for 
10 minutes thereby increasing the yield in the subsequent 30,000 x g 
pellet but probably at the expense of purity.
The ?2 pellet fraction was initially examined by electron- 
microscopy (Plates 1 and 2) and as was expected is contaminated by 
large mitochondria. However, numerous membrane fragments, in some 
cases vesiculated, are also visible.
To further characterise the P^ membrane fraction the distribution 
of a number of enzymes characteristically found in insect muscle was 
investigated. Enzyme activities were assayed as described in the 
Methods (p. 65 ). Results are given as the means of either 2 or 3 
experiments (No. of expts) and are expressed as RSA (relative specific 
activities) where :
% total enzyme activity recovered in the fraction
RSA =
% total protein recovered in the fraction
An RSA value of greater than unity indicates an enrichment of 
the enzyme activity in that fraction.(Table 4) GPT, GDH, GOT, GPox and GAD 
are all glutamate metabolising enzymes and are considered to be 
associated with mitochondria (Donnellan eĵ  al .̂, 1974 ), thus an 
enrichment of these in any fraction is indicative of mitochondrial 
enrichment in that fraction. All of the above mentioned enzymes are
Fig. 11
Fractionation Scheme of James (1977)
Thoracic muscle
2% (w/v) suspension of muscle in 0.25M 
sucrose containing 5 mM Tris Cl and 1 mM 
EGTA (pH 7.1) homogenised (12 passes at 
120 rpm) and filtered through nylon mesh.
Filtrate
Centrifuged at 1,000 x g for 5 min. A
Supernatant (S, )
Centrifuged at 7,500 x g for 10 min. B
Supernatant (S«)
Centrifuged at 30,000 x g for 60 min.
Supernatant (S-)
Membrane pellet suspended 
in homogenisation buffer 
and re-centrifuged at
30,000 X g for 60 min.
PLATE 1 Electronmicrograph of the P^ Membrane
Fraction from Locust Muscle
1
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PLATE 2 Electronmicrograph of the P^ Membrane 
Fraction from Locust Muscle
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enriched in the fraction, suggesting that this fraction is composed 
mainly of mitochondria. The greatest RSA value for GOT is in the
fraction with enrichment also in the fraction,which is consistent
with the bimodal distribution of this enzyme reported by Donnellan elt 
al (1974), in subcellular fractions of fleshfly (Sarcophaga barbata) 
flight muscle. Of all of these enzymes only GPox and GAD had RSA 
values greater than one in both the P^ and P^ fractions. The enzyme 
GPox has been shown to be firmly bound to the inner membrane of 
flight muscle mitochondria (Chance and Sacktor, 1958; Donnellan et al., 
1970; 1974). Therefore, an enrichment in the P^ fraction suggests 
the presence of these membranes and/or whole mitochondria in this 
fraction.
The GAD activity was predominantly in the P^ fraction, again 
suggesting the presence of mitochondria in the fraction because the 
intramitochondrial location of this enzyme has been established in 
preparations of fleshfly flight muscle (Langcake and Clements, 1974). 
However, GAD may possibly have a role in the synthesis of GABA as an 
inhibitory neurotransmitter in nerve endings.
The distribution of total ATPase activity indicates considerable 
enrichment in Y but the activity was not sensitive to ouabain 
Briley (1981) found that in similar preparations from locust muscle
this activity was stimulated by Ca** and was inhibited by azide, 
features which are characteristic of myofibrillar and/or sarcoplasmic 
reticulum ATPase activity. Thus the enrichment in Y2  may indicate a 
considerable content of vesiculated saroplasmic reticulum in this 
fraction. Briley (1981) has also found an enrichment of stimulated 
ouabain-sensitive p-nitrophenylphosphate phosphatase CpNPP) activity
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in the fraction. This activity is thought to represent Na^K—
ATPase and is usually associated with plasma membranes in vertebrate 
tissues. An enrichment of pNPP in the P^ fraction could therefore 
suggest an enrichment of plasma membrane in this fraction.
The RSA values reported here, in conjunction with the work of 
Briley (1981) suggest that:-
1. The P^ fraction is enriched in mitochondria. Some 
mitochondrial activity (GPox and GAD) is also seen in P^.
2. Although there is a lot of total ATPase activity in
this activity is not ouabain sensitive and probably corresponds to 
myofibrillar and/or sarcoplasmic reticulum ATPase activity.
3. pNPP activity in may indicate an enrichment of plasma 
membranes.
4. An enrichment of GAD activity in P^ may also indicate an 
enrichment in nerve endings if GABA is synthesised within the 
nerve terminals.
In conclusion the P^ fraction,as prepared in Fig.10,contains 
predominantly membrane fragments,the origins of which are uncertain. 
Mitochondria are also present in this fraction but to a lesser extent 
than in the P^ fraction.
2. The Solubility of L-Glutamate in the Scintillation Fluid;
It was noted that the recorded cpm decreased with time when 
320pl of [ H Jglutamate,isotopically diluted to a concentration of
_510 M,was placed in scintillation fluid and counted. Closer examin­
ation revealed that the L-glutamate appeared to be precipitating in 
a time dependent manner. To overcome this effect 0.5 ml of H2O were
TABLE 5
The Solubility of L-Glutamate in Scintillation Fluid
Time [ V - L -
glutamate
[^H]-L- 
glutamate 
+ 0.5 ml
HgO
[^H]-L- 
glutamate 
+ unlabelled 
L-glutamate
[^H]-L- 
glutamate 
+ unlabelled 
L-glutamate 
+ 0.5 ml HgO
0 1,390,163 cpm 1,338,824 cpm 1,137,999 cpm 1,403,216 cpm
1 hour 96% 100% 70% 100%
22 hours 84% 100% 23% 100%
6 days 73% 99% 20% 98%
5 ml Scintillation Fluid 
+ 20 yl 10 [^H]-L-glutamate
+ 15 yl 5 mM L-glutamate
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added to the 5 ml of scintillation fluid in which samples were 
routinely counted. Table 5 shows the cpm at the intervals indicated 
for samples in scintillation fluid (5 ml) with and without water 
and with and without addition of excess unlabelled L-glutamate.
Firstly,it should be noted how the cpm decreased with time in
the absence of H^O (100% to 73% in 6 days). This reduction in cpm
is greatly accentuated by the addition of an excess of unlabelled 
L-glutamate (5 mM; 100% to 70% in 1 hour) where the cpm at zero time 
is only 80% of the expected value. It appears,therefore,that the 
detectable cpm are markedly reduced even before counting commences. 
However, in both cases i.e. with and without an excess of unlabelled 
L-glutamate, this decrease in cpm with time is to some extent 
prevented by the addition of 0.5 ml H2O/5 ml scintillation fluid. 
Henceforth,0.5 ml H2O was routinely added to 5 ml scintillation fluid 
before counting.
3. Experiments using D-plutamate to Account for Non-Specific Binding;
In early experiments, incubation of [^H ]-L-glutamate Cl x 10 ^M) 
with the membrane fragments was carried out in the presence of an 
excess of unlabelled D-glutamate (1 mM) to account for non-specific 
binding. D-Glutamate was chosen because it has no physiological 
activity in the insect nervous system and is structually very 
similar to L-glutamate and therefore any site capable of differentiating 
between the D and L isomers would be considered to be a specific binding 
site for L-glutamate.
Binding was carried out as described in the Methods (p.68 )
3and bound [ H ]-L-glutamate was separated from free by filtration 
through GF/C filters. The experiments were carried out in the presence
TABLE 6
+ 3Effect of Na on [ H]-L-Glutamte Binding Using D-Glutamate to Account
for Non-Specific Binding:
Prep. No. Binding (pmol/mg prot.)
+ + •» roa+ Na — Na - Na.
1 24.6 22.9 93%
2 14.9 12.5 84%
3 39.2 17.2 44%
4 8.7 4.3 11%
5 9.9 13.7 140%
6 10.6 12.6 119%
Results are the means of triplicates S.E. = 20 - 30% 
[^H]-L-glutamate =10 ^ M 
D-glutamate — 5 mM
Choline chloride 0.14 M used in Na^ free buffer
Binding was as described in the Methods (p. 68 ).
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(0.15M) and absence of Na , on the assumption that high affinity
3
uptake of [ H]-L-glutamate would be sodium dependent and therefore 
addition of sodium to the incubation media may result in an apparent 
increase in binding.
Table 6 shows the results of 6 experiments ,each carried out in 
triplicate. As can be seen the binding varies considerably from 
preparation to preparation. Four out of the six experiments showed 
an increase in [̂ H ]-L-glutamate binding on the addition of Na^ but 
for the other two experiments the converse is true. In all experiments 
the standard error was high.
Increased pH ]-L-glutamate binding to a similar locust muscle 
membrane preparation, in the presence of Na^ has been reported by 
other workers (James, 1977; Cleworth ££ al̂ ., 1980). For this reason and
because the majority of experiments reported here in the presence
+ . . 3and absence of Na gave similar results, further [ H]-L-glutamate
binding experiments reported in this thesis were carried out in a 
Na^ free buffer as a 
of pH ]-L-glutamate.
means of minimising any high affinity uptake
3The use of D-glutamate to account for non-specific [ H ]-L- 
glutamate binding has not been widely used (James, 1977; Cleworth, 
personal communication). The majority of workers use the method 
of "unlabelled ligand excess" where the unlabelled ligand must compete 
with the labelled ligand for the specific binding sites. This method 
is considered to be more reliable when the labelled and unlabelled 
ligands are chemically distinct (see AChR Discussion p.155 ).
However, in the case of L-glutamate such studies are hampered by the 
lack of any well characterised receptor agonists or antagonists and
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therefore the only ligand which can be used with confidence, in
such an assay, is unlabelled L-glutamate, A comparison of the two
methods,that is, excess D-glutamate or excess L-glutamate for the
3determination of non-specific and hence specific [ H ]-L-glutamate 
binding ,was made.
4. A Comparison of Binding Using Excess D-glutamate and Excess Unlabelled 
L-Clutamate to Account for Non-Specific Binding;
Binding was carried out as described in the Methods (p.68 ).
3 -5Bound [ H ]-L-glutamate (10 M) was separated from free by filtration
through CF/C filters. When excess D-glutamate (1 mM) was used to
account for non-specific binding;
specific binding = the amount of [ H ^L-glutamate bound in the presence of
an excess of unlabelled D-glutamate.
Non-specific binding
= (Amount bound in the absence of unlabelled L- or 
D-glutamate) - (Amount bound in the presence of 
D-glutamate).
When an excess of unlabelled L-glutamate (ImM or 5mM) was used to 
account for non-specific binding;
Non-specific binding
= the amount bound in the presence of an excess of 
unlabelled L-glutamate.
. . Specific binding
= (Amount bound in the absence of unlabelled L- or 
D-glutamate) - (Amount bound in the presence of 
unlabelled L-glutamate).
TABLE 7
Comparision of Binding in the Presence of an Excess of Unlabelled 
D-Glutamate and in the Presence of an Excess of Unlabelled L-Glutamate:
Preparation 
No.
Binding (pmol/mg prot.)
• A B C D E
Total Non­
specific 
(excess 
L-glut.)
Specific 
A - B
Specific 
(excess 
D-glut.)
Non- 
Specific 
A - D
1 0.523 1.161 - 0.638 0.071
2 1.197 1.512 - 1.049 0.148
3* 1.482 0.831 0.651 1.241 0.241
Results are the means of triplicates S.E. = 20 - 30%
* Unlabelled L-glutamate at a concentration of 5 mM, 1 mM for 
preparations 1 and 2.
D-glutamate was at a concentration of 1 mM
3 . -5[ H]-L-glutamate was at a concentration of 10 M
A = Total binding i.e. binding in the absence of either excess L - 
or D-glutamate.
B = Non-specific binding measured in the presence of excess unlabelled 
L-glutamate
C = Specific binding i.e. (Total binding) - (Binding in the presence 
of excess unlabelled L-glutamate).
D = Specific binding i.e. binding in the presence of excess D-glutamate 
E = Non-specific binding i.e. (Total Binding) - (Binding in an excess 
of D-glutamate) .
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Table 7 shows the results of three experiments»each in triplicate,
in which a comparison was made of specific binding measured by
incubation in an excess of unlabelled L-glutamate (ImM and 5mM) and
by incubation in an excess of unlabelled D-glutamate.
Firstly, it should be noted that it was only when unlabelled
L-glutamate concentration was increased from ImM - 5mM that specific 
3[ H]-L-glutamate binding was displaced. This could be indicative
of binding of very high affinity, a large number of specific binding
sites, or different affinities for the ligand in the labelled and
unlabelled state. The last point is unlikely because tritiation of
a ligand has little effect on structural conformation.
If excess unlabelled L-glutamate and excess D-glutamate are
equally effective in accounting for non-specific binding, then the
figures in columns C and D (specific binding) should compare
favourably. This was not the case, as there was apparently more
non-specific binding measured in the presence of an excess of unlabelled L-glut-
amate
than could be accounted for by D-glutamate. In such a crude preparation 
as the ?2 membrane fraction and in consideration of the widespread 
occurrenceof L-glutamate^non-specific (non-neuroreceptor) L-glutamate 
binding sites would be expected to exceed the specific binding sites.
This is borne out by the results of experiments in which unlabelled 
L-glutamate is used as the displacing ligand and therefore this method 
was routinely adopted in all further experiments to account for non­
specific binding.
5. The Binding Assay;
In all of the binding experiments reported here a number of 
problems have persisted and have so far precluded any assessment of the 
significance of the results obtained. The problems are outlined
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below:-
1. Filter blanks were inconsistent and sometimes unusually 
high; in some cases values higher than that of the sample were 
obtained.
2. Poor reproducibility between triplicates within a 
preparation (standard error as high as 35% in some cases).
3. Often no displaceable binding,i.e. no specific binding was 
obtained.
4. When specific binding was obvious it was not reproducible 
from preparation to preparation.
In an effort to irradicate or at least to minimise these 
problems a number of procedures were employed to try to lower the 
filter blanks and to reduce the non-specific binding.
3
a) Experiments to Reduce the Binding of [ H ]-L-Glutamate to 
the Filters:
In some of the previous experiments the [ H ]-L-glutamate bound
to the filters alone (i.e. without P2 membrane present) was found to
be very high, in some cases higher than when the sample was filtered,
thus rendering results from that particular experiment invalid.
Three possible reasons for high filter blanks were investigated.
Firstly, it was thought that the time of filtration (i.e. time for
sample plus wash to pass through the filter) may have affected the
blanks. Experiments were carried out in which the filtration time
was varied from 3S - lOS, a filtration time which is probably still
3sufficiently rapid to ensure minimal dissociation of [ H. ]-L-glutamate 
-receptor complex assuming L-glutamate binds with a similar affinity 
to its receptor as do other neurotransmitters (AChR Discussion p.154)
TABLE 8
3The Effect of Filtration Time on the Non-Specific Binding of [ H] 
L-Glutamate to the Filters:
Buffer Filtration Time (sec.)
3 5 10 ;
(cpm bound) cpm bound) (cpm bound) !
L.S. 551 346
I
48 '
L.S. + 1 %  BSA 299 366 t
L.S. + 5mM L-glutamate 366 385 36
L.S.+ 1% BSA + 5mM 
L-glutamate 345 355
L.S. = Locust saline
Results are means of quadruplicates S.E. < 5%
3 . ”5[ H]-L-glutamate was at a concentration of 10 M
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Secondly, the effect of presoaking the filters in 1% (w/v) BSA and/ 
or 5mM L-glutamate was investigated. The rationale for this 
procedure was to try to occupy all potential non-specific [ h ]-L- 
glutamate binding sites on the filter. Finally, after filtration 
and washing was complete,the filters were trimmed to the exact 
diameter of the millipore filtration tower, thus cutting away any 
[̂ H ]-L-glutamate which had become trapped in the seal between the 
millipore tower and the scinter support and was therefore unlikely 
to have been efficiently washed.
Table 8 shows that presoaking in BSA and/or L-glutamate had 
no effect on the levels of the filter blanks whereas increasing the 
filtration time from 3S to lOS lowered the radioactivity associated 
with the filter by a factor of ten. Trimming the filters caused a 
drop in cpm, from about 1000 cpm to about 100 cpm and also decreased 
the standard error from 30% to 5% (mean of quadruplicates).
In all subsequent experiments the filters were trimmed after 
filtration.
b) The Effect of Filtration Time on the Binding of [^H ]-L- 
Glutamate to the Membrane Fragments;
Binding was carried out as described in the Methods (p.68 ).
]-L-glutamate was at a final concentration of 10 ^M. Two 
filtration times were used;3s and 10s. . The filters were trimmed 
before counting.
Table 9 , shows total, non-specific and specific binding of
3[ H]-L-glutamate for the two filtration times. No improvement in
the reproducibility of the overall assay (mean of quadruplicates ± S.E.)
TABLE 9
Effect of Filtration Time on Binding of H -L-Glutamate to the Fraction:
Filtration Time Binding (pmol/mg prot.)
Total Non-Specific Specific
3 sec 2.23 ± 0.50 1.23 ± 0.22 1.0 ± 0.46
10 sec 3.39 ± 0.43 2.20 ± 0.60 1.73 ± 0.74 ;
Results are the means of quadruplicates ± S.E.
3 “5[ H]-L-glutamate = 10 M
Unlabelled L-glutamate = 5 mM
Binding was carried out as described in the Methods Cp* 68 )
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was observed when the filtration time was increased from 3s to 10s.
Although filtration time and trimming the filters had no effect 
on improving the reproducibility of results from preparation to 
preparation, in all subsequent experiments the two practices were 
carried out to try to ensure low blanks.
3c) Comparison of [ H]-L-Glutamate Binding Assayed by the
Filtration and by the Microfuge Centrifugation Methods;
-5 3 3Binding was carried out at 10 M [ H]-L-glutamate. Bound [ H]-
L-glutamate was separated from free ligand by either filtration
through Whatman GF/C filters or by centrifugation at 2,000 x g in
a Beckman Microfuge for 5 minutes (Methods p. 69).
The microfuge centrifugation method of separating bound from 
3free [ H]-L]glutamate was even less reliable that the filtration
method giving greater standard error (Table 10). It was noticed
that the resultant pellet after centrifugation at 2,000 x g was
very small and loosely packed, suggesting that the membranes may
not all have sedimented. Extended centrifugation times failed to
produce tightly packed pellets such that it was difficult to remove
the supernatant without possible loss of pelleted material. Thus the
3microfuge method of separating bound from free [ H]-L-glutamate was 
not considered further.
d) The Effect of Freeze-Thawing the Membrane Fraction on
3[ H]-L-Glutamate Binding;
Freeze-thawing of the membrane fragments was carried out
3because of two possible factors which could be affecting [ H]-L- 
glutamate binding to its putative receptor. Firstly, it was highly 
probable that the membrane fragments of the suspension were reforming
TABLE 10
Comparision of Binding Assayed by the Microfuge Centrifugation and by 
the Filtration Methods;
Prep- 
aratior 
No.
Assay Binding (pmol/mg prot.)
Non-Specific Total Specific
1 Centrifugation 1.35 ± 0.53 2.49 ± 0.8 1.14 ± 0.48
1 Filtration 0.704 ± 0.55 2.064 ± 0.33 1.36 ± 0.32
2 Centrifugation 5.4 ± 1.02 5.3 ± 2.23 -
2 Filtration 2.20 ± 1.21 3.93 ± 0.86 1.73 ± 0.74
Results are the means of quadruplicates ± S.E
3 “5[ H]-L-glutamate = 1 0  M
Unlabelled L-glutamate = 5 mM
Binding was carried out as described in the Methods Cp* 68 )
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as vesicles, as suggested by the electronmicrographs (Plates 1 and2)
and so perhaps rendering a number of specific L-glutamate binding
sites inaccessable. Secondly, Olsen eL aly, (1980),when investigating binding
to putative GABA receptors in preparations of mammalian CNS, reported
improvement of binding after freeze-thawing which he attributed to
release and removal by washing of a possible endogenous inhibitor
of [ H]GABA binding, which may have been endogenous GABA, and would
have occupied specific binding sites and so caused an underestimation
of binding sites. A similar situation has been suggested for glutamate
binding to preparations of mammalian brain (Roberts,1981 ) and the
3same could be possible when examining [ H]-L-glutamate binding to 
locust muscle.
The F2  membrane suspension was twice subjected to freeze- 
thawing in liquid nitrogen. At the end of each cycle the membranes 
were recentrifuged at 30,000 x g for 20 min and the pellets resuspended 
in fresh locust saline. The binding was carried out as described in 
Methods (p. 68 ). ipH]-L-glutamate was at a concentration of 10 ^M 
and bound pH ]-L-glutamate was separated from free pH ]-L-glutamate 
by the filtration method.
Table 11 compares binding to a sample which has been freeze- 
thawed X 2 and one that has not. Freeze-thawing appeared to have a 
detrimental effect on total and hence specific binding as non-specific 
binding was relatively unchanged. It should also be noted that this 
is a particularly good preparation in that there is apparently a 
high level of specific binding and the standard error is low (mean 
of quadruplicates, S.E. <10%). From these results it is impossible 
to determine whether the purpose of freeze-thawing has' been achieved
TABLE 11
Effect of Freeze-Thawing on [ H]-L-Glutamate Binding:
Freeze-Thawed Binding (pmol/mg prot.)
Non-Specific Total Specific
0 2.03 ± 0.23 14.77 ± 1.4 12.73 ± 1.4
x21 1.61 ± 0.025 8.67 ± 0.185 7.06 ± 0.189
Results are the mean of quadruplicates ± S.E
=  10pH ]-L-glutamate 
Unlabelled L-glutamate = 5 mM
Binding was carried out as described in the Methods Cp. 68 )
Fie. 12 The Effect of Varying the Protein Concentration on
[ H]-L-Glutamate Binding to the Muscle Fraction
3 - S[ H]-L-glut., 10 M; unlabelled L-glut. 5mM; bound
3[ H]-L-glut. was separated from free by filtration 
■ total Binding; O  non-specific binding;
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but it appears that the putative L-glutamate receptor from locust 
muscle is not as stable to freeze-thawing as the putative GABA 
receptor from mammalian CNS.
6 . The Effect of Protein Concentration on pH ]-L-Glutamate Binding 
(Filtration Assay):
If the specific binding of pH]-L-glutamate that is observed 
in these experiments represents binding to membrane receptor sites 
in the P2 fraction, then the binding should increase linearly with 
protein concentration (Introduction p. 15 ).
Protein was varied from 20 - 100 yg at a pH ]-L-glutamate
-5concentration of 10 M and specific binding was found to increase 
proportionally (Fig. 12) (Mean of quadruplicates, S.E. <10%). It 
should also be noted that both total and non-specific pH ]^L^glutamate 
binding intersect the y -axis at the same point and this corresponds 
to the filter blank. Therefore, for this preparation of membrane 
fragments the assay appears to measure a true specific binding. On 
frequent repetition of this experiment the majority of the results 
that were obtained were similar but on occasion, although total binding 
still increased with increased protein,non-specific binding varied 
considerably, suggesting that for many preparations an excess of 
unlabelled L-glutamate was not effective in quantitatively displacing 
specific binding at each membrane concentration.
7. The Effect of Storage at 4°C on Specific pH ]-L-Glutamate Binding;
In view of the great variability encountered between different 
membrane preparations it was decided to investigate the feasibility 
of preparing large quantities of membranes, sufficient to provide
TABLE 12
3The Effect of Storage on Specific [ H| -L-Glutamate Binding:
Time Specific Binding
(days)
0 100%
1 56%
2 23%
Results are the means of quadruplicates S.E. < 10%
3 -5[ H] -L-glutamate = 10 M
Unlabelled L-glutamate = 5 mM
Binding was carried out as described in the Methods (p. 68 )
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material for a complete set of binding data. Membranes (P2) were
prepared and stored at 4°C for up to 2 days. At various times the
3 -5 . .?2 membrane fraction was assayed for [ H]-L-glutamate (10 M) binding
by the filtration assay (Methods p. 68 ), Table 12 shows the specific 
3binding of [ H]-L-glutamate at the times stated, expressed as a 
percentage of the specific binding to the fresh preparation. It 
was found that after 2 days specific binding drops to only 23% of 
the activity of the fresh membranes. Consequently, all subsequent 
assays of binding activity were carried out on freshly prepared ?2 
membrane fragments.
8 . The Effect of Varying the Unlabelled L-Glutamate Concentration
3on r Hi~L-Glutamate Binding (Filter Assay):
3Binding was carried out at a [ H]-L-glutamate concentration 
of 10 ^M and at 3 concentrations of unlabelled L-glutamate;- 5mM, 
lOmM and 15mM (Methods p. 68 ).
3No significant change in specific [ H]-L-glutamate binding was 
observed for the three concentrations of unlabelled ligand.(pig, 13). A 
concentration of 5 mM unlabelled L-glutamate was used in all subsequent 
experiments because higher concentrations of unlabelled L-glutamate 
raised the possibility of displacement of labelled ligand from some 
non-specific as well as from specific binding sites.
9. Saturability of pH ]-L-Glutamate Binding (Filter Assay);
Demonstration of saturable specific pH ]-L-glutamate binding 
to the ?2 membrane fragments would provide evidence for a specific 
L-glutamate receptor in this locust muscle preparation, (Introduction 
p. 15 ). Such data would also give an indication of the affinity of
Fig. 13 The Effect of Varying the Concentration of Unlabelled
L-Glutamate on [ H]-L-Glut. Binding to the 
Muscle Fraction.
C - L - g l u t ., 10  ̂M; bound [^H]-L-glut. was separated 
from free by filtration. #  specific binding;q 
non-specific binding. (Results are the means of 
quadruplicates S.E.<12%)
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the ligand for its putative receptor.
3The [ H]-L-glutamate concentration was varied from lyM -
150yM and binding was carried out as described in Methods (p.68 )•
As may be seen (Fig lA^specific binding does not saturate but tails
off at the higher concentrations. Scatchard analysis of the data
(Fig. 14(b)) suggests the presence of two binding sites, one of high
affinity, 62.75yM and 36.51 pmol/mg protein and one of lower
affinity 380yM and B^^^ 193 pmol binding sites/mg protein. The
two lines have correlation coefficients of 0.65 and 0.77 respectively.
These results are not definitive, firstly because of the poor
correlation coefficients and secondly,when the experiment was repeated 
3the specific [ H]-L-glutamate binding profile was inconsistent, on
some occasions the points being so scattered that no clear binding
profile could be discerned. In addition,the standard error of the
mean of triplicates within any one preparation for either the total
or non-specific binding was often as high as 30%. The latter observation
could infer an inability of the filtration method to separate bound 
3 3[ H]-L-glutamate from free [ H]-L-glutamate efficiently and/or with 
constancy . An alternative method of separating membrane bound ligand 
from free ligand is centrifugation of the sample after incubation at
a sufficiently high g force to rapidly pellet the membrane fragments
3 . 3and the bound [ H ]-L-glutamate, leaving the free [ H]-L-glutamate
in the supernatant. The centrifugation procedure also offers the
advantage that until the membrane pellet becomes firmly packed, the
equilibrium of ligand binding is not disturbed.
Fig. 14(a) The Effect of Concentration on [ H]-L-Glutamate Binding 
to the Muscle Fraction.
3Unlabelled L-glut. 5mM; bound [ H]-L-glut. was separated 
from free by filtration; ■ total binding; q  non­
specific binding; # specific binding. (Results are 
the means of two experiments each in triplicate.
S.E. < 15%).
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Fig. 14 (b) It should be noted that the experimental values
presented in Fig. 14 (b) are composites of the
two proposed binding sites and this analysis may
not give true values of and B . A more® D  max
rigorous treatment of the data is that of Rosenthal, 
H.E. (1967), Anal. Biochem., p.525. This and 
other interpretations are discussed in N^rby, J.G., 
Ottolengli, P. and Jensen, J. (1980), Anal.
Biochem., 102, p.318. Such a rigorous analysis 
was not applied to the data in Fig. 14 (b) because 
only an approximation of the 's was required from 
these preliminary results.
Fig. 14 (b) Scatchard analysis of the data represented 
in Fig. 14 (a)
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310. A Comparison of the [ H t~L-Glutamate Binding Assayed by the
Filtration and Airfuge Centrifugation Methods;
3Earlier attempts of separating bound [ H]-L-glutamate from 
free by centrifugation used a Beckman microfuge, at its maximum 
force of 2,000 x g. This method proved unsuccessful even though 
the samples were centrifuged for 5 min (Results Table 10), hence 
the method was abandoned on the grounds that the Beckman microfuge 
could not produce a sufficiently high g force to quickly form a 
firm pellet of the membranes. However, the Beckman airfuge reaches 
a force of 100,000 x g in less than 10s and it was found that the 
^ 2  membrane fragments had formed a tight pellet after a centrifugation 
time of 1 min at this g force.
Binding was carried out as described in the Methods Cp• 68 )
3[ H ]-L-glutamate was separated from free by either filtration through 
Whatman GF/C filters or by centrifugation in a Beckman airfuge at 
100,000 X g for 1 min.
Table 13 shows total, non-specific and specific binding of
3{ H]-L-glutamate, measured by both methods for 4 separate membrane
3preparations. Specific J[ H]-L-glutamate binding was consistently
higher and the standard error lower ( <; 8%) as assayed by the airfuge
3centrifugation method than [ Hj-L-glutamate specific binding as
assayed by the filtration method. Therefore,the airfuge centrifugation
3 3method of separating bound [ H]-L-glutamate from free [ H]-L-glutamate
is apparently more efficient and more reliable for any one preparation
(S.E. < 8%) than the filtration method (S.E. < 60%). However, it
should be noted that there is no improvement in the inconsistency
of the amount of [^H]-L-glutamate bound from preparation to preparation,
TABLE
Comparision of Binding Assayed by the Airfuge Centrifugation 
Procedure and by the Filtration Assay:
Prep. 
No.
Assay Binding (pmole/mg protein)
Non-Specific Total Binding Specific Binding
Binding
1 Centrifugation 24.23 ± 1.56 56.68 ± 2.26 32.46 ± 2.7
1 Filtration 17.83 ± 2.97 21.94 ± 1.30 4.11 ± 3.2
2 Centrifugation 59.45 ± 1.77 67.28 ± 2.41 7.83 ± 2.99
2 Filtration 19.35 ± 0.57 24.42 ± 1.59 5.07 ± 1.69
3 Centrifugation 26.06 ± 3.74 319.09 ± 11.23 293.03 ± 11.8
3 Filtration 32.0 ± 1.31 109.7 ± 4.54 77.7 ± 4.73
4 Centrifugation 44.8 ± 6.68 172.34 ± i.Ol 127.54 ± 7.79
4 Filtration 17.01 ± 0.69 76.66 ± 3.21 59.65 ± 3.28
Results are the means of quadruplicates ± S.E
3 “5[ H]-L-glutamate = 1 0  M
Unlabelled L-glutamate = 5 mM
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This would suggest a variable as yet undetected,and independent of 
the method of assaying specific binding of [^H]-L-glutamate. 
Nevertheless, because of the improved S.E. the airfuge centrifugation 
assay was used in all subsequent experiments, unless stated otherwise,
11. Comparison of the Specific Binding of [ H]-L-Glutamate in the
Various Fractions;
Previous experiments had been carried out on the P^ membrane
fraction, on the assumption based on the work of James (1977) that
this fraction was enriched in the putative L-glutamate receptor. To
confirm this assumption, binding was assayed in all fractions.
Binding was carried out as described in the Methods Cp. 68 ).
[̂ H ]-L-glutamate was at a concentration of 10 ^M. Bound pH]-L-
glutamate was separated from free [ H]-L-glutamate by the filtration
assay for the fraction and by the airfuge centrifugation for the
total homogenate, P^, and P^ fractions.
Table 14 , shows the specific binding, purification (taking
specific binding in the total homogenate as unity), total protein
recovered and hence total binding activity recovered. The greatest
specific binding activity was in the P^ fraction, representing a
purification of 4 with respect to the total homogenate. However only 
320% of total [ H ]-L-glutamate binding activity was recovered in this 
fraction. A lot of specific binding activity appeared in the P^ 
fraction (69%) but non-specific binding to this fraction was also 
very high. When choosing a suitable fraction for further study of 
pH]-L-glutamate binding,minimal non-specific pE]-L-glutamate bind­
ing to that fraction is preferred because of the unsatisfactory methods
TABLE 14
Comparison of Specific Binding in Different Fractions
Fraction Specific
Binding
(pmol/mg 
prot.)
Purifi­
cation
Tot. Prot. 
(mg)
Tot. 
Binding
(pmol)
% Binding 
Recovered
Tot. Hom. 17.1 ± 3.6 1 226.5 3873 100%
33.4 ± 3.0 2 80.0 2672 69%
Si 6.69 ± 0.86 0.39 124.5 832.9 22%
- 58.25 - -
^2 70.8 ± 1.5 4 10.9 771.72 20%
Results are the means of triplicates ± S.E
pH ]-L-glutamate = 10  ̂M
Unlabelled L-glutamate = 5 mM
Binding was carried out as described in the Methods (p. 68 ),
Fig. 15 The Effect of Varying the Protein Concentration on
[ H]-L-Glut. Binding to the Muscle Fraction. 
[^H]“L“glut. 10  ̂M; unlabelled L-glut. 5mM; bound
3[ H]-L-glut. was separated from free by airfuge 
centrifugation. ■ total binding; O  non-specific 
binding; #  specific binding. (Results are the 
means of triplicates. S.E.<10%)
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available to account for non-specific binding. Thus the fraction 
was chosen in preference to the P^ fraction for further study,
12. The Effect of Varying Protein Concentration on the Binding of 
3[ H] -L-Glutamate (Airfuge Centrifugation Assay):
3It was necessary to show that specific binding of [ H] -L- 
glutamate to the P^ membrane fraction was linear with respect to 
protein concentration for the airfuge centrifugation method of
assay,
Binding was carried out as described in the Methods Cp. 69 );
3 . -5 . .[ H]-L-glutamate was at a concentration of 10 M. Protein was varied
from 0.19 mg to 1.0 mg.
3Specific [ H]-L-glutamate binding increased proportionally
with protein (Fig. 15 Mean of triplicates S.E. < 10%). Both the
lines representing total and non-specific { H]-L-glutamate binding
failed to go through the origin but intersected the y-axis at the
same point; this corresponds to non-specific binding to the separating
3material (see AChR Discussion p. 155 ) and to [ H]-L-glutamate trapped 
in the pellet.
13. The Effect of Varying the Concentration of Unlabelled L-Gliitamate
3on the Specific Binding of J H]-L-Glutamate (Airfuge Centrifugation 
Assay);
Binding was carried out as described in the Methods (p. 69 ). 
pH ]-L-glutamate was at a concentration of 10 ^M and unlabelled L- 
glutamate was varied from 1 mM - 20 mM. The results are shown in 
Table 15. Increasing the unlabelled L-glutamate in this concentration 
range caused no further displacement of specific binding. It can
TABLE 15
The Effect of Varying Cold L-Glutamate on Non-Specific and Specific 
Binding as Assayed by the Airfuge Centrifugation Assay;
Total Binding = 64.73 pmol/mg protein 
±1.92
Unlabelled L-Glutamate 
(mM)
Binding (pmol/mg prot.)
Non-Specific Specific
1 27.45 ± 2.23 37.28 ± 2.94
5 28.54 ± 2.12 36.19 ± 2.86
10 27.96 ± 1.27 36.77 ± 2.30
20 28.19 ± 2.3 36.54 ± 2.99
Results are the means of quadruplicates ± S.E.
3 —5[ H]-L-glutamate = 10 M
Binding was carried out as described in the Methods Cp. 69 )•
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therefore be assumed from this experiment that all the specific 
L-glutamate specific binding sites are occupied by unlabelled L- 
glutamate when the unlabelled ligand is at a concentration of 5 mM. 
This concentration of unlabelled L-glutamate was used to account for 
non-specific binding in all subsequent experiments.
314. The Dependence of [ H]-L-Glutamate Binding on Concentration 
(Airfuge Centrifugation Assay):
Binding was carried out as described in the Methods Cp. 69 ).
3Unlabelled L-glutamate was at a concentration of 5 mM and [ H]-L-
glutamate was varied initially from 1.5 - 110 ̂ f'Vand then from IpM -
3 3200yM. Bound [ Hj-L-glutamate was separated from free [ E]-L-
glutamate by the airfuge centrifugation assay.
The lower concentration range was investigated because of
reports by other workers (Biziere e^ al̂ ,, 1980; Roberts, 1981) of
K^'s in the hanomolar range, for membrane preparations from rat brain.
Using locust muscle membrane fragments, the lower concentration 
3range of [ H]-L-glutamate was investigated numerous times. The same 
problems persisted as has been obvious throughout this work, namely 
poor reproducibility of specific binding of pH]-L-glutamate.
Fig.16 (a)(b) and (c) show examples of specific binding of t Ĥ^ 
L-glutamate obtained in different experiments, apparently under the 
same experimental conditions. As can be seen, not only the amount of 
pH]-L-glutamate specifically bound is inconsistent from preparation 
to preparation but also the binding profile varies considerably.
Fig.16(a) suggests saturation. Fig.16 (b) shows no indication of 
approaching saturation,and Fig.16 (c) suggests either two binding
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TABLE 16 A Summary of the 's Obtained for L-Glutamate Binding
to the Muscle Fraction
Preparation Number
1 63.0 /xM 380 /xM
2 2.0 nM 63.0 /pM
3 12.5 nM 1.3^
4 47.9 nM
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sites or cooperativity. These results are just examples of the 
diversity of results obtained and on some occasions no displacement 
and hence no specific [ H]-L-glutamate was observed. However, on 
some occasions, Scatchard analysis of the binding data yielded a 
value for K^. A summary of the different K^*s calculated for 
different preparations is given in Table 16 . Included in this
table are the results of experiments carried out over a wider 
concentration range, 0.1 yM - 200 yM.
Although these values are very scattered, the presence of 
three binding sites for [ H]-L-glutamate can be tentatively suggested; 
a high affinity binding site in the nM range, a medium affinity 
binding site in the lower yM range and a low affinity binding site 
in the high yM region.
215. Experiments to Investigate the Variation in [ H]-L-Glutamate 
Binding from Preparation to Preparation 
The previous set of experiments which investigate the dependence
2of [ H ]-L-glutamate binding on concentration exemplifies the variation in specific 
3[ H ]-L-glutamate binding to this P^ membrane fraction, under apparently 
the same conditions of preparation and assay. The standard error 
of the mean of triplicates was low, < 8% for all these preparations, 
suggesting a constancy in the binding assay for any one preparation.
Also it is unlikely that any change in the physical parameters of the 
binding assay conditions (incubation, centrifugation conditions, 
washing and counting of sample) of sufficient magnitude to affect 
the amount of specific binding would go undetected. On the other 
hand, the preparation of the tissue, although carried out under
TABLE 17
The Effect of Longer Centrifugation Time on RSA of GPox in the 
Supernatant;
Fraction RSA Specific Binding 
(pmol/mg prot.)
Tot. Homogenate 1 22.8 ± 3.2
S^ 10 min * 0.174 3.65 ± 0.78
S^ 20 min 0.106 3.44 ± 0.53
S^ 30 min 0.122 3.96 ± 0.91
S^ 45 min 0.132 3.01 ± 0.32
^2 1.371 94.4 ± 3.35
Results are the means of quadruplicates ± S.E.
[̂ h ]-L-glutamate concentration = 10
Unlabelled L-glutamate = 5 mM
Enzyme activity was assayed as described in the Methods (p. 65 ) 
Binding was carried out as described in the Methods (p. 69 )..
* Centrifugation time
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apparently the same conditions for every preparation (homogenisation,
centrifugation and age of preparation), is more likely to include as
yet undetected and therefore unaccounted for, variants which could
3affect the specific [ H]-L-glutamate binding and therefore a number
3of possible factors which could affect [ H]-L-glutamate binding to 
the membrane fragments were considered.
a) The Effect of Longer Centrifugation Time at 3000 x g on the 
RSA of GPox in the Supernatant :
Electronmicrographs (Plates 1 and 2) of the P^ membrane fraction 
showed that although this fraction is largely composed of membrane 
fragments there is still a lot of contamination by mitochondria. 
Mitochondrial contamination of this fraction was also suggested by 
the enrichment of enzymes (Table 4 ) that have a mitochondrial
localisation in other insect systems (Donnellan, 1974) . It was 
thought that perhaps mitochondria were interfer-ing with the neuro­
receptor specific binding of pH]-L-glutamate, either by high affinity 
uptake or metabolism of the labelled L-glutamate. Therefore, in 
an attempt to reduce the mitochondrial contamination of the P^ 
membrane fraction, longer times of centrifugation at 3,000 x g were 
investigated in relation to the RSA of one typical mitochondrial 
marker enzyme (GPox ), in the supernatant, (S^). It was hoped that 
more mitochondria would pellet with the longer centrifugation times 
and hence a reduction of GPox RSA values would appear in the S^ 
supernatant,possibly accompanied by increased specific pH]-L- 
glutamate binding.
Table 17 shows the RSA values in the S^ supernatant after 
10, 20, 30 and 45 min. centrifugation at 3,000 x g . Specific pH]- 
L-glutamate binding to the S^ fraction is also shown.
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The increased times of centrifugation at 3,000 x g investigated 
had no effect on the RSA of GPox in the S^ supernatant, hence there 
was still an enrichment of this enzyme and also presumably of 
mitochondria in the P^ pellet fraction, indicated by a RSA of greater 
than 1. Also no increase in specific [^H]-L-glutamate binding was 
apparent in the S^ supernatant with increased centrifugation time, 
and therefore in subsequent experiments the tissue was prepared as 
outlined in Fig. lo.
b) The Effect of Ethanol on pH_]-L-Glutàmàté Binding;
Ethanol causes an increase in the force of the neurally
evoked contractions of the innervated retractor unguis muscle of the
locust (McDonald e^ a]^., 1974). The authors suggest that alcohol,
either directly or indirectly,increases the intracellular concentration
of calcium _ by interacting with the cellular membranes to promote
calcium ion influx to the contractile mechanism of the muscle fibres.
If this is the case then it is possible that the interaction of the
alcohol with the cellular membranes could be at the L-glutamate
receptor and so could disturb the normal ion-gating mechanisms controlled
by this receptor. Michaelis e^ a^ (1978) have also shown that ethanol
3administered to rats i^ vivo causes changes in the [ H ]-L-glutamate 
binding capacity of brain membrane fractions,subsequently assayed 
in vitro.
The pH ]-L-glutamate from The Radiochemical Centre, Amersham,
used in the experiments in this thesis was in solution in 2% ethanol.
3When isotopic dilution of [ H ]-L-glutamate is carried out the final
-5 3concentration of ethanol in a 10 M [ H ]-L-glutamate solution is 4mM.
TABLE 18
The Effect of Ethanol on the Binding of pH }-L-glutamate;
Final Ethanol 
Concentration Binding (pmol/mg protein)
Non-Specific Total Specific
0 36.44 ± 6.32 65.33 ± 7.55 28.89 ± 9.85
4mM 49.51 ± 3.72 60.68 ± 7.36 11.16 ± 8.25
3 . -5[ H]-L-Glutamate was at a concentration of 10 M.
Unlabelled L-glutamate was at a concentration of 5 mM.
Binding was carried out as described in the Methods Cp. 69. )
Results are the means of quadruplicates ± S.E.
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It was thought that in view of both electrophysiological studies
on locust muscle of McDonald e^ BlL (1974) and the studies on rat
brain im vivo carried out by Michaelis (1978) , these concentrations
3of ethanol could be affecting the binding of [ H]-L-glutamate to
2
the membrane fraction. To see if this was the case, [ H]-L-
glutamate binding to the same P^ membrane fragment preparation was
carried out using two samples of [ H]-L-glutamate from the same batch;
one blown down to dryness under nitrogen, taken up in locust saline
and isotopically diluted to give a final concentration in the incubation
tube of 10 ^M pH ]-L-glutamate, the other sample was isotopically
diluted as usual to a final concentration of 10 ^M pH]-L-glutamate.
3As can be seen from Table 18, specific binding of [ H]-L-
glutamate to the membrane fragments was higher in the ethanol free
sample. Total binding was unchanged by removing the alcohol.
Therefore it would appear from this experiment that ethanol at a
3concentration of 4 mM causes a decrease in specific [ H_}-L-glutamate 
binding.
3All samples of [ H]-L-glutamate were therefore taken to
dryness before use, in all subsequent experiments. This procedure,
however, had little effect in improving the reproducibility of the 
3amount of [ H]-L-glutamate bound from preparation to preparation.
c) The Effect of Incubation of the P  ̂Membrane Fragments and 
3[ H]-L-Glutamate in the Centrifuge Tubes;
In previous experiments incubation was carried out in a total 
volume of 500 yl, of which 150 yl was removed and centrifuged. This 
500 yl contained , on average, 200 yg - 300 yg of protein and a final 
concentration of 10 ^M pH]-L-glutamate and when accounting for
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non-specific binding 5 mM unlabelled L-glutamate. When the
incubation was carried out in centrifuge tubes, in a total volume
3of 150 yl, the final concentrations of [ H]-L-glutamate and unlabelled
~5L-glutamate were maintained at 10 M and 5 mM respectively but the 
protein was increased from 200 - 300 yg per 150 yl as opposed to 
200 - 300 yg per 500 yl previously used. Incubation in the centrifuge 
tubes would ,firstly ,eliminate any possible inaccuracies in trans­
ferring samples from the incubation tube to the centrifugation tube.
In addition,the increased protein concentration should result in
3an increase in the amount of specifically bound [ H]-L-glutamate per
150 yl sample and the standard error of the mean between triplicates
would be expected to be smaller because of the increase in recorded
counts associated with one sample.
Incubation in centrifuge tubes initially appeared to improve
both the reproducibility within and between preparations. However,
after an initial series of experiments, it became obvious that in a
3majority of experiments more [ H]-L-glutamate was apparently being
bound in the presence of an excess of unlabelled L-glutamate than in
its absence. In previous experiments the inconsistency of [^H]-L-
3glutamate binding, and the occasional absence of specific [ H]-L- 
glutamate binding has been attributed to an,as yet,undetected 
artifact in the preparation and/or the binding assay. In these 
experiments it was thought unlikely that the increased protein 
concentration in the incubation mixture was the cause of the erroneous 
but consistent results. In a number of the previous experiments 
using the lower concentration of protein, there was no apparent 
displacement of [^H]-L-glutamate binding by an excess of unlabelled
- 9 5 -
L-glutamate, but the amount of labelled glutamate that was bound 
was so low that it was not possible to determine whether the unlabelled 
glutamate had in fact caused an increase in binding. A number of 
possibilities for these as yet inexplicable results were subsequently 
investigated.
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16. Experiments to Investigate the Apparently Increased Binding of 
3[ H]-L-Glutamate in the Presence of an Excess of-Unlabelled L-Glutamate:
3a) The Metabolism of [ H]-L-Glutamate:
3It was thought that perhaps [ H]-L-glutamate was being 
metabolised by enzymes associated with the membrane fraction 
and that increased tissue concentrations, hence also in the associated 
enzymes,would cause an increase in the amount metabolised. Further­
more, if the enzymes involved were sensitive to positive cooperativity, 
then an increased concentration of L-glutamate would result in an
increased metabolism of both labelled and unlabelled L-glutamate.
3Alternatively, the phenomenon of increased apparent [ H]-L-glutamate
binding in the presence of an excess of unlabelled L-glutamate could
be the result of simple mass action. In incubations in which there
is a low concentration of substrate,i.e. in the absence of unlabelled
L-glutamate, metabolism may be at a low level. However, when the
concentration of substrate is increased by the addition of unlabelled
ligand, there may be an increase in metabolism and more substrate
could be pushed through the system, resulting in an apparent' increase 
3in [ H]-L-glutamate binding.
In an attempt to inhibit any possible metabolism of L-glutamate,
the metabolic inhibitor monofluroacetate was included in the incubation
media and/or the incubation was carried out at 4°C instead of the
more usual temperature of 23°C. In the two experiments carried out
under the above conditions, there was still an increase in pH]-L-
glutamate binding in the presence of excess unlabelled L-glutamate,
3indicating that metabolism of the [ H]-L-glutamate was unlikely to be
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contributing to the apparent binding.
The presence of possible metabolites of pH ]-L-glutamate in
the incubation media was investigated by thin layer chromatography.
Protein-free samples were examined after incubation for 0, 15, 30
and 60 min with 10 pH ]-L-glutamate with and without 5 mM
unlabelled L-glutamate. The plates were run in two dimensions and
the standards were run in one dimension along both sides (Methods
p. 70 ). The pattern of stained spots was the same for all the
incubation times investigated and only the sample spot corresponding
to L-glutamate had any radioactivity associated with. it. So it would
3appear that no metabolism of [ H]-L-glutamate occurs during incubation 
times up to 60 min.
b) The Effect of Preincubation with Unlabelled L-Glutamate 
3on [ H]-L-Glutamate Binding;
membrane fragments were incubated with 5 mM unlabelled
L-glutamate for 5, 10 and 15 min at 23°C^prior to the addition of 
3 . . —5[ H]-L-glutamate (final concentration 10 M) and further incubation
for 15 min. Control membrane samples were incubated for the same
times and at the same temperature, in the absence of unlabelled L-
glutamate, prior to incubation with pH]-L-glutamate.
Table 19 shows the results from two experiments, each carried
out in quadruplicate and both apparently under the same conditions.
Firstly, in comparing the results from the two preparations it appears
3that in preparation (a) there is more [ H ]-L-glutamate bound in the
presence of an excess of unlabelled L-glutamate whereas in preparation
3(b) the converse is true and there is apparent specific [ HfL-glutamate
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binding as defined by the "excess unlabelled ligand" method of
assessment. This exemplifies the variation in [^H]-L-glutamate
binding from preparation to preparation where the only apparent
difference is that the tissues were prepared on different days and
suggests that the probable artifact which causes an increase in
[ H]-L-glutamate binding on addition of an excess of unlabelled
L-glutamate is not present in every preparation or alternatively
is suppressed in some preparations. Secondly, in both preparations 
3the amount of [ H ]-L-glutamate associated with the tissue appears 
to increase with longer pre-incubation times and this increase is 
greater when excess unlabelled L-glutamate is present.
One supposition, on the basis of the latter observation is 
that the pH]-L-glutamate binding capacity of the membranes changes 
with time. If only preparation (b) is considered, this change is 
associated with a non-specific pH ]-L-glutamate binding component, 
as both total and non-specific pH]-L-glutamate binding increase 
similarly,leaving specific pH ]-L-glutamate binding unchange. However, 
the same cannot be said for preparation (a), as there is apparently 
no specific [ H ]-L-glutamate binding to this preparation, as defined 
by the"excess unlabelled ligand"method of assay. One could speculate 
that there are two factors affecting the binding of [ H ]-L-glutamate 
to the membrane fraction, one of which is affected by preincubation 
of the tissue at room temperature and is obvious in preparation (b) 
and a second which is manifested by the presence of an excess of 
unlabelled L-glutamate. Both artifacts could be affecting the [ H ] 
-L-glutamate binding to preparation (a).
TABLE 19
The Effect of Preincubation with Unlabelled L-Glutamate on [ H ]-
L-Glutamate Binding:
(a) Preparation No. 1
Preincubation Time 
(min)
+ Excess L-Glutamate 
(pmol/mg prot.)
- L-Glutamate 
(pmol/mg prot.)
5 74.9 54.9
10 86.9 55.9
15 90.0 59.9
Results are the means of quadruplicates. S.E. < 8%.
(b) Preparation No . 2
Preincubation Time 
(min)
+ Excess Unlabelled 
L-Glutamate
- Unlabelled 
L-Glutamate
5 33.2 52.3
10 39.4 54.5
15 45.3 60.6
Results are the means of quadruplicates. S.E. < 5%
3 -5[ H]-L-glutamate = 10 M
Unlabelled L-glutamate = 5 mM
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3c) Effect of pH on [ H]-L-Glutamate Binding;
Binding was carried out over a pH range of 5.5 - 9. All 
solutions were adjusted to the required pH prior to incubation.
Fig. 17 shows the total binding and the binding in the presence 
of an excess of unlabelled L-glutamate (5 mM). Fig. 17 shows that 
most binding occurs at the lower pH range and is unchanged between 
pH 6 - 7. However,in all cases there was more apparent binding in 
the presence of an excess of unlabelled L-glutamate indicating that 
the pH of the incubation media is not responsible for this phenomenon,
Fig. 17 The Effect of pH on [ H]-L-Glutamate Binding to the
Muscle Fraction in the Presence and Absence of 
Unlabelled L-Glutamate.
3Unlabelled L-glut. 5 mM; bound [ R]-L-glut. was 
separated from free by airfuge centrifugation;
#  + unlabelled L-glut. O  “ unlabelled L- 
glut. (Results are the means of quadriplicates. 
S.E.<8%)
a.
§
01
IO.o
4J 3 1—( bO 
I
1-1I
CO
I
5.5 6.0 6.5 7.0
pH
8.0 8.5 9.0
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317. The Effect of Various Marine Toxins on Specific [ H]-L-Glutamate 
Binding;
Two toxins a and 3 cephalotoxin (M^ 19,200 and 33,900
respectively) have been isolated from the octopus. Octopus vulgaris
(Cariello and Zanetti, 1977). Both these toxins along with a third
toxin, suberitine (M^ 28,000), isolated from the marine sponge,
Suberitus domuncula (Cariello and Zanetti, 1979) have a paralysing
effect, possibly by neuro-muscular blockade, on the crab, Pachigrapsus
marmoratus. Furthermore^it was also suggested from preliminary
investigations on a preparation of locust muscle that the cephalo-
toxins act at the synaptic level inhibiting glutamate mediated
transmission (Cariello and Zanetti, 1977) , For these reasons the
cephalotoxins and suberitine were investigated as potential antagonists
of L-glutamate binding to the P^ membrane fragments prepared from
locust muscle. All three toxins were in limited supply as they were
a gift from Professor Lucio Cariello and were not commercially
available. Therefore, only a preliminary study was possible.
Initially the effects of the lower concentrations of toxins
on the specific binding of [^H ]-L-glutamate CIO ^M) were investigated
(Table 20a). Non-specific binding was accounted for by incubation
3in the presence of 5 mM unlabelled L-glutamate. Bound [ H]-L-
3glutamate was separated from free [ H] -L-glutamate by the airfuge
centrifugation assay. The results were expressed as the percentage 
3of specific [ H]-L-glutamate binding displaced by the toxins at tlie
concentrations used. Using the lower concentrations all three toxins
3displaced specifically bound [ H]-L-glutamate, suberitine being the 
most potent, followed by 3-cephalotoxin and a-cephalotoxin in that
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order (Table 20a ). In a subsequent preparation the concentration
of all three toxins was doubled but only with g-cephalotoxin was
there a corresponding increase in displacement of specific [ H]-L-
glutamate binding. With suberitine the displacement was decreased
3by a factor of 2.5, whereas binding was greater than total [ H]-L- 
glutamate binding when the concentration of a-cephalotoxin was 
doubled.
After carrying out these experiments a small quantity of only
suberitine remained, which was used in later experiments,that showed 
3an increase in [ H]-L-glutamate binding in the presence of excess
3
unlabelled L-glutamate. The effect of suberitine on [ H]-L-glutamate
binding was again investigated to see if it too caused an increase 
3in [ H]-L-glutamate binding.
[^H]-L-glutamate (10 ^M) binding to the membrane fragments
was assayed in the presence and absence of 5 mM L-glutamate and/or
31 yM suberitine, as described in the Methods (p. 69 ). Table 20 (b)
shows the results of two experiments,each carried out in triplicate.
In both cases, unlabelled L-glutamate caused an apparent increase 
3in [ H]-L-glutamate binding. This increase was lower when incubations
were carried out in the presence of both unlabelled L-glutamate and
suberitine, suggesting that perhaps suberitine reduced the increase
3in apparent binding of [ H ]-L-glutamate seemingly caused by unlabelled
3L-glutamate. However, suberitine alone did not displace [ H]-L-
glutamate binding as in the previous experiments (Table 20a ) and
in preparation 2 (Table 20b ) apparently caused a slight increase in 
[ H ]-L-glutamate binding, although not to the same extent as did 
unlabelled L-glutamate.
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The results are interesting in that suberitine seemed to
3reduce the increase in [ H] -L-glutamate binding apparently caused
by unlabelled L-glutamate. Further study may assist in providing
an explanation for the erroneous results obtained in the presence
of an excess of unlabelled L-glutamate. Furthermore, these
preliminary experiments suggest that a and 3 cephalotoxin and
3suberitine may be capable of displacing specifically bound [ H] -L- 
glutamate and as such may be useful probes for the binding site of 
the putative glutamate receptor. However, it is clear that con­
siderably more work must be done before their usefulness can be 
properly assessed.
TABLE 20 (a)
. . 3The Effect of Cephalotoxin and Suberitine on Specific [ H]-L- 
Glutamate Binding;
Toxin Coneentrâtion 
(yM)
3% Displacement of Specific [ H]- 
L-Glutamate Binding
a-Cephalotoxin 18 24%
a-Cephalotoxin 36 increased binding
3”Cephalotoxin 9 58%
3-Cephalotoxin 18 79%
Suberitine 31 80%
.Suberitine 62 33%
3 . -5[ H]-L-glutamate was at a concentration of 10 M.
Unlabelled L-glutamate was at a concentration of 5 mM.
Binding was carried out as described in the Methods (p. 68 )
Standard error of the mean of quadruplicates ^ 10%.
TABLE 20 (b)
The Effect of Suberitine on [ H]-L-Glutamate Binding;
Preparation
Number
L-Glutamate 
Present (5 mM)
Suberitine 
Present (31 yM)
3[ H]-L-glutamate 
Bound 
(pmol/mg prot.)
1 - — 229.87 ± 10.6
1 + - 365.88 ± 5.22
1 - + 221.11 ± 10.2
1 + + 301.63 ± 12.16
2 - - 324.86 ± 3.25
2 + - 421.24 ± 9.73
2 - + 344.49 ± 3.46
2 + + 363.40 ± 6.32
Results are the means of triplicates ± S.E.
Binding was carried out as described in the Methods (p. 68 )
3 . ~5[ H] -L-glutamate was at a concentration of 10 M.
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GENERAL DISCUSSION
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The major constraint on progress in the biochemical character­
isation of glutamate neuroreceptors in both vertebrates and inverte­
brates is the lack of a diagnostic glutamatergic ligand. The 
problem is compounded in insects by the inability to obtain a 
preparation enriched specifically in synaptic membranes. The lack 
of a ligand that binds to glutamate receptors with a specificity 
and a high affinity analSi^ous to a-BgTx binding to the vertebrate nAChR 
has resulted in the use of the natural ligand, L-glutamate, as the 
receptor probe. In turn this presents serious problems in receptor- 
ligand binding studies;
1. As the natural neurotransmitter is the only ligand 
available as a specific probe for the receptor, it follows 
that it is the only ligand that can be confidently employed 
in the "excess unlabelled ligand" method (p. 76 ) of 
accounting for non-specific binding. Theoretically this should 
present no problems (Turner, 1980) but in practice a chemically 
distinct ligand is preferred (see AChR Discussion p. 155 ).
2. For a compound to be physiologically neuroactive binding
to its receptor must be readily reversible to avoid densensit-
isation and thus allow recovery of the membrane to its resting
state. Therefore, if L-glutamate is the neurotransmitter at
the insect neuromuscular junction, as postulated, a relatively
short half-time of dissociation of receptor-1igand complex
in vitro would be anticipated. Consequently, the techniques
3used in this thesis to separate membrane bound [ H]-L-glutamate 
3from free [ H]-L-glutamate may not be rapid enough to prevent 
significant dissociation (see AChR Discussion p. 154 ).
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3. L-Glutamate, unlike acetylcholine, plays a central role 
in intermediary metabolism, and consequently is a substrate 
for numerous enzymes which represent non-neuroreceptor^but 
specific,binding sites for this amino acid. Furthermore, 
if present and under the right conditions these enzymes 
could metabolise the L-glutamate added to a preparation and^ 
if this is not accounted for,an overestimation of the amount 
of L-glutamate available for neuroreceptor binding would 
ensue.
Preparation of synaptosomes from insect muscle has proved 
difficult because of the fragility of several of the constituents 
of the muscle cell, in particular the mitochondria, and also because 
of the cells’ high content of sarcoplasmic reticulum. (Donnellan, 
e^ al^., 1974; Briley, 1981; see Introduction p. 36 )• Consequently, 
suitable marker enzymes associated with specific membranes have 
not yet been delineated. As a result of these insurmountable 
problems the membrane preparations currently available are ill- 
defined and heterogeneous.
Clearly, rectification of either of the two major problems 
- an ill-defined preparation and lack of a diagnostic ligand - would 
minimise the adverse characteristics of the other. Unfortunately, 
a solution to either is not apparent in the immediate future because 
firstly, the discovery of a high affinity specific ligand for 
L-glutamate would require an intensive study of analogues of the 
amino acid,which may prove to be pharmacologically active and/or 
a systematic physiological and biochemical investigation of the 
numerous natural toxins available. The former line of investigation
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has commenced on preparations of mammalian brain (see, Davies et al, 
1980) but it is more likely that a study of natural toxins will 
reveal a potent L-glutamate antagonist, as was the case in the 
discovery of a-bungarotoxin. However, because the range of natural 
toxins is so wide and because rarely are both biochemical and 
physiological studies carried out simultaneously, it would be 
fortuitous if such a toxin/antagonist was to become immediately 
apparent. Secondly, the starting material for binding studies is 
frequently a crude membrane preparation and in such preparations 
specific binding to non-receptor sites may well obscure the specific 
binding to the receptor under study.
The fractionation scheme in Fig. 10 was employed with a view 
to removing the bulk of the mitochondria, a paramount but readily 
identified contaminant, from the preparation with, minimal reduction 
in the yield of membrane fragments. Both electronmicrographs 
(Plates 1 and 2) and enzyme studies (Table 4 ) on the P^ fraction 
indicate that this has been achieved. Enzyme studies localised 
mitochondrial enrichment to the P^ pellet fraction whereas electron­
micrographs showed P^ to be largely composed of membrane fragments 
with limited mitochondrial contamination. On the basis of these 
results the P^ membrane fraction presented a likely point at which 
to commence investigations of putative L-glutamate receptors in 
insect muscle. The conclusions drawn from electronmicrographs and 
enzyme studies were later confirmed in that the differential 
centrifugation of Fig. 10 yielded a P^ membrane fraction which was 
enriched in specific pH ]-L-glutamate binding activity (Table 14 ).
From the outset the most persistent problem in the binding
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3studies lay in obtaining a consistent amount of specific [ H]-L- 
glutamate binding from preparation to preparation; a problem which
was compounded in initial binding experiments using GF/C vacuum
3 3filtration to separate bound [ H]-L-glutamate from free [ H]-L-
glutamate by the frequently high standard error, often greater than
30% of the sample value, between triplicates and quadruplicates.
Poor reproducibility between samples suggests an inconsistency
in the method of assaying specific binding activity, possibly
attributable to an inefficiency in the separation technique such
3that not all of the free [ H]-L-glutamate passes through the filter
on every occasion. This seems to be a more probable explanation
than the likelihood that the binding capacity of the sample changes
between samples.
High standard errors within a preparation were curbed to a
certain extent by trimming the filter discs after filtration and
by rigorously controlling the time taken for the sample and the wash
to filter. Thus, in preparations in which reproducible displaceable 
3[ H]-L-glutamate binding was observed, binding was apparently
specific L-glutamate receptor bindingas shown by the linearity of
specific [ H]-L-glutamate binding with increasing protein concentration
and thus is in agreement with point B of the criteria (p. 15) for
3defining a physiological receptor. Specific [ H]-L-glutamate binding
3
was also dependent on the concentration of [ H]-L-glutamate (Fig.14 (a)) 
but the classic hyperbolic binding curve, indicative of a single 
class of saturable binding sites, was not obtained. The observed 
binding profile is suggestive of either two classes of binding sites 
or positive cooperativity of L-glutamate binding. Only after
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extensive study at numerous concentrations can Scatchard analysis 
of the data distinguish between the two. Unfortunately, the 
limited data in these studies made it impossible to conclude 
irrefutably which was the case. If the results are interpreted 
as two populations of specific L-glutamate receptors, a high affinity 
(low K^) population, corresponding to neuroreceptor binding sites 
and a lower affinity (higher K^) population possibly corresponding 
to a specific Na^ independent (as all experiments were carried out 
in Na^ free buffer) uptake system, two K^’s of 62.75 yM and 380yM 
respectively are obtained. Such an interpretation is corroborated 
firstly, by evidence to suggest that high affinity uptake is the 
most probable mode of removal of the natural transmitter from the 
synaptic cleft (see Introduction p. 36 ) and secondly by the work 
of Briley (1981) which demonstrates specific uptake of L-glutamate 
into a vesiculated membraneous fraction of locust flight muscle, of 
which only a proportion is sodium dependent. It is quite conceivable 
that in this ill-defined membrane fraction specific uptake sites 
for L-glutamate are contributing to the specific binding component 
and are possibly interfering with the higher affinity ^neuroreceptor 
binding site.
Freeze-thawing of the sample caused a decrease in only the
3 . .specific [ H]-L-glutamate binding component (Table 11 ) a reduction
perhaps associated with impairment of specific uptake sites for 
L-glutamate. The effect of freeze-thawing was not investigated any 
further because the objective of freeze-thawing at this stage in the 
study was to improve the specific binding capacity of the membranes 
by possible exposure of previously inaccessable specific binding sites
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and/or to remove possible sequestered endogenous L-glutamate (p. 81).
A decrease in specific [ H]-L-glutamate binding to a freeze-thawed
preparation indicated that this objective had not been attained.
3An alternative method of separating bound [ H]-L-glutamate 
3from free [ H]-L-glutamate is by centrifugation (see AChR Discussion
p. 153 ). Initially, separation by centrifugation was attempted
using a Beckman microfuge centrifuge, the maximum force of which is
2000 X g . Probably because of the relatively low g force the membranes
were not sedimented to a tight pellet and consequently the amount 
3of [ H]-L-glutamate associated with the membranes was inconsistent ’ 
between triplicates,moreso than when assayed by the GF/C filtration 
method. On the other hand, the Beckman airfuge produces its maximum 
force of about 100,000 x g within 15 seconds and after one minute 
at this g force the membranes had sedimented to a tightly packed 
pellet. After comparison (Table 13 )the airfuge centrifugation 
method was chosen in preference to the GF/C vacuum filtration method 
for the following reasons;
1. The airfuge centrifuge appeared to separate more
3thoroughly bound from free [ H]-L-glutamate as indicated
3by the increase in the specific [ H]-L-glutamate binding.
2. The standard error of the mean of triplicates was greatly
reduced, a reduction that persisted in subsequent preparations.
33. A constant time to separate bound [ H]-L-glutamate from
3free [ H]-L-glutamate was more readily maintained because with 
the airfuge centrifugation method this factor is dependent on 
the speed and the centrifugation time, both of which are readily 
controlled, whereas the rate of filtration is dependent on
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parameters such as water pressure and porosity of the
glass sinter support, which are not so easily controlled.
Despite these improvements using the airfuge centrifugation
separation technique, the major problem of poor reproducibility 
3of [ H]-L-glutamate binding from preparation to preparation persisted
and is therefore more likely to be a result of some^as yet undetected^
artifact(s) in the membrane preparation rather than in the method
of assay. All experiments were carried out under the same apparent
conditions, with respect to tissue preparation and the binding assay.
3A prerequisite to improving the specific binding of [ H]-L-glutamate,
by changes either in the preparation procedure or in the binding
assay conditions, is a standard by which any such improvements can
3be assessed. The inconsistency in [ H]-L-glutamate binding from day 
to day does not readily permit this and therefore the effect of 
alterations could only be compared within any one preparation.
3Consequently, when a change which apparently improved specific [ H]-
L-glutamate binding in one preparation was employed in subsequent
3experiments and no displacement of [ H]-L-glutamate observed, 
the validity of such a change was questioned and reversion to the 
original procedure demanded.
Preliminary attempts at improving the reproducibility from 
preparation to preparation were unsuccessful and are outlined below:
1. It was thought that the quantity of mitochondria
contaminating the P^ membrane fraction may have been a variable
factor. Therefore, longer centrifugations at 3,000 x g were
3implemented and both the specific [ H] -L-glutamate binding and 
the appearance of a typical mitochondrial enzyme, GPox, were
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monitored in the supernatant. A four-fold increase in
centrifugation time had no effect on either the GPox in the
3supernatant or the specific [ H]-L-glutamate binding to 
this fraction.
2. Removal of ethanol from the radiolabelled L-glutamate
3solution (p. 92 ) appeared initially to improve specific [ H]- 
L-glutamate binding. However, when routinely removed it 
did not prevent inconsistent binding from preparation to 
preparation.
3. Increasing the amount of tissue per incubation sample ,
on the premise that this would enhance detection of specifically 
3bound [ H]-L-glutamate, had the desired effect in a number
of preparations and initially also appeared to promote constant
binding from preparation to preparation. However, in a
number of subsequent experiments erroneous results were
3consistently obtained in that more [ H]-L-glutamate was 
apparently associated with the membranes in the presence of an 
excess of unlabelled L-glutamate and is therefore contrary 
to the presumed basis for the "excess ligand" method of 
defining specific binding. This point will be discussed in 
greater detail later.
A further anomaly in these binding studies was that for a
3number of consecutive experiments reproducible, displacable [ H]- 
L-glutamate binding was obtained, whereas in another batch of con­
secutive experiments this binding disappeared for no apparent reason. 
Nevertheless, in the preparations in which displaceable binding was 
detected, the indications are of a specific L-glutamate binding
- 112 -
component, a conclusion that is tentatively reached for the following 
reasons:
31. Displacement of [ H]-L-glutamate was obtained in the 
presence of an excess of unlabelled L-glutamate. The displaced 
binding can be attributed to specific binding sites as defined 
by the "excess ligand" method of assay (p. 155 ).
2. Increasing the unlabelled L-glutamate from 5mM to 20 mM
3did not result in displacement of more [ H]-L-glutamate, 
indirectly indicating a finite number of specific binding 
sites all of which are occupied by 5 mM unlabelled ligand.
3. Displaceable [ H]-L-glutamate binding increased linearly 
with protein concentration (Fig. 15 ),strongly suggesting 
that true specific binding to the tissue was being monitored 
and not artifactual "specific" binding to the separating 
materials.
34. Specific [ H]-L-glutamate binding was dependent on the
3concentration of [ H]-L-glutamate and in some cases (Fig.16a ) 
specific binding appeared to saturate, providing evidence 
for a finite number of specific binding sites.
The latter observation was unfortunately not the case in every 
experiment in which the concentration of pE]-L-glutamate was varied. 
Nevertheless, bearing these problems in mind,three populations of 
specific L-glutamate binding sites in this membrane fraction' 
can be tentatively identified (Table 16 ). The population of highest 
affinity has a in the low to mid nanomolar range, the second 
population has a in the high nanomolar/low micromolar range and 
the lowest affinity site has a in the middle to high micromolar
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range. Distinction between these sites is difficult, firstly 
becaase all three are not apparent in every preparation and secondly^ 
all three appear to be sodium dependent, a property that has been 
used to differentiate between high and low affinity binding sites 
in other preparations (James, 1977; Baudry & Lynch, 1980). A 
systematic study of the effects of a range of monovalent and divalent 
cations may aid in the elucidation of L-glutamate binding sites of 
differing affinities^as work carried out by Baudry and Lynch (1979; 
1980) on preparations of mammalian brain has indicated a possible 
receptor regulatory role for these ions.
Alternatively, the use of potential L-glutamate neuroreceptor 
agonists and antagonists may distinguish differences between the 
three populations of putative receptors. A number of analogues 
of both L-glutamate and L-asparate have been shown to inhibit the 
action of L-glutamate in the vertebrate CNS (Introduction p. 45 ;
Davies ^  a1̂ ., 1980) and at the insect neuromuscular junction (see 
Introduction p. 45 ; Usherwood, 1978 ). Although all these anta­
gonists inhibit the action of L-glutamate, in a number of cases 
no cross-reactivity of ligands has been noted, indicating that they 
could be acting at different sub-populations of L-glutamate receptors
Because the majority of these studies with potential agonists 
and antagonists have been with electrophysiological techniques, a 
major reservation must be borne in mind when drawing analogies with 
biochemical studies. Electrophysiological studies tend to use the 
muscle intact, whereas the biochemical approach is to subfractionate 
the muscle to isolate the neuroreceptor. It is quite conceivable 
that the receptor would exhibit differentpharmacological properties 
under these conditions. For example.
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the morphology of the intact muscle may present permeability
problems to ligands aimed at the receptor molecule. The problem
would be less apparent with subcellular preparations. Conversely,
the topography of the receptor molecule within the membrane may
be important to its function. Isolation may modify its capacity
to bind ligands with which it appears to interact ^  vivo (see
Davies £t a]̂ ., 1980; Krogesgaard-Larsen, 1980; Introduction, p. 45 ).
Preliminary studies with the marine toxins^o and 3 cephalotoxin
and suberitine, were encouraging in that they showed an apparent
3ability to displace specific [ H]-L-glutamate binding. However,
when the experiment was repeated with higher concentration of toxins,
3increased displacement of [ H] -L-glutamate binding was not observed 
with all three toxins. This may have been due to problems inherent 
in the preparation. Unfortunately, complete characterisation 
(IC^Q, Kp) of the marine toxins, binding was impossible because of 
the limited supply. They do however, represent an attractive area 
for further investigation in that their paralysing effects in studies 
on crusteans in vivo ' are indicative of a possible neuro-muscular 
blockade (Cariello & Zanetti, 1977; 1979).
The majority of reports of biochemical characterisation of 
putative L-glutamate neuroreceptors have been concerned with 
preparations of mammalian brain (see Briley e_t a1̂ ., 1981). In 
comparison to studies on putative insect glutamate receptors, workers 
investigating mammalian glutamate receptors have an advantage in 
that well characterised preparations of synaptic membranes are readily 
available. However, in both instances, binding studies are hampered 
by the same lack of high affinity specific L-glutamate receptor
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probes. Although at a more advanced stage, the position of L- 
glutamate receptors in mammalian brain is still unclear, the 
reasons for which are summarised below:
1. The K^’s reported cover a very wide range 11 nM - 55 yM 
(Table 21 ). This variation may be partly due to the choice 
of the brain fraction under study^in that different sections 
of the brain will not possess identical populations of 
receptor. Thus a number of receptor populations with 
different K^’s would be expected in whole brain preparations.
As yet, only two populations of binding sites have been 
reported for such preparations (Michaelis a^,, 1974;
Biziere al., 1980). Furthermore, the physiological 
significance of the highest affinity binding sites
10 - 20 nM) is doubtful because the rate of dissociation 
of L-glutamate from such sites would be relatively slow, 
thus enhancing desensitisation and preventing recovery of 
the membrane to an excitable state.
2. Minor changes in the preparation procedure,such as 
increased periods of ultrasonication and more extensive washing 
of the fractions, appear to result in an increased affinity
of the receptors for L-glutamate (Sharif and Roberts, 1980a).
In addition, lyophilisation apparently increases the binding 
capacity of the membranes without affecting the K^.
3. In a number of reports the profile of |̂ H ]-L-glutamate 
specific binding does not saturate in the concentration range 
investigated (Foster and Roberts, 1978; Vincent and McGeer, 
1980). Therefore, in these studies a finite number of specific
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L-glutamate binding sites cannot be identified.
4. The distinction between sodium dependent and sodium
independent binding sites is unclear. Vincent and McGeer
(1980) were unable to detect a sodium independent population
of L-glutamate binding sites in membrane preparations of
rat striatum, whereas Foster and Roberts, (1978) reported
3an inhibition of specific [ H]-L-glutamate binding in rat
cerebellar membranes upon the addition of Na ions (100 mM).
On the other hand, high concentrations of sodium (10 mM -
3100 mM) have been reported to increase specific [ H]-L- 
glutamate binding to rat hippocampal membranes, an increase 
the authors attribute to a high affinity uptake binding site 
(Baudry and Lynch, 1981).
5. To date, there has been only one report of an attempted 
purification of the L-glutamate binding component from 
mammalian brain (Michaelis, 1975). A 200 fold purification 
was claimed after affinity chromatography on Con A -Sepharose 
of a Triton X-100 extract of a rat brain preparation. In 
consideration of the numerous workers in the field it is 
curious that no reports of purification have appeared in the 
intervening years.
The above discrepancies in studies on putative L-glutamate 
receptors from mammalian CNS illustrate that the problems experienced 
in studies carried out in this thesis are not confined to insects. 
None of the proposed L-glutamate binding sites are sufficiently 
well-characterised to permit unequivocal designation as a
synaptic glutamate receptor.
TABLE 21
A Summary of the K^’s and B^^^ ’s Obtained for L-Glutamate Binding
To Rat Brain:
Preparation Bmax
(pmol/mg prot.)
Reference
Membrane fragments 
from cerebral cortex
8yM 30 Roberts (1974)
Membrane fragments 
from whole brain
0.2yM 
4 .4yM
180
880
Michaelis et al, 
(1974)
Synaptic membranes 
from cerebellum 774nM 73 Foster & Roberts (1978)
Synaptic membranes 
from cerebellum 300nM 117 Sharif & Roberts (1980)
Membrane fragments 
from hippocampus
770nM
2400nM
6.5
75.0
Baudry & Lynch 
(1981)
Membrane fragments 
from whole brain
llnM
80nM
Biziere et al, 
(1980)
Synaptic membranes 
from striatum 16.6nM 0.4 Roberts (1981)
Proteolipid from 
cerebral cortex
300nM
5yM
55yM
530
16,600
320,000
De Robertis & Fiszer 
de Plazas (1976)
Partially purified 
glycoprotein
0.85yM 65,500 Michaelis (1975)
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3The most serious problem encountered in [ H]-L-glutamate
binding studies to locust muscle membranes was that of increased 
3[ H]-L-glutamate binding in an excess of unlabelled L-glutamate.
A similar incongruity has not been reported for binding studies
to preparations of mammalian brain. Results indicate ( p. 96 )
that the most obvious explanation for this phenomenon, metabolism 
3of [ H]-L-glutamate, was not taking place over a 60 minute incubation
period as neither incubation at 4°C or in the presence of mono-
fluoroacetate suppressed the increased binding. Monofluoroacetate
is ultimately synthesised to fluorocitrate which is an inhibitor
of aconitase^hence the TCA cycle is blocked, resulting in a general
3block of the cell’s metabolism. Therefore major metabolism of [ H]- 
L-glutamate would be inhibited in the presence of this compound. 
Furthermore, thin layer chromatography of protein-free samples 
revealed only L-glutamate to be radiolabelled. Similarly, pR did 
not appear to be the cause of the increased binding (Fig. ^7 )•
Results of experiments in which samples were pre-incubated with, and 
without unlabelled L-glutamate suggest two things; firstly, that 
the non-specific binding capacity of the membranes increases with 
time and secondly, that unlabelled L-glutamate, in some cases, 
further stimulates this increased binding capacity (Table 19 ). 
Therefore, in such cases the "unlabelled ligand excess" method of
3determining' non-specific [ H]-L-glutamate binding is not independent 
of unlabelled ligand. Reasons as to why this should be are not 
forthcoming. Perhaps low-affinity L-glutamate uptake system(s), 
which could constitute a non-specific binding component, are activated 
by incubation of the tissue at room temperature. If this is the case 
then such a system is apparently stimulated further by an excess of
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unlabelled L-glutamate. Moreover, the ratio of radiolabelled
-5L-glutamate to unlabelled L-glutamate at concentrations of 10 M
and 5 mM respectively, is 1:500; Therefore as it is unlikely that
any system can discriminate between tritiated and unlabelled L-
3glutamate, for every pmol of [ H]-L-glutamate associated with the
membranes, 500 pmol of unlabelled L-glutamate must also be
associated. This would mean that the total amount of L-glutamate
associated with one milligram of tissue would be of the order of
tens of nanomoles. High concentrations such as this would mask
any specific neuroreceptor L-glutamate binding but are within the
concentrations determined for uptake of L-glutamate into a similar
membranous preparation (Briley, 1981).
If such an uptake system is operating then it must be
assumed that positive cooperativity is an inherent part of it, in
3that unlabelled L-glutamate enhances the uptake of [ H]-L-glutamate.
This hypothesis,however, does not explain why this system is only
apparent in a few preparations and therefore suggests that the
preparations are not identical in every case.
Obviously further investigations into putative L-glutamate
neuroreceptor binding to locust muscle demands elucidation and
elimination of this problem. Reappraisal of the preparation
procedure presents the most logical point at which to start. The
tedious operation of monitoring glutamate metabolising enzymes,
measuring pH]-L-glutamate binding and uptake, and making electron-
micrographs at every stage in a number of preparations might enable
3detection of a relationship between variable [ H]-L-glutamate binding 
to the membrane fraction and some other variant. Such studies
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might also establish the stage in the preparation when the variables
are first manifested and thus give an indication of where changes
should be made in the fractionation procedure i.e.homogenisation
3or centrifugation. Until reproducible, specific [ H]-L-glutamate 
binding is obtained further biochemical characterisation of putative 
L-glutamate synaptic receptors cannot proceed using this method of 
receptor identification.
An alternative approach might come from the discovery of a 
specific, high-affinity ligand which binds to the ionophoJe controlled 
by the L-glutamate receptor. If both the receptor and the ionophore 
reside on the same macromolecule then purification of a radiolabelled 
ligand-ionophore complex would result in a simultaneous purification 
of the L-glutamate receptor.
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SECTION 2 : STUDIES ON THE PUTATIVE NICOTINIC ACETYLCHOLINE 
RECEPTOR IN THE LOCUST CNS
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MATERIALS
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Materials were obtained as stated on p.62. In addition; a-bungaro-
toxin was obtained from the Boehringer Corporation (Lewes, Sussex, 
125U.K.). I ( ) was obtained from the Radiochemical
Centre (Amersham, Bucks., U.K.).
125I activity was determined by counting in an LKB 1280 Ultrogamma 
counter.
Gel filtration reagents were supplied by Pharmacia Ltd. (Hounslow, 
U.K.).
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METHODS
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1. Tissue Preparation:-
Two week old adult locusts, in the 5th instar were used for 
all experiments. The animals were decapitated and the heads were 
either used immediately or stored frozen at -20°C for periods of 
up to one week. The supra-oesophageal ganglion was exposed by 
shaving off the cuticle from the mouth parts to the top of the head 
and fatty tissue was wiped away. The supra-oesophageal ganglion 
was then distinguishable, having a deeper orange colour than the 
surrounding tissue. Using fine forceps the ganglion was removed, 
taking as little as possible of the optic lobe, and placed on ice. 
One hundred heads provided, on average, 400 mg of starting material.
2. Tissue Fractionation:
The tissue was fractionated as outlined in the flow diagram 
in Fig. 18, the details of which are given below,
a) Preparation of the Membrane Fragments:- 
The tissue was suspended in buffer A (Table 22) (~57o w/v;
i.e. material from 100 heads/8 ml). The suspension was homogenised 
in a Potter-Elvejham homogeniser with a motor-driven pestle, radical 
clearance 0.15 mm, 20 passes at 500 rpm. The homogenate was then 
filtered through nylon bolting cloth (159 pm mesh). The filtrate 
(taken as the total homogenate) was then centrifuged at 500 x g 
for 10 min. to remove heavily pigmented eye material. The super­
natant (S^) was carefully removed using a pasteur pipette and 
centrifuged at 100,000 x g for 30 min. in a Beckman L5-50B ultra­
centrifuge, using the SW 50.1 rotor (av. radius = 8.35 cm). The
pellet (Pg) was resuspended in buffer A (~400 mg starting material
125(100 heads)/8 ml). All fractions were assayed for [ I]-a"bungaro- 
toxin binding activity and for protein content on the day of
Figure 18
TISSUE FRACTIONATION SCHEME FOR LOCUST
SUPRA - OESOPHAGEAL GANGLIA
100 heads 400 mg ganglia 
Homogenised in 8 ml buffer A (5% w/v) 
Filtered through nylon mesh (159 y&m)
Filtrate (Total Homogenate) 
500 X g for 10 min.
(discarded) P^ S^
100,000 X g for 30 min.
Either
1. Resuspended in buffer A 
(400 mg starting material/
8 ml) 
if to be assayed
OR
2. Resuspended in buffer B 
(400 mg starting material/
1 ml)
- incubated for 30 min. at 
23°C
Suspension
100,000 X g for 2 min
S^ (Detergent 
Extract)
P^ (very small)
Affinity Chromatrogaphy 
for Further Purification
Table 22 Composition of the Buffers used in the Fractionation 
of Locust Supra-oesophageal Ganglia
Buffer A:
10 mM Potassium phosphate
pH 7.4, containing 
0.25 M Sucrose
1 mM EDTA
2 mM Benzamidine hydrochloride
0.1 mM Benzethonium chloride
0.1 iriM PKenylmethane sulphonyl fluoride (PMSF)
Anti-
Proteases
Buffer B
10 mM Potassium phosphate 
pH 7.4, containing 
0.14 M NaCl
l7o (v/v) Triton X-100 (unless stated otherwise) 
The above anti-proteases
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preparation.
125b) Detergent Solubilisation of the [ l]-a-Bungarotoxin 
Binding Component from the Pellet Fraction:
The P^ pellet fraction was resuspended in buffer B (Table 22 ) 
(~400 mg starting material/ml), incubated for 30 min. at 23°C and 
then centrifuged at 100,000 x g for 2 min. in a Beckman Airfuge.
The supernatant (S^) was retained for assay or used in the further 
purification of the a-bungaortoxin binding component.
c) Partial Purification of the a-Bungarotoxin 
Binding Component:
(i) Preparation of the Affinity Beads:
a-Bungarotoxin was coupled to Sepharose 4B following the 
method of March e^ £l. (1974).
Sepharose 4B (20 ml packed beads) was washed with 0.1 M NaCl 
(500 ml) and distilled water (250 ml). The beads were resuspended 
in cold water (20 ml total volume) and 2 M sodium carbonate (40 ml 
added). The solution was stirred at 4°C. a-Bungarotoxin (2 mg) 
was dissolved in 0.2 M sodium hydrogen carbonate (40 pi) pH 9.4. 
Cyanogen bromide (3 g) dissolved in acetonitrile (1 ml) was added 
to the Sepharose 4B suspension and stirred for 2 min. at 4°C. The 
mixture was rapidly filtered, washed with ice cold water (200 ml) 
and the Sepharose 4B beads added to the a-bungarotoxin solution 
and stirred for 21 h. at 4°C. The beads were washed with water 
(160 ml) and resuspended in 1 M glycine, pH 9.0 (80 ml). The 
affinity beads were collected by filtration and washed alternately 
with 0.1 M acetate buffer, pH 4.0, containing 1 M NaCl (100 ml) 
and 0.1 M borate buffer, pH 8.0, containing IM NaCl (100 ml). This 
process was repeated three times and the affinity beads were
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equilibrated with 0.01 M potassium phosphate buffer, pH 7.4, con­
taining 0.1% (v/v) Triton X-100. The beads were stored at 4°C in 
the presence of 0 .02% (w/v) NaN^.
(ii) The Purification Procedure:
The detergent extract (S^) ( 400 mg starting material/ml)
(1 ml) was mixed with 1 ml of toxin-Sepharose beads (a-bungarotoxin 
coupled to Sepharose 4B cyanogen bromide-activated affinity beads. 
Methods 2 (c) (i) p.125) and incubated for 90 min. at 23°C with 
occasional shaking. The affinity beads were then packed into a 
small column (2 x 1 cm) and non-bound material removed as follows: 
the column was washed with 4 ml buffer A (Table 22) containing
0.1% (v/v) Triton X-100; this was followed by the same buffer con­
taining 1 M NaCl (4 ml); and finally by 4 ml of the former buffer. 
The a-bungarotoxin binding component was eluted with buffer A 
(Table 22) containing 0.1% Triton X-100 (v/v) and 1 M acetylcholine 
and the elutant was dialysed for 16 h. against 4 x 2  1 of 10 mM- 
phosphate buffer, pH 7.4, containing 0.1% (v/v) Triton X-100 and 
potassium azide (0.02% w/v). The non-diffusible material and the 
wash fractions were assayed for a-bungarotoxin binding activity 
(Methods 4, p.l27). The toxin beads were regenerated for re-use 
by washing with 10 mM-phosphate buffer, pH 7.4, containing 1 M NaCl 
followed by 10 mM-phosphate buffer, pH 7.4 containing 1% (v/v) 
Triton X-100 (5 vols. each).
1253. The Preparation of [ I1-g-Bungarotoxin
125a-Bungarotoxin was labelled with I by the method of
Urbaniak et al. (1973).
125Carrier-free Na I (100 m Ci/ml) in dilute NaOH solution 
(10 pi) was added to a-bungarotoxin (10 pg) dissolved in 0.05 M
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potassium phosphate, pH 7.5 (20 yl). Then, 0.5% (w/v) chloramine 
T in 0.05 M potassium phosphate buffer, pH 7.5, (10 pl) and 0.05 M 
postassium phosphate buffer, pH 7.5 (10 pl) were added. The mix­
ture was stirred for 1 min. at 23°C after which 0.016% (w/v) sodium 
metabisulphite in 0.05 M potassium phosphate buffer, pH 7.5,
(750 pl) and 1% (w/v) potassium iodide in 0.05 M potassium phosphate
125buffer, pH 7.5,(200 pl) were added. [ I]-a-Bungarotoxin was separ- 
125rated from free I by passage down a Sephadex G25 column (25 cm x
1 cm) equilibrated with 0.01 M potassium phosphate buffer, pH 7.4,
containing 1% (w/v) bovine serum albumin and eluted with the same
buffer. Fractions (1 ml) were collected and samples (10 pl) counted
in an LKB 1280 Ultrogamma counter. Peak tubes were pooled and the
125specific activity of the [ I]-a- bungarotoxin was calculated,
assuming 100% recovery of protein. -toxin was stored at 4°C
in elution buffer for up to 4 weeks. The biological activity of
the labelled a-bungarotoxin was determined by measuring the amount 
125of [ l]-a-bungarotoxin bound to an excess of purified acetylcholine
receptor from Torpedo marmorat&_, prepared by Dr. S . Wonnacott. The 
method of assay was as described in the methods (p.127). Biological 
activity is defined as :-
125^ ,  .I bound
Biological Activity = x 100 %
Total I added
125The biological activity of the [ I]-a-bungarotoxin prepared 
and used in all experiments ranged from 50 - 60% with no loss of 
activity on storage for periods of up to 4 weeks at 4°C.
1254. Assay to Determine the Specific Binding of [ I]-g-Bungarotoxin 
Samples (85 pl; 30 - 200 pg protein for the TH, P^ and 
fractions; 60 - 100 ng for the partially purified binding component)
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were incubated for 90 min, at 23°C in the presence of
bungarotoxin (0.2 - 600 nM) in buffer A for the TH and fractions
and buffer B (Table 22) for the and partially,purified binding
component (total volume 150 Pl). Non-specific binding was taken
125as the amount of [ II-a-bungarotoxin bound in the presence of
an excess of d-tubocurarine (10 ^ M). Results were expressed as 
125pmol C I]-a-bungarotoxin bound/mg protein.
125Bound [ I]-a-bungarotoxin was separated from free toxin 
by one of the following four methods:
a) The Centrifugation Assay:
For particulate fractions separation was achieved by centri­
fugation at 100,000 X g for 1 min. in a Beckman Airfuge. The 
pellets were superficially washed with 2 x 200 pl of buffer A and 
counted. Blanks contained buffer only.
b) The Ammonium Sulphate Precipitation Assay:
For detergent extracts and for soluble fractions, an ammonium- 
sulphate precipitation assay, adapted from the method of Meunier 
e^ aR. (1972) was used. Saturated ammonium sulphate was added 
after incubation to give a final concentration of 30% (v/v) (75 Pl 
saturated solution/150 Pl incubation mixture). The samples were 
left for 16 h. at 4°C and then filtered on Whatmann GF/C filter 
discs, presoaked for 15 min. in 1% (w/v) bovine serum albumin.
The filter discs were washed with 30% (v/v) ammonium sulphate solu­
tion (3 ml) and counted. Blanks contained buffer only.
c) The DEAE Cellulose Filtration Assay:
For the partially purified a-bungarotoxin binding component 
filtration on DEAE cellulose discs adapted from the method of 
Schmidt and Raftery (1973) was used. The reaction was terminated
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after incubation by vacuum filtration through two DE 81 cellulose 
filter discs (2 cm diameter). The discs were washed with 10 mM 
potassium phosphate buffer, pH 7.4, containing 1% (v/v) Triton 
X-100 and 0.1% (w/v) bovine serum albumin (5 ml). Filtration of 
the sample and the wash was complete in less than 5 sec. Blanks 
contained buffer only. The washed discs were then counted,
d) The GF/C Filtration Assay:
In some instances, for the fraction, filtration on Whatmann 
GF/C filters discs was used. After incubations the samples were 
vacuum filtered through GF/C filter discs (2 cm diameter), presoaked 
for 15 min. in 1% (w/v) bovine serum albumin. The filter discs 
were washed with buffer A (3 ml) and counted. Blanks contained 
buffer only.
5. Determination of the Dissociation Rate Constant:
Samples, either the resuspended P^ particulate fraction 
(~500 yg/ml) or the partially purified a-bungarotoxin binding com­
ponent (~400 ng/ml), were incubated in the presence of 3 nM 
j.l25f ]-a-bungarotoxin for 90 min. at 23°C in buffer A for the P^ 
fraction and buffer B without the 0.14 M NaCl, for the partially 
purified binding component. After incubation a 1000 fold excess
unlabelled a-bungarotoxin was added. Samples (150 Pl) were taken
125at intervals up to 180 min. and the amount of [ I]-a-bungarotoxin
125remaining specificially bound was measured. Bound [ I]-a-bungaro-
toxin was separated from free by the centrifugation assay (Methods,
4 (a) p.128) for the P^ fraction and by the DEAE cellulose filtration
assay (Methods 4 (c) p.128) for the partially purified binding com-
125ponent. Non-specific [ I]-a-bungarotoxin binding (i.e. in the 
presence of 10 ^ M d-tubocurarine) and blanks (buffer only) were
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measured for every time point. Results were expressed as percentage 
125[ l]-a-bungarotoxin specifically bound after the addition of the 
excess unlabelled a-bungarotoxin. 100% binding was taken as that 
specifically bound before the addition of unlabelled toxin, taking 
into account the volume dilution by the unlabelled toxin.
6. Determination of Values for the Binding of Various
Ligands to the Pellet Fraction:
Samples (~50 protein) were incubated with [ -a-bungaro­
toxin ( Z'O nM) (final volume 150 yl) for 90 min. at 23°C in the
-3 -9presence of a range of concentrations (10 M - 10 M) of various 
125ligands. Bound [ I]-a-bungarotoxin was separated from free 
125[ I]-a-bungarotoxin by the centrifugation assay (Methods 4 (a)
p.l27). Non-specific binding was taken as the amount bound in the 
-3presence of 10 M d-tubocurarine. Results were expressed as the 
percentage of a-bungarotoxin remaining specifically bound at that 
particular ligand concentration. 100% binding was taken as the 
amount specifically bound in the absence of ligand. Measurements 
using acetylcholine were carried out in the presence of neostigmine 
(10"4 M).
7. Sedimentation in a Sucrose Density Gradient:
Continuous sucrose density gradients were prepared by making 
five step discontinuous gradients with 4%, 8%, 12%, 16% and 20% 
(w/v) sucrose in buffer B without the 0.14 M NaCl (Table 22) and 
leaving them to stand overnight (~12 h.) at 23°C.
a) The Detergent Extract:
The detergent extract samples (100 pg protein) were prepared 
125by incubation with [ I]-a-bungarotoxin (3 nM) in buffer B (final
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volume 100 pl) for 90 min. at 23°C. Controls were incubated in an 
excess of unlabelled a-bungarotoxin (1.25 x 10 ^ M). After incu­
bation the samples were mixed with the standard marker enzymes, 
3-galactosidase (E. C. 3. 1. 2. 1. 2. 3; ^ = 16; 140 pg/28 pl),
catalase (E. C. 1. 11. 1. 6 ; S^q ^ = 11.4; 800 pg/32 pl) and
yeast alcohol dehydrogenase (E.G. 1. 1. 1. 1. ; S^q ^ = 7.4;
400 pg/40 pl) and the mixture (160 pl) was layered carefully on 
the gradients. Velocity sedimentation was performed in the SW : 50.1 
rotor of a Beckman L5-65 ultracentrifuge and runs were carried out 
at 100,000 X g (av.rad.^ 8.35 cm) for 6 h. at 23°C. After centri­
fugation, the sucrose gradients were pumped from the tube bottom 
with a Gilson peristaltic pump and 6-drop fractions (80 pl av.) 
were collected. Fractions were then counted in an LKB 1280 ultro­
gamma counter and assayed for marker enzyme activity (Bergmeyer, 
1974).
b) The Partially Purified a-Bungarotoxin Binding Component:
The partially purified a-bungarotoxin binding component
sample (200 pl) was carefully layered on the sucrose gradient. The
marker enzymes (same concentrations as Methods 7(a)) were layered
on another sucrose gradient. Velocity sedimentation was performed
simultaneously for the sample and the marker enzymes, as described
in Methods 7(a) (p.l30). After centrifugation, the sucrose gradients
were pumped from the tube bottom with a Gilson peristaltic pump
and 6-drop fractions (80 pl av.) were collected. For the gradients
containing the samples, all fractions were assayed for a-bungaro-
125toxin binding activity and bound [ I]-a-bungarotoxin separated 
from free by filtration through two DE 81 DEAE cellulose filters 
(Methods 4(c) p.128). Non-specific binding was accounted for by
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assaying all fractions from a duplicate gradient in the presence
-3of 10 M d-tubocurarine. Gradients containing the marker enzymes 
were assayed for enzyme activity (Bergmeyer, 1974).
8 . Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis
(S&S-PAGE):
Polyacrylamide gel electrophoresis was carried out under 
denaturing conditions according to the method of Weber and Osborn 
(1969). All samples were placed in a boiling water bath for 2 min. 
in 0.01 M potassium phosphate buffer, pH 7.4, containing 5% (w/v) 
sodium dodecyl sulphate and 2.5% (v/v) 3-mercaptoethanol. A list 
of samples applied is given below and all contained 0 .02% (w/v) 
bromophenol blue and 10% (w/v) sucrose:-
1. Molecular weight standards (10 pl of 1 mg/ml)
32. Membrane fragments (P^) labelled with [ H]-MBTA 
(100 pl)
3. Partially purified a-bungarotoxin binding component 
(20 pg protein/100 pl)
Electrophoresis was carried out in disc gels (8 cm x 0.5 cm) 
using 8% (w/v) acrylamide and 6 mA/gel at an operating voltage of 
30 V for 5 h. at 23°C. Gels that were run with [^H]-MBTA labelled 
membranes were frozen immediately (unstained), at -20°C, sliced at 
1 mm intervals, placed in a scintillation cocktail (Methods 10 
p.133) and left for 48 h. to solubilise. Gels that were run with 
the other samples were fixed and stained simultaneously with 0.25% 
(w/v) Coomassie blue R in 54% (v/v) methanol/9% (v/v) acetic acid 
at 23°C overnight (approx. 14 h.). They were destained with 5% 
(v/v) methanol 17% (v/v) acetic acid by heating in a boiling water 
bath and scanned densitometrically at 620 nm. The molecular weight
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standards used were: human I g M y  chain (74,000); human I g M y  
chain (50,000); human immunoglobulin light chain (23,500); and 
ribonuclease A (13,700).
Relative mobilities of the stained protein bands were cal­
culated from the following relationship 
Relative Mobility =
Distance of Protein Migration Length of gel before staining
Length of gel after staining Distance of bromophenol blue
migration
In the case of the unstained gels of labelled samples
Distance of labelled peak migration
Relative Mobility =
Distance of bromophenol blue migration
9. The Preparation of the Partially Purified a-Bungarotoxin
Binding Component for SDS-PAGE:
The partially purified a-bungarotoxin binding component eluted 
from the affinity column was dialysed against 4 x 2 1  distilled 
water. The non-diffusible fraction (3 ml ; ~30 yg protein) was 
lyophilised on an Edwards, Modulyo freeze-drier and the residue 
was taken up in 100 yl of 0.01 M potassium phosphate buffer, pH 7.4, 
containing 5% (w/v) sodium dodecyl sulphate and 2.5% (v/v) 
g-mercaptoethanol. The samples were then placed in a boiling water 
bath for 2 min., mixed with 10 yl bromophenol blue (final concentra­
tion 0 .02% w/v) and sucrose (final concentration 10% w/v) and 
subjected to SDS-PAGE as described in Methods 8 (p.132).
10. Affinity Labelling of the P^ Pellet Fraction:
The labelling procedure followed the method of Barrantes et al., 
(1975). The affinity ligand 4-(N-maleimido)-benzoyltrimethylammonium 
iodide (MBTA) was synthesised with a tritium label by Dr. R. Harrison
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by the method of Karlin et al., (1971) to a specific activity of 
126 yCi/ mol MBTA.
The membranes were reduced by resuspending the pellet 
fraction (~2 mg protein) in 0.5 ml of 1 mM dithiothreitol in 0.01 M 
Tris-HCl buffer, pH 7.3, containing 0.1 M NaCl, 1 mM EDTA and left 
at 23°C for 10 min. The samples were then centrifuged at 100,000 x g 
for 2 min. in a Beckman Airfuge. The pellets were resuspended in 
0.01 M potassium phosphate buffer (pH 7.4, containing 0.15 M NaCl
and 1 mM EDTA (total vol. 0.5 ml) and recentrifuged at 100,000 x g.
, -4Again the pellets were resuspended and a-bungarotoxin (1.25 x 10 M 
final concentration) was added to the control sample. The membranes 
were left at 23°C for 1 h. [^H]-MBTA (1 nmol) dissolved in 0.1 mM 
HCl (25 yl) was added to each membrane sample and incubated at 
23°C for 2 min. Excess g-mercaptoethanol (10 yl) was added and 
the membranes were centrifuged at 100,000 x g for 2 min. The 
pellets were dissolved in 0.01 M potassium phosphate buffer, pH 7.4, 
containing 5% (w/v) sodium dodecyl sulphate and 5% (v/v)
3 -mercaptoethanol and boiled for 5 min. Each sample was then sub­
jected to polyacrylamide gel electrophoresis under denaturing 
conditions (Methods 8 p.132). After electrophoresis, the gels were 
frozen at -20°C for 30 min., sliced at 1 mm intervals and each 
slice was incubated for 48 h. at 23°C with a solubilisation/scintill­
ation cocktail which contained toluene (1 1), hyamine hydroxide 
(10 ml), soluene 350 (10 ml), 2,5-diphenyloxazole (6 g), (Aloyo, 
1979). The samples were then counted in a Packard scintillation 
spectrometer.
11. Assay for Acetylcholinesterase:
Acetylcholinesterase activity was measured in all fractions
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by the method of Ellman et al̂ . (1961).
12. Protein Determination:
Protein determination was by the method of Lowry £t al. 
(1951). When fractions contained Triton X-100, sodium dodecyl 
sulphate (5% w/v) was added to reagent A. Bovine serum albumin 
was used as the standard protein.
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RESULTS
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1251. A Comparison of [ I]-a- Bungarotoxin Binding to Fractions
Prepared from Locust Supra-Oesophageal Ganglia;
Binding to the fractions, as prepared in Fig.18, was carried out
as described in the Methods 4 (p.127). [ I]-a-bungarotoxin was at a
final concentration of 15 nM. Non-specific binding was accounted for
by incubation in the presence of excess (1.25 x 10 ^M) unlabelled
125a-bungarotoxin. Bound [ I ^a-bungarotoxin was separated from free
toxin by the ammonium sulphate precipitation assay for the total
homogenate and the fraction, by the centrifugation assay for the
P^ and P^ fractions and by the DEAE cellulose filtration assay for
the fraction (Methods 4 p.l27).
Table 23 shows the non-specific, total and specific binding for
these fractions. It also shows the purification factor, taking binding
in the total homogenate as unity. As can be seen the greatest specific
activity was in the fraction. 60-70% of total specific binding
activity of the initial homogenate was also routinely recovered in
this fraction. In all fractions except the P^ fraction tha non-specific
binding exceeds the specific binding. Binding in the fraction was
inconsistent and represented 0-10% of total specific binding activity of
the initial homogenate. Although the specific binding in the P^
fraction is high, binding was difficult to assay accurately, because
of the very fibrous nature.of this fraction.
As the P^ fraction appeared to be the fraction with, the highest
specific binding and had a high recovery of the total specific
binding activity, it was used in subsequent experiments. A value of 
12580-85 pmol [ I ]-a-bungarotoxin binding sites/g wet weight of whole
ganglia was calculated from specific binding to the total homogenate before 
filtration through the nylon mesh.
TABLE 23
Comparison of the Binding of [ l3-a-Bungarotoxin to Various Fractions
FRACTION BINDING (p.mol/mg protein)
PURIFICATION
FACTOR
Non-Specific
Binding
Total Binding Specific Binding
T.H. 1.07 ± 0.0125 1.303 ± 0.03 0.233 ± 0.330 1
3.395 ± 0.079 4.63 ± 0.160 1.235 ± 0.173 5.3
Si 0.733 1.205 0.473 2.0
^2 1.24 ± 0.078 2.59 ± 0.065 1.35 ± 0.102 5.8
1.18 ± 0.035 1.72 ± 0.060 0.54 ± 0.069 2.3
Fractions were prepared as in Fig. 18 . Samples (30 - 200 yg protein) 
were incubated at 23°C for 90 min in the presence of [^^^I]-a-
bungarotoxin 15 nM (Methods 4 p.127). Non-specific bin^/was in the
-4presence of 1.25 x 10 M unlabelled a-bungarotoxin. Results are means 
of quadruplicates ± S.E. except for fraction - mean of duplicates.
TABLE 24
Comparison of the GF/C Filtration Assay and the Centrifugation Assay 
125to Separate [ I] -a-Bungarotoxin Bound to the Total Homogenate or 
the Pellet Fraction from Free Toxin; Effect on Specific Binding
FRACTION ASSAY USED SPECIFIC BINDING 
(pmol/mg protein)
TH Centrifugation 0.229 ± 0.033
TH Filtration 0.211 ± 0.015
^2 Centrifugation 1.348 ± 0.102
^2 Filtration 1.281 ± 0.14
125Samples (30 - 200 yg protein) were incubated with [ l]-a-
bungarotoxin (15 nM) for 90 min at 23°C. Non-specific binding was
-4in the presence of unlabelled a-bungarotoxin (1.25 x 10 M). 
Results are the means of two experiments, each carried out in 
triplicate ± S.E.
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2. Experiments with the Pellet: Fraction:
A. The Binding Assay:
(i) Comparison of the GF/C Filtration Assay and the Centrifugation 
Assay:
Binding was carried out as described in the Methods 4 (p. 127).
125Separation of bound from free [ I]-a-bungarotoxin (15 nM) was by 
either the GF/C filtration assay (Methods 4 p. 127) or the centrifugation 
assay (Methods 4 (a) p. 12/). Non-specific binding was accounted for 
by incubation in the presence of an excess of unlabelled a-bungarotoxin 
(1.25 X lO'^M).
125Table 24 shows specific [ I]-a-bungarotoxin binding to both
the total homogenate and to the P^ fraction as measured by both the
GF/C filtration assay and the centrifugation assay. As can be seen
125there is no difference in the specific [ 1] -a-bungarotoxin binding
of the fractions assayed by the two methods.
The centrifugation assay was adopted as the routine method for
1 25separation of bound from free f I]-a-bungarotoxin for the P^ fraction,
125(ii) Comparison of [ I]-a-Bungarotoxin Binding in the Presence 
of Excess Unlabelled a-Bungarotoxin and of Excess 
d-Tubocurarine to Account for Non-Specific Binding:
125r I]-a-Bungarotoxin was at a final concentration of 15 nM,
-4 . -3unlabelled a-bungarotoxin 1.25 x 10 M and d-tubocurarine 1 x 10 M.
As Table 25 shows there is little difference in the non-specific 
binding as accounted for by unlabelled a-bungarotoxin or by d-tubo­
curarine and hence no difference in the specific binding.
-3In subsequent experiments d-tubocurarine (10 M) was used 
routinely to account for non-specific binding.
TABLE 25
ri 25.Comparison of the Binding of [ I]-a-Bungarotoxin to the Fraction, 
in the Presence of Excess Unlabelled g-Bungarotoxin and of Excess 
d-Tubocurarine to Account for Non-Specific Binding.
UNLABELLED 
LIGAND USED BINDING (pmol/mg protein)
d-Tubocurarine
a-Bungarotoxin
Non-Specific
Binding
1.24 ± 0.078
1.35 ± 0.009
Total Binding
2.59 ± 0.065 
2.80 ± 0.09
Specific Binding
1.35 ± 0.102 
1.45 ± 0.09
Experiments were carried out as described in the Methods 4 (a) (p.128) 
125[ I ]-g-bungarotoxin was at a concentration of 15 nM. Non-specific
binding was in the presence of either unlabelled a-bungarotoxin
—A “5(1.25 X 10 M) or d-tubocurarine (1 x 10 M). Results are the means
of two experiments, each carried out in triplicate ± S.E.
TABLE 26
.125.The Effect of Preincubation with Excess d-Tubocurarine on [ I]-g-
Bungarotoxin Binding to the P  ̂Fraction.
TIME (min) BINDING (pmol/mg Protein)
Non-Specific
Binding
Total Binding Specific Binding
5 3.60 7.25 3.65
10 3.57 7.37 3.80
15 3.75 7.72 3.97
20 3.80 7.47 3.67
Experiments were carried out as described in the Methods 4 (p.127).
125[ l]-g-Bungarotoxin was at a concentration of 12 nM. Non-specific
-3binding was in the presence of d-tubocurarine (1 x 10 M). Results 
are the means of quadruplicates S.E. < 2%.
TABLE 27
.125,The Effect of Incubation Time on Specific [ I] -g-Bungarotoxin 
Binding to the Fraction.
CONDITIONS SPECIFIC BINDING 
(pmol/mg protein)
90 min at 23°C 
16 hours at 4°C
2.68
3.12
125Samples (^200 yg protein) were incubated with [ 3] -g-bungarotoxin
(16 nM) for either 90 min at 23°C or for 16 hours at 4°C. Binding 
was assayed as described in Methods 4 (a) (p.127). Results are the 
means of quadruplicates. S.E. < 2%.
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(iii) The Effect of Preincubation with an Excess of
125d-Tubocurarine on [ I]-g-Bungarotoxin Binding:
-3Table 26 shows the effect of preincubation with 10 d-tubo-
curarine for the times shown on non-specific and hence specific 
125binding of [ I ]-g-bungarotoxin (16 nM) to the P^ fraction. As
can be seen there is little difference in either non-specific or 
specific binding for the preincubation times shown.
125(iv) The Effect of Incubation Time on Specific [ I]-g- 
Bungarotoxin Binding:
Samples of the P^ fraction were incubated in the presence of 
16 nM [^^^I]-g-bungarotoxin for either 90 min at 23°C or for 16 hours 
at 4°C and Table 27 shows the specific binding for the two conditions. 
As can be seen there is little difference in the specific binding 
under the two sets of conditions. Incubation for 90 min at 23°C 
was routinely used in subsequent experiments.
1 25B. The Effect of Varying Protein Concentration on [ I]-g-
Bungarotoxin Binding:
Fig. 19(a) and (b) shows the effect of varying the protein
125concentration on the binding of two concentrations of [ I]-g-
bungarotoxin to the P^ fraction. Fig.19 (b) shows binding at an 
125[ I]-g-bungarotoxin concentration of 24 nM over a protein range
of 10-30yg* Fig 19(a) shows binding at a concentration of 16 nM 
125[ I]-g-bungarotoxin over a protein range of 50-200yg.
Specific binding is directly proportional to the amount of 
protein present but is lower than the non-specific binding. In the 
graphical presentations of these data total and non-specific binding 
do not pass through zero because of apparent binding to the centrifuge
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tube and trapping of ligand in the "dead" space of the pellet.
Standard error in both cases was less then 5%, determined from two 
separate series of experiments each carried out in triplicate.
125C . Time Course of Specific [ I ]-a-Bungarotoxin Binding;
Incubation was at 23°C for up to 120 min. Incubation was 
125terminated and bound [ I ]-a-bungarotoxin separated from free toxin
by the centrifugation assay (Methods 4 (a) p.127). Two concentrations 
125of [ I ]-a-bungarotoxin were used 12 nM (Fig. 20 (b)) and 600 nM 
(Fig*'>20 (a)).
As can,be seen from either graph, specific binding saturates 
with time and reaches equilibrium in 10-15 min. The standard error 
was less then 5% for two separate series of experiments each carried 
out in triplicate.
125D. The Dependence of Binding of [ l]-g-Bungarotoxin on
Concentration (40-600 nM) :
Experiments were carried out over a concentration range of 
12540 nM - 600 nM [ I]-a-bungarotoxin. Fig. 21 is an example of a
125typical plot of pmol [ I]-a-bungarotoxin bound/mg protein against
concentration for total, non-specific and specific binding C 1 expt.
in triplicate, S.E. < 5%). Specific binding appears to be approaching
125saturation up to an [ I]-a-bungarotoxin concentration of 360 nM
but then doubles between this concentration and 600 nM. In other
preparations specific binding was found to increase linearly within
125this concentration range of [ I ]-a-bungarotoxin and in all preparations 
specific binding was lower than non-specific binding.
Fig. 21, The Dependence of Binding of [ ll-aBgTx 
Binding to the Membrane Fraction on 
Concentration (40nM - 600nM) .
70r
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600400200
1 2 5[ X]-a-BgTx CnM)
-3 125d-Tubocurarine 10 M; bound [ I]-aBgTx was separated
from free by airfuge centrifugation; ■ total binding;
O  non-specific binding; #  specific binding. (Results
are the means of triplicates S.E. < 5%).
Fig. 22 (a). The Dependence of Binding
125of [ I]-aBgTx to the 
Membrane Fraction on 
Concentration (0.5 - lOnM)
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separated from free by airfuge centrifugation;
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#  specific binding (Results are the means of
triplicates S.E.< 4%).
00
00
C O
punog
punog
00 C N
!=>
o
pq
00CO
CO■pC0)
cd
pL,
iuI
C N
C N
00
• H
PO}-iA
S
I
00
J
•H
rt
P
CO
fl(U
rtuP4
CN rt
P4 rt
rt
rt
rQ ir,
p B
rt V
o S
p
CN w
00 P4
C CO
•H rt
X!
rt P rt
•H p
pq o rt
p o
X •H
H 00 t—1
00 rt PL
pq •H •H
S T3 >-l
1 rt P
• H
H pq rt
LT) •H
CN X
I—1 H rrt
00 o
pq rt
O 3 rt
•H 1
•H M p
Ü m PL
rt CN X
ÇU p I—1 rt
CO o
u CO
M-l Pu u
O •H «P
ËP >P OCO •H
•iH U CO
CO rt rt
Po o A rt
rP B CO rt
rt cx B
rt m
<J 00 o rt
,c
p p
}-i r— 1 o
rt rt
rrt II PL, rt
o rt
p X I—1
rt rt I—1 CO
Ü G • H P
CO pq pq T—1
P)
CO
rt
,Q a pq
o  o
00JJ /p u n o g
— 141 —
1 25E . The Dependence of Binding of f" I]-a-Bungarotoxin on
Concentration (0.5 - 10 nM):
125Samples were incubated with [ I] -a-bungarotoxin over a 
concentration range of 0.5 - 10 nM. Fig. 22 (a) shows the binding 
profile for total, non-specific and specific binding for one experi­
ment carried out in triplicate (S.E. < 4%). From this graph it can
125be seen that specific binding saturates in the region of 5 nM [ I]- 
a-bungarotoxin.
Fig.22 (b) is a Scatchard Plot of the mean of three experiments
each carried out in triplicate. From this plot a dissociation constant
(K^) of 1.38 nM and a maximum number of binding sites of 1,18
125pmol [ I]-a-bungarotoxin bound/mg protein was obtained. The
correlation coefficient (r) was 0.993.
Fig.22 (c) is a Hill plot of the same data as Fig. 22(b).
The B obtained from the Scatchard plot CB = 1.18 pmol/mg max  ̂ max
protein) was used in fitting the saturation data to the Hill equation.
The points lie on a straight line (r = 0.991) with a slope of 0.97
and therefore the Hill number (n^) is considered to be 1.0 and so 
125specific [ I ]-a-bungarotoxin binding obeys classic mass action 
laws and no cooperativity is taking place.
125F. Determination of the Rate of Dissociation (k_ĵ ) for [ I]" 
a-Bungarotoxin Binding;
The experiment was carried out as outlined in the Methods 5 (p129)
125[ I ]-a-bungarotoxin was at a final concentration of 3 nM. Fig.23 Ca)
1 25shows a plot of % r I]~a-bungarotoxin specifically bound versus 
time, for one experiment carried out in duplicate. Fig.23 (b) is a
Fig. 23 (a) Determination of the Rate of Dissociation (k_^)
150 for [ ]] -aBgTx Binding to the Membrane Fraction.
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-3. 125 125d-Tubocurarine 10 M; [ I] -aBgTx 3nM; bound [ I] -aBgTx separated
from free by airfuge centrifugation. Results are the means of
triplicates).
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125plot of Log [% I-a BT] bound versus time for the same experiment.
The dissociation followed first order kinetics until more than 
12550% of the [ I]-a-bungarotoxin had dissociated (Fig.23 (b). From
125this a t^ ^time take for 50% of specifically bound [ l] -a-bungarotoxin 
to be displaced) was calculated to be 65 min. Using the relationship 
0.693
-4-1k_^ was calculated as 1.7 x 10 S . The experiment was repeated twice
— “1 —^ “2. « more and k_ĵ ’s of 3.6 x 10 S and 3.04 x 10 S were obtained.
From the equation:
[R ] + [L ] [RL]
k_l
Where |R ] = the concentration of binding sites
125[L ] = the concentration of [ !d -a-bungarotoxin 
[RL] = the concentration of receptor-ligand complex 
k^^ = the association rate constant
the intrinisic dissociation constant =
The on-rate (k^^) for most neurotransmitter binding has been
6 - 1 - 1calculated to be of the order of 10 M S . Assuming this value 
125applies to [ I ]-a-bungarotoxin binding to the fraction, and using
the mean off-rate (k_^) calculated from these experiments (2.78 x
—A —1 “XO10 S ), a of 2.78 x 10 M was calculated; this is a factor
of ten times smaller than the obtained from equilibrium studies 
-9(1.38 X 10 M). The dissociation is biphasic; after dissociation 
of approximately 60%, the rate of dissociation in much slower, with 
only approximately 5% [ ll-a-BT dissociating in the next 120 minutes.
Fig. 24. Determination of the IC^^'s for Various Ligands
125Displacing [ I]-aBgTx Binding to the 
Membrane Fraction,
125_
MmCM
S'S
A Benzoquinonium 
O  Curare 
■ a-BgTx
□ ACh C+ neostigmine) 
•  Esèrine 
A Nicotine 
Décaméthonium
100_
I0
1a•H
Iu
X
%
?
f
-6 -5
Ligand
d-Tubocy^grine 10 M; [ ll -aBgTx 2nM; binding sites 0.4nM; 
bound [ I ]-aBgTx separated from free by airfuge centri­
fugation. (Results are the means of 2 expt. each carried 
out in triplicate S.E, <4%).
TABLE 28
IC *Values of Various Ligands for 1 Inhibition of Specific50
Bungarotoxin Binding to the Fraction.
LIGAND IC^Q
(M)
-9a-Bungarotoxin 8.9 x 10
“6d-Tubocurarine 3.2 x 10
-6Benzoquinonium 4.11 x 10
“6Eserine 4.73 x 10
-6* Acetylcholine 6.68 x 10
Nicotine 3.98 x 10 ^
Atropine 1.12 x 10 ^
-4Dexetimide 3.50 x 10
-4Carbamoylcholine 4.47 x 10
•  —4Décaméthonium 6.31 x 10
Hexaméthonium > 10 ^
Neostigmine > 10 ^
“3* Acetylcholine was assayed in the presence of 10 M neostigmine.
The experiment was carried out as described in the Methods 6 Cp.130). 
125[ I]-a-Bungarotoxin was at a concentration of 0.2 nM. Results are 
the means of two experiments each carried out in triplicate. SwE.< 4%
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G. Determination of the Values of Various Ligands
I Inhibiting p-^^ij-g-Bungarotoxin Binding;
The IC^Q for a given unlabelled ligand is defined as that
concentration of unlabelled ligand at which maximum specific binding
of labelled ligand is displaced by 50%. Under certain conditions
and allowing for a number of assumptions (Discussion p.164) the
for a particular ligand very closely approximates to the equilibrium
dissociation constant for binding(K.) for that ligand.
125In these experiments the concentration of [ I]-a-bungarotoxin
used was 2.0 nM and the concentration of protein was 50pg/150 ÿl (taking
125^max 1*18 pmol [ I ]-a-bungarotoxin binding sites/mg protein, 50yg
1 25protein/150yl = 0.4 nM of T I]-a-bungarotoxin binding sites).
125Fig.24 shows the displacement of [ I]-a-bungarotoxin by different 
ligands. Table 28is a summary of the values and hence under the
above conditions (Discussion p.l64)^the K^'s of the ligands.
3H. [ E]-MBTA Labelling of the Membrane Fragments;
3Membranes were prepared and labelled with [ R]-MBTA as outlined
in the Methods 10 (p.133). Control samples were preincubated with.
-4excess (1.25 x 10 M) unlabelled a-bungarotoxin before the labelling 
procedure. Molecular weight markers were run on a separate disc gel 
simultaneously, the calibration line for which is represented in 
Fig.25 .
Only one major peak of pH ]-MBTA label was obtained after count­
ing (Fig. 26 ) and this corresponded to a molecular weight of 58,000.
This peak of radioactivity was not apparent on the control sample.
Fig. 25 Calibration Curve of Standards for SDS-PAGE 
( -MBTA).
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Fig. 26 [ H ]-MBTA Labelling of the ?2 Membrane Fragments
Distribution of Radioactivity after SDS-PAGE
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3. Experiments on the Detergent Extract:
125A. Comparison of Specific [ I]-g-Bungarotoxin Binding to the 
?2 Fraction Solubilised in Various Concentrations of
Triton X-100;
The ?2 fraction was resuspended in buffer B (Table22 ) containing
either 0.1%, 0.5% or 1% (v/v) Triton X-100 (Methods 2 Cb) p.125).
125[ I ]-a-bungarotoxin binding was assayed at three concentrations,
0.5 nM, 3 nM and 10 nM. The ammonium sulphate precipitation assay
125(Methods 4 (b) p.128) was used to separate bound [ Ü -a-bungarotoxin 
from free toxin in this and all subsequent experiments on the detergent 
extract.
125Fig. 27shows specific binding of [ I]-a-bungarotoxin to the
solubilised fraction, at the different concentrations of Triton X-100
125used. As can be seen from this, more [ l]-a-bungarotoxin binding
protein was solubilised in buffer containing 1% Triton X-100 (at 
12510 nM [ I]-a-BT, 1.82 pmol bound/mg prot.) than either 0.1% or
1250.5% (v/v) Triton X-100 (at 10 nM [ I] -a-BT, 0.815 and 0.655 pmol
bound/mg protein, respectively). The experiment was carried out in
quadruplicate (S.E. < 3%). For subsequent experiments buffer B
containing 1% (v/v) Triton X-100 was used and the solubilised
fraction will henceforth be called the "detergent extract",
125After solubilisation 90% of the [ I]-a-bungarotoxin binding
activity in the fraction was routinely recovered in either a
100,000 X g or 200,000 x g supernatant. This is equivalent to 50-60%
125recovery of the total specific [ I] -a-bungarotoxin binding.
4-1OUA
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ï0
MHbOpq101
iqm
C M
I
125Fig. 27 Comparison of Specific [ I]-aBgTx Binding to 
the Membrane Fraction Solubilised in Various 
Concentrations of Triton X-100.
2
1
5 10
125[ I]-a-BgTx (nM)
-3, 125[ I]-aBgTx wasd-Tubocurarine 10 '̂ M; bound 
separated from free by (NH,)^ SO, ppt. and 
filtration; O  1% (v/v) Triton; #  0.5% (v/v) 
Triton; ■ 0.1% Triton. (Results are the 
means of quadruplicates S.E. < 3%).
Fig. 28 The Effect of Protein Concentration on 
125[ I]-aBgTx Binding to the Detergent Extract.
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[ I]-aBgTx, 2nM; d-tubocurarine 10 M; bound [ I]-aBgTx 
was separated from free by (NH^)^ SO^ppt. and filtration;
■ total binding; O  non-specific binding; #  specific 
binding (Results are the means of 2 expt. each in triplicate 
S.E. < 5%).
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125B. The Effect of Protein Concentration on Binding of [ I]- 
g-Bungarotoxin:
Fig. 28 shows the effect of increasing the protein concentration
125(40-15Oyg per-ll33hl)on total, non-specific and specific [ I]-a-bungarotoxin 
(2 hM) binding to the detergent extract. Specific binding is proport­
ionate to protein concentration and is greater than non-specific
125binding at this concentration of [ I]-a-bungarotoxin. Total and 
non-specific binding do not go through zero because of apparent binding 
to the filters. The experiment was carried out twice in triplicate 
(S.E. < 5%) .
125C . The Dependence of Binding of [ I]-a-Bungarotoxin on 
Concentration (0.5 - 10 nM):
125Binding was carried out over a range of [ I]-a-bungarotoxin
concentration of 0.5 - 10 hM.
Fig. 29 (a) shows the binding profile for total, non-specific and 
125specific [ I]-a-bungarotoxin binding (mean of two experiments, each
in triplicate, S.E. < 4%). As can be seen specific binding shows a
125tendancy to saturate and it is only at 10 nM [ I]-a-bungarotoxin
that non-specific binding exceeds specific binding.
Fig. 29 (b) shows a Scatchard analysis of the specific binding.
125A Kp of 5.6 nM and a B^^^ of 1.714 pmol [ I]-a-bungarotoxin bound/mg 
protein were obtained. The points lie on a straight line with a 
correlation coefficient of 0.950.
Fig. 29 (c) shows a Hill plot of the same data taking B ^ ^  as
1.714 pmol/mg protein. The points lie on a straight line Cr = 0.991) 
the slope of which is 0.972 giving a Hill number (n ) of 1.0 and hence 
it can be assumed that no cooperativity is taking place.
m
CN
125Fig. 29 (a) The Dependence of [ l] -aBgTx Binding to the 
Detergent Extract on Concentration.
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from free by (NH^)^ SO^ ppt and filtration; ■ total 
binding; O  non-specific binding; #  specific binding. 
(Results are the means of 2 expt. each in triplicate 
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D. Sedimentation in a Sucrose Density Gradient;
Sedimentation in a sucrose density gradient was carried out as
described in Methods 7 (a) (p.130).
Fig. 30(a) shows the distribution of radioactivity after 
125sedimentation of the [ I]-a-bungarotoxin-detergent extract complex
125and Fig. 30(b) shows the radioactive distribution of free [ I]-a-
bungarotoxin. The profiles are the same, suggesting that the detergent 
extract - toxin complex has completely dissociated under these 
conditions.
4. Experiments on the Partially Purified g-Bungarotoxin Binding 
Component:
The a-bungarotoxin binding component was partially purified as
outlined in Methods 2 (c) (p.125). Binding was as described in
Methods 4 (c) (p.128) and non-specific binding was accounted for by
-3incubating in the presence of an excess of d-tubocurarine CIO M),
A. The Extent of Purification:
1 25Tables 29(a) and (b) show the specific binding C[ 
bungarotoxin; 10 nM) and the purification factor (total homogenate 
= 1 .0), at four stages in the fractionation scheme for two separate 
preparations. It can be seen, firstly, that both the specific activity 
and the extent of purification are different for the two preparations 
although the percentage recovery of binding activity (taking the total 
homogenate as 100%) is similar. Secondly, it appears that in both 
preparations, most of the protein is lost between the fraction and 
the solubilisation in Triton X-100. Accompanying this loss of protein 
there is a loss of total pmol of specific binding activity. So it 
would appear that at this stage not only is a lot of non-specific
TABLE 29
The Extent of Purification at Various Stages in the Preparation. 
PREPARATION (a)
Fraction Protein 
Cone. 
(mg/ml)
Tot.
Prot
(mg)
Sp.Act
(pmol/
mgprot
Purifi­
cation
Tot. 
Binding 
(pmol)
% Recovery 
of 
Binding
Tot.Hom. 6.8 54.4 0.207 1 11.1 100
3.825 30.6 0.414 2 12.67 114
Detergent
Extract 4.725 4.82 1.526 19 7.35 66
*PPaBTBC 0.004 0.0264 230.0 1100 6.07 55
PREPARATION Cb)
Tot.Hom 5.37 37.62 0.412 1 15.5 100
4.35 30.232 0.702 1.7 21.22 137
Detergent
Extract 5.27 5.27 1.694 2.4 8.93 58
*PPaBTBC 0.01575 0.0819 71.91 174.5 5.89 38
P.P.aBT.BC = Partially Purified aBT Binding Component 
125[ I]-a-BgTx was at a concentration of 10 nM. The fraction was 
prepared as described in the Methods 2 (c) (p. 125). Binding was 
carried out as described in Methods 4 (c) (p. 128).
TABLE 30
Summary of the Extent of Purification for Six Preparations
Prep. Protein 
/Cone. 
(mg/ml)
Specific 
Binding 
(pmol/ 
mg prot)
% Recovery Total 
Binding Acitivity 
(Tot.Hom. = 100%)
Purification 
(Tot. Hom. =1)
1 0.0075 13.96 9 56
2 0.0030 75.88 26 404
3 0.0040 230.00 48 1100
4 0.0030 6.68 “ 50
5 0.0012 26.53 - 190
6 0.0160 71.91 38
------------------- -
174
125[ I]-aBgTx was at a concentration of 10 nM. The fraction was 
prepared as described in the Methods 2 (c) (p. 125). Binding was 
carried out as described in Methods 4 (c) (p. 128).
Fig. 31 The Effect of Varying the Protein Concentration
125on the Specific Binding of [ I]-aBgTx to the 
Partially Purified Binding Component.
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binding protein lost (purification factor 19 and 3 for preparations
125(a) and (b) respectively) but also there is a loss of specific [ I] -a- 
bungarotoxin binding protein. This is not the case for the next step 
in the purification procedure i.e. passage through the affinity column. 
Although the total protein recovered at this stage is greatly 
reduced, the loss of total specific binding activity is minimal and 
hence the purification maximal.
Table 30 is a summary of the protein concentrations, specific 
binding and purification factors for six preparations. This table 
shows how the specific binding (6.68 - 230 pmol bound/mg protein) 
and the extent of purification (50 - 1100) varies considerably 
from preparation to preparation.
B . The Effect of Varying the Protein Concentration on Specific
125[ I ]-g-Bungarotoxin Binding:
125Specific binding of [ I]-a-bungarotoxin CIO nM) was found to 
vary proportionally with protein concentration CO.37 - 1.12 Tig per 150 yl).The 
experiment was repeated and the same result was obtained. (Fig. 31)
125C . The Dependence of Binding of [ I]-a-Bungarotoxin on 
Concentration (0.5 - 10 nM):
Binding was carried out over a concentration range of 0,5 - 10 nM
125[ I ]-a-bungarotoxin. Fig. 32(a) shows specific and non-specific 
binding. Non-specific binding is shown after subtraction of the filter 
blanks, and as can be seen it is much lower than specific binding.
Fig. 32(b) is a Scatchard plot of the specific binding data and 
from this a of 1.71 nM and a B^^^ of 22.4 pmol bound/mg protein 
was obtained, with a correlation coefficient of 0.89. Each point is a 
mean of quadruplicates (S.E, <5%).
125Fig. 32 (a) The Dependence of C I]-aBgTx Binding 
to the Partially Purified Binding 
Component on Concentration.
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Fig, 32 (c) is a Hill plot of the same data taking as
22.4 pmol bound/mg protein. This plot gives a Hill number (n^) of 
0.992, (r = 0.969) which can be taken as unity and hence it would 
appear that no cooperativity is taking place.
D. The Determination of the Rate of Dissociation (k_^) for 
125[ I]-g-Bungarotoxin Binding:
The k_^ was determined as described in the Methods 5 (pl29 ).
The experiment was carried out in triplicate and samples were taken
at the time intervals indicated after the addition of excess unlabelled
a-bungarotoxin (x 1000 molar excess). Samples incubated in the
presence of an excess of d-tubocurarine (10 M) were also taken at the
same intervals, to account for non-specific binding. Results are
1 25expressed as a percentage of total specific r I]-a-bungarotoxin 
binding i.e. taking the amount bound before the addition of the excess 
unlabelled a-bungarotoxin as 100% and taking into account the volume 
dilution.
125Fig. 33 shows a plot of percent [ I]-a-BgTx bound against time
(1 experiment in triplicate S.E.< 3%). After 1 minute only 30% of 
125the [ I]-a-bungarotoxin remained bound and so the rate of dissociation
was too fast to obtain an accurate measurement of k_^ by calculating 
t^ ^. Therefore a visual estimate from the time course of t^  ̂ and 
t o was made. The term "greater than", must always be employed
U  • o
because as the time course is exponential, the actual t^ ^ will not 
be directly proportional to either t^  ̂or t^ g. It will always be 
faster and an under estimation of k_^ will be obtained using t^  ̂or
^0 .8 *
Fig. 33 The Determination of the Dissociation Rate
125Constant (k_^) for [ I]-a-BgTx Binding 
to the Partially Purified Binding Component
100
§ !0rû
a 50 ■ 00 PQ13I
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CMI—I
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TIME (min)
I- X]-a-BgTx, 2mM; d-tubocurarine 10 M;bound [ I]-a-
BgTx was separated from free by DEAE cellulose filtration. 
(Results are the means of triplicates S.E. < 3%).
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Using the equation:
log (^b/^) = k_^.t
where A = Amount bound at zero time o
A = Amount bound at time t
k_^ = the off rate
t = time in sec.
Estimation of k . from t_ „ (i.e. when 90% of labelled toxin has -1 Ü . y
“3dissociated), where t^  ̂ is 600 s, k_^ is calculated to be > 3.8 x 10
-1 -3 -1S , from t^ g (150 s), k_^ > 10.7 x 10 S . The values are of the
same order of magnitude and the mean of k_^ 's estimated from t^  ̂and
t_ o is > 7.25 X 10"3 s"^.
X
Using the relationship = ——  at equilibrium (where is
the intrinsic dissociation constant and k^^ is the on-rate) and
6 - 1 - 1assuming that k^^ is equal to 1 x 10 M S , which is very close to
experimentally determined values for most neurotransmitter receptors,
-9Kp was calculated to be > 7.25 x 10 M, a value which is very close 
toiJt\e Kjj estimated from equilibrium binding studies (_1.71 nM) .
E . Sedimentation in a Sucrose Density Gradient:
Sedimentation in a sucrose density gradient was carried out as
described in the Methods 7 (b) (p.131). A plot of sedimentation
coefficient against the fraction number with peak enzyme activity for
each standard marker enzyme gave a straight line (r = 0.993) Fig.34
Every fraction from the gradient containing the sample was 
125assayed for [ I ]-a-bungarotoxin binding activity. The activity 
sedimented as a single component (Fig. 35) with a S^q ^ = 14.2 S, 
corresponding to a molecular weight of 400,000 - 450,j000̂  using the 
approximation (Schachman, 1959):-
Fig, 34 The Calibration Curve for the Marker 
Enzymes after Sedimentation in a 
Sucrose Density Gradient
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2 = catalase (11.4s; 232,000 M^)
3 = yeast alcohol dehydrogenase
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Fig. 35 The Distribution of Specific [ ̂ ̂ ^lil-aBgTx Binding 
Activity after Sedimentation in a Sucrose Density 
Gradient of the Partially Purified Binding Component.
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Centrifugation was at 100,000 x g for 6 h.; every fraction
125was assayed for aBgTx binding activity; [ X]-aBgTx 10 nM;
“3 125d-tubocurarine 10 M; bound [ X]-aBgTx was separated
from free by DEAE cellulose filtration. Marker enzymes:
1 = B galactosidase (16.05); 2 = catalase (11.45); 3 =
yeast alcohol dehydrogenase (7.45).
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^^20,w^2
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Molecular Weighty
Molecular Weighty
'^3
The contribution of bound detergent to the Stokes’ radius was 
not taken into account. The experiment was repeated and a value of 
14.1 S was obtained.
^ * SDS Polyacrylamide Gel Electrophroesis;
SDS polyacrylamide gel electrophoresis of the partially purified 
a-bungarotoxin binding component was carried out under denaturing 
conditions as described in the Methods 8 and 9 (p.132). Fig. 25 
shows the calibration line for the standard markers. CLog^^ Molecular 
Weight ) vs distance of Protein Migration).
The partially purified a-bungarotoxin binding component gave 
three faint but distinct bands on this gel system. The bands 
correspond to molecular weight of 60,000, 41,000 and 25,000. Fig. 37 
shows densitometric analysis of the same gel and shows clearly the 
three bands as peaks.
5. Determination of Acetylcholine Esterase Activity in All Fractions;
Table31 shows the relative specific activities (RSA’s) of 
acetylcholine esterase in the various fractions.
% Enzyme activity recovered in the fraction
RSA =
% Total protein recovered in the fraction 
where enzyme activity and total activity in the total homogenate is
taken as 100%. As can be seen no fraction has a RSA value greater than
one but activity is greatest in the S^ xand ? 2  fractions. No enzyme
activity was recorded in the partially purified fraction.
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TABLE 31
RSA Values for Acetylcholine Esterase Activity in Various Fractions
FRACTION RSA
Total Homogenate 1
Si 0.679
0.130
0.588
Detergent Extract 0.461
Partially Purified 
Binding Component 0
RSA = Relative Specific Activity
% Total Enzyme Activity 
% Total Protein
Enzyme activity was assayed as described in the Methods 11 (.p .134)
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DISCUSSION
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Radiolabelled ligand binding studies have played a major role 
in the identification, purification and characterisation of putative 
receptors. Initial binding studies can be made on very crude 
preparations which are often little more than a whole tissue homo­
genate. Once specific, high affinity binding of a specified ligand 
has been identified, purification can proceed and the binding 
characteristics can be monitored through the various stages of 
purification. Finally, when purification to homogeneity has been 
achieved, complete characterisation can be carried out. The ultimate 
aim of all such studies is to assign a physiological receptor role 
to what are initially no more than specific ligand binding sites 
(Criteria, Introduction p .15 ). To date, of the three putative 
acetylcholine receptors in insect CNS (Introduction p.20), only in 
the case of the putative nAChR has enough complementary evidence 
accumulated to warrant its definition as a synaptic acetylcholine 
receptor. The characterisation of this particular receptor has been 
critically dependent on the snake venom a-toxins as diagnostic receptor 
probes. The procedures employed in the isolation and purification of 
the insect nAChR have been developed from the well established 
methodology associated with the nAChR of fish electric organ and 
vertebrate skeletal muscle (see, Fulpius, 1976). The studies reported 
in this thesis sought to apply this expertise to the characterisation 
and purification of the nAChR of the supra-oesophageal ganglion of the 
desert locust, Schistocerca gregaria.
The Binding Assay:
The primary objective in receptor binding studies is to quantitate 
the specific binding of a ligand to the tissue in question. In the
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great majority of cases detection of the ligand depends on radiolabelling 
and the first consideration must be the choice of a technique which 
will efficiently separate bound radiolabelled ligand from free radio­
labelled ligand. The choice of a separation technique is largely 
dependent on whether the putative receptor is in a particulate or in 
a soluble form. The a-bungarotoxin binding component studied in this 
thesis was investigated in both states. For preparations in which the 
binding component remained in the membrane-bound form a centrifugation 
assay was chosen. Although there was little difference in binding 
between this procedure and a vacuum filtration method, the centrifugation 
method was adopted for the routine assay of particulate fractions.
It offered advantages in terms of reproducibility of separation times 
with an ensuing improvement in the extent of variation of experimental 
results.
For the soluble fraction an ammonium-sulphate precipitation 
assay, derived from Meunier al̂  (1972), was chosen in preference to 
an ion-exchange separation by vacuum filtration on DEAE cellulose 
discs because the fraction contained large amounts of soluble proteins 
which could easily saturate the rather limited capacity DEAE filter 
discs; indeed such a problem was encountered in studies on the nAChR 
from human skeletal muscle (Stephenson, 1980). On the other hand, 
the ammonium-sulphate procedure results in the precipitation of all 
proteins, soluble and particulate, specific and non-specific. However 
free toxin is not precipitated under these conditions. The precipitated 
bound toxin is then separated from free toxin by a simple physical 
filtration. Therefore this precipitation method was also suitable 
for fractions which contained both soluble and particulate material, 
such as the total homogenate and the fractions.
- 154 -
Ion-exchange on DEAE-cellulose filter discs was used for the 
assay of the preparation of the partially purified a-bungarotoxin 
binding component because such preparations contained very low 
amounts of protein, the majority of which was the specific binding 
component. The ion-exchange assay also offers considerable advantages 
in that the entire procedure takes only about 2 hours compared with 
the 24 hours required for the ammonium sulphate procedure.
The major constraint on separation techniques is the rate of 
dissociation of the receptor-ligand complex at the temperature at 
which the separation is carried out. Dissociation will commence 
immediately the equilibrium is changed either by removal of the free 
radiolabelled ligand, such as occurs during separation, or by dilution 
as will occur during washing of the receptor-ligand complex. Thus 
complexes that dissociate rapidly will require separation and washing 
techniques that minimise the amount of dissociation.
It has been estimated that a separation and washing time of 
approximately 0.15 x t^ ^ (where t.̂   ̂ is the half-time for dissociation 
of the complex) results in less than 10% dissociation. In the bulk 
of the work described here separation and washing procedures were 
routinely completed in less than one minute for the centrifugation 
method and about 6 seconds for the filtration methods, thus ensuring 
minimal dissociation of membrane-toxin-oémplex (t_ - ~ 30-65 minutes)' O.j
and the partially-purified-binding-component-toxin-complex 
(t_o ^ > 1 minute ), respectively. In the case of the ammonium 
sulphate precipitation assay samples are left for at least 16 hours 
for the precipitate to form, however, it appears that free toxin is 
still in equilibrium with the receptor-toxin precipitate (Stephenson, 
1980). The efficiency of the separation techniques used will be
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inactivation of preparations (Schmidt-Nielson e_t , 1977). The rationale 
for such a procedure is that heating the tissue destroys the tertiary 
structure of proteins and hence the specific binding conformation of 
the receptor but that binding to non-physiological sites will not 
be impaired. Schmidt-Nielson e^ a^., (1977) have compared this method 
with the more conventional displacement procedures and concluded that 
they are equally effective, both in membrane-bound and in detergent- 
treated preparations of housefly heads.
125In work reported in this thesis non-specific [ l]-aBgTx binding
to all fractions was routinely estimated by incubation in the presence
“3of an excess of d-tubocurarine (10 M). Closely similar results were 
obtained with excess aBgTx.
Subcellular Localisation of the a-Bungarotoxin Binding Component;
Most reports of a-BgTx binding to insect CNS have shown the a-BgTx 
binding component to be associated with particulate sub-fractions of 
the tissue (see Introduction p.26). The work reported in this thesis 
shows that aBgTx binding is associated with a 100,000 x g pellet 
fraction of homogenates of locust supra-oesophageal ganglia and is in 
agreement with the majority of reports of other preparations of insect 
CNS (see Sattelle, 1980a). Contrary to these findings however is the 
recent report of March e^ a^., (1980) which suggests that the aBgTx binding 
component from housefly heads readily behaves as a soluble protein.
They found an enrichment of a-BgTx binding activity in a 150,000 x g 
supernatant of a preparation of whole housefly heads homogenised in 
buffered sucrose. However, an earlier report from these workers showed 
that a-BgTx binding was associated with a 20,000 x g pellet prepared 
under apparently similar conditions (Cattell e^ , 1980). This apparent
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125discussed further when the rate of dissociation of bound [ I] 
aBgTx from the membrane fragments and from the partially purified 
fraction is considered (p. 162).
In all the fractions studied a proportion of the total
125[ I]-aBgTx binding was non-specific. Non-specific binding may 
be composed of several components:
1. Binding to tissue components other than the site under
investigation.
2. Free radiolabelled ligand not removed by washing.
3. Binding to separation materials.
The most widely used method to account for non-specific 
binding is the "unlabelled ligand excess" method, where specific 
binding of the radiolabelled ligand is defined as the difference 
between the total binding and the binding that occurs in the presence 
of an excess of unlabelled ligand. The method depends on displacement 
of labelled ligand only from sites having a high affinity and as such 
can be subject to interference from binding to sites with high affinity 
but which are of no physiological relevance (Turner, 1980). This 
problem can, to some extent, be circumvented by adopting procedures 
that depend on displacement of radiolabelled ligand by a chemically 
different ligand,,that is a potent agonist or antagonist. In this 
case the probability of competition between labelled and unlabelled 
ligand for any common high-affinity but non-specific site is less 
and in general the use of well characterised, structurally distinct 
unlabelled ligands is to be preferred in the displacement of specific 
binding (Bennett, 1978).
A quite different approach to the problem of distinguishing 
between specific and non-specific binding relies on the heat
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discrepancy could perhaps result from the method of assay of the
binding activity. The earlier study was mainly concerned with an
125investigation of [ I]-a-BgTx binding to a total homogenate of
housefly heads, in which filtration through Whatman GF/C filters
was used to separate bound from free toxin. It must be assumed that
the same method was employed to measure binding activity in the various
subcellular fractions as the report gives no indication of any
variations in the binding assay. If indeed this is the case, then an
under-estimation of binding activity in the soluble fractions would
be expected as it is unlikely that Whatman GF/C filters retain soluble 
1 25receptor i I ]-a-BgTx complex. The later study (March et al., 1980) 
in which the binding component is greatly enriched in the soluble 
fraction, uses the DEAE filtration assay and it may well be that this 
soluble component was not detected in the earlier studies that used 
the GF/C filtration procedure.
There are as yet insufficient data to provide an explanation for 
the ready solubility of the flyhead binding protein. In the case of 
nAChR from vertebrate muscle there is an extensive literature concerned 
with the proteolytic degradation of the receptor during purification 
and it is generally agreed that proteolysis is a major problem 
(Lindstrom e_t aJ., 1979; Lindstrom £t al̂ ., 1980a; Shorr e^ a1̂ ., 1981). 
Rather less attention has been paid to this matter in the insect work 
and certainly there are no reports of systematic studies of the effects 
of proteolysis and/or the effects of anti-protease agents on the 
various putative AChR's from insect material. March (1980) included
a number of anti-proteases, that have been employed in studies on the 
nAChR from mammalian muscle (Stephenson, 1980), in the homogenisation
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buffer but it is not established that the agents used are effective
inhibitors of the particular proteases encountered in the flyhead.
There is the possibility that the behaviour of the fly binding proteins
represents a true species variation but other workers have reported
a particulate localisation for [ I ]-a-BgTx binding activity in housefly
heads (Jones & Sumikawa, 1981;Eldefrawi & Eldefrawi^ 1980), however
in these studies no quantitative assessment of overall recovery of
binding activity in the various fractions was given.
In none of the reports of identification of an a-BgTx binding
component in insect CNS, is there a detailed account of the homogenisation
procedure used. It would seem that release of the putative nAChR
into a soluble fraction would depend not only on the nature of the
association of the receptor with the post-synaptic membrane but also
on the degree of disruption of that membrane by the homogenisation
procedure used. The procedure used in this thesis was relatively
harsh in comparison to methods used in the preparation of synaptic
membranes from mammalian brain (see Jones, 1975). As shown in Table 23
125the behaviour of the [ 1\ -a-BgTx binding component is indicative of
a protein tightly associated with its membrane.
The Membrane Fragments (?2 Fraction)
125Specific [ I ]-a-BgTx binding to the membrane fragments increased 
linearly with tissue concentration indicative of specific binding and 
thus is in agreement with one of the criteria for defining a physiological 
receptor (Introduction p. 15 ).
Specific binding was saturable with respect to time, reaching 
equilibrium in 10 to 15 minutes. To demonstrate that a putative receptor 
has a high affinity and finite number of binding sites for a particular
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ligand it is necessary to obtain estimates of the intrinsic dissociation
constant, K^, and the maximum number of binding sites per unit weight
of tissue, B . These values are usually calculated from equilibrium max
binding studies over a saturating concentration range of ligand.
Initially such studies with the membrane fragments were carried
125out over a concentration range of 40 nM - 600 nM [ l]-a-BgTx, This
range was chosen because preliminary results from Cattell e_̂  al (1980a)
suggested the presence of both a high (K^, 3.1 <r\M; B^^^ 0.204 nmol/g prot.)
and a low (K^ 549.6 nM; B^^^ 14146 nmol/g prot.). affinity binding site
for a-BgTx binding to an homogenate of housefly heads. At these
125concentrations specific binding of [ I]-a-BgTx to the membrane
fragments of locust supra-oesophageal ganglia was inconsistent between
preparations. In some experiments specific binding appeared to approach
saturation but Scatchard analysis of the data gave no reliable estimates
of or B^^^. It was thought that perhaps this concentration range
125of [ I]-G-BgTx was masking a possible high affinity binding site
which would saturate within a lower concentration range. Specific
binding was investigated over a concentration range of 0.5 nM - 10 nM 
125[ I]-a-BgTx. Specific, saturable binding was observed and was
consistent from preparation to preparation. Scatchard analysis of the
binding data gave values of K^, 1.38 nM and B^^^, 1.18 pmol/mg protein.
The binding data showed no evidence of cooperativity as indicated by
a Hill number of one. A of this magnitude indicates high affinity 
125binding of [ I]-a~BgTx to the membrane fragments; although higher than
the s quoted for a-BgTx binding to the nAChR^s of the electroplax ,
-10 - 12.and of vertebrate skeletal muscle, 10 M - 10 (see, Karlin, 1980)
the value of 1.38 nM is in agreement with the K^'s calculated for
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125[ I ]-a-BgTx binding to other insect preparations (Table 32) and
• • ""9 “8to preparations of mammalian CNS, 10 M - 10 M, (see, Oswald &
125Freeman, 1981). A B^^^ of 1.18 pmol [ l]-a-BgTx bound/mg protein 
agrees well with a value of 2 pmol/mg protein reported by Eldefrawi and 
Eldefrawi (1980), for a similar preparation from housefly heads.
Other workers have reported values of B^^^ of approximately an order 
of magnitude lower for the binding of a-BgTx to crude homogenates 
of fruitfly heads (Dudai, 1980) or of whole flyheads (Cattell 1980a) 
suggesting that these preparations are comparable in specific binding 
activity to the total homogenate of locust supra-oesophageal ganglia 
(Table23 ).
125A concentration of 80 - 85 pmol [ I]-a-BgTx binding sites/g 
wet weight locust supra-oesophageal ganglia, was estimated from measure­
ments of specific binding to the total homogenate, a figure comparable 
to the value of 88 pmol/g fruitfly heads reported by Hall (1980).
Thus both locust supra-oesophageal ganglia and fruitfly heads represent 
a slightly richer source of toxin binding activity than ElectrophOrus 
electroplax (Raftery e^ a]̂ ., 1971) and denervated rat diaphragm 
(Berg e£ a1̂ ., 1972), both of which have in the order of 20 - 66 pmol 
of toxin binding activity/g tissue, and a much richer source than 
rat brain, which contains about 6 pmol binding activity/g wet weight 
(see, Schmidt e^ al., 1980 ). However, a major problem of working 
with insects is their size, a single locust supra-oesophageal ganglion 
weighs on average 4 mg (wet weight) and so although a relatively rich 
source of a-BgTx binding activity, hundreds of ganglia must be used to 
obtain sufficient material on which to commence potential purification 
schemes.
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As an alternative to binding studies at equilibrium, can be
estimated from measurements of the individual rate parameters, the
on-rate constant (k^^) and the off-rate constant (k_^), where =
k_^/k^^. The k^^ for binding of neurotransmitters to their receptors,
6 -1 -1is usually about 10 M S (Bennett, 1978). In practice little 
variation in k^^ is seen between widely differing preparations. 
Furthermore, the conditions chosen for most binding experiments ensure 
that equilibrium is reached and therefore the precise value of k^^ 
is usually of little practical relevance. On the other hand, k_^ is of 
great relevance to the choice of technique for the separation of 
bound from free ligand or indeed to any procedure that may perturb 
the equilibrium. Thus investigations that may result in separation of 
free ligand from receptor-ligand complex, such as sedimentation in a 
sucrose density gradient, electrophoresis in non-denaturing systems or 
gel filtration will necessarily be constrained.
The k_^ is most commonly measured by one of two methods of 
"infinite" dilution of the radiolabelled ligand when equilibrium has 
been reached. Either a 100-fold volume-excess of incubation buffer 
is added or alternatively a 1000 fold molar excess of unlabelled ligand 
is added; radiolabelled ligand that remains bound is then measured 
at intervals. The second method,referred to as the molar-excess method, 
was chosen in preference to the volume dilution method because apparent 
negative cooperativity may arise artifactually at high receptor and low 
ligand concentrations due to the "retention effect". As the receptor 
site concentration approaches or exceeds the of the radiolabelled 
ligand, diffusion of dissociated radiolabelled ligand away from free 
receptor sites is progressively hampered, probably because of the very
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high local concentrations of unoccupied binding sites. This does 
not happen with the molar excess method, as the total concentration 
of ligand, (labelled and unlabelled) is high and only labelled ligand 
is infinitely diluted.
125Dissociation of [ I ]-a-BgTx from the membrane fragments was
found to be biphasic; a fast phase in which 50% dissociated in̂ ; 70
minutes followed by a very slow phase where only 5% dissociated in
the next 120 minutes. A similar biphasic pattern of dissociation was
observed by Eldefrawi and Eldefrawi (1980) for a preparation from
housefly heads; 37% dissociated in the first 10 minutes and 23% in
the next 110 minutes. The slower dissociation rate does not represent
non-specific binding because the data refer exclusively to those sites
-3that are protectable with 10 M d-tubocurarine. The faster phase of
dissociation follows first-order kinetics (Fig.23 ) and a half-time
of dissociation of 65 minutes was calculated; from the mean of three
-4experiments a k_^ of 2.78 x 10 S was obtained. This value agrees
well with values obtained by other workers both for particulate
fractions and for a partially purified preparation (Table32 ) from insect
CNS. Half-times of dissociation of around 30 minutes have been
calculated for locust, Locusta migratoria, (Breer, 1981) and flyhead
homogenates (Jones & Sumikawa', 1981). There is littlie difference between 65 minutes
and 30 minutes when compared to the tp  ̂for the electroplax receptor-
toxin complex which is of the order of days (Rang, 1975; Cohen &
Changeux, 1975). A half-time of dissociation of tens of minutes gives
a value of 0.15 t^  ̂of about 9 minutes (see p.154 ) and therefore rather
125less than 10% of the bound [ I]-"a-BgTx will have dissociated during 
the separation of free from bound ligand by the centrifugation method.
- 163 -
as the separation time using this method is less than one minute.
These relatively short half-timeSof dissociation indicate that
a-BgTx binding to the various insect preparations investigated to
date, is slowly reversible and in this respect differs markedly from
the nAChR of the electroplax and vertebrate skeletal muscle where
binding of a-BgTx is essentially irreversible (t^ ^ > lOOh), but
resembles the putative nAChR from mammalian CNS from which a-BgTx
dissociates more rapidly with a t^  ̂ of 5-15 hours (see, Oswald and
125Freeman, 1981). Furthermore, dissociation of [ I]-a-BgTx from 
preparations of mammalian brain has been shown to be biphasic for toad 
(Oswald, 1979) and goldfish (Oswald and Freeman, 1979), a further 
similarity with the particulate form of the putative nAChR from locust 
supra-oesphageal ganglia.
In defining a putative cholinergic receptor, demonstration of, 
high-affinity, specific binding of a-bungarotoxin is in itself 
inadequate evidence to justify the designation, nicotinic acetylcholine 
receptor. It must also be shown that the specific binding of a-BgTx 
is inhibited by other nicotinic ligands. A widely used convention is the 
expression of inhibition data as IC^^'s. The IC^^ of a particular 
ligand is that concentration of ligand which will either inhibit 50% 
of maximum specific binding of another ligand at equilibrium or will 
retard the initial rate of binding of that ligand by 50%. The former 
method of estimating the IC^^'s of various ligands was chosen for 
this membrane fragment preparation because less sample is required to 
obtain a displacement curve than measurement of initial rates over a 
range of ligand concentrations.
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Under certain conditions and allowing for a number of assumptions
the for a particular ligand closely approximates to the equilibrium
dissociation constant for binding (K^) for that ligand. It must be
assumed that the displacing ligand behaves at the binding site very
similarly to the bound ligand and that binding phenomena under investigation
follow classic mass action laws. The experimental conditions for
IC^Q - for a particular ligand are related to both the concentration
125of the labelled ligand i.e. [ I}-a-BgTx in these experiments and the 
concentration of binding sites. As the concentration of radiolabelled 
ligand utilized in displacement studies is increased, the difference 
between the IC^^ of the unlabelled displacing ligand and the binding 
dissociation constant of that ligand (K^) progressively widens, at 
fixed tissue concentration, according to the following equation;
K. = ^^50_______
1 + [L] %
where = binding dissociation constant for unlabelled ligand 
IC^Q = IC^Q measured for the same unlabelled ligand
[L] = Concentration of radiolabelled ligand, i.e.
1 2S[ I ] - a - B g T x
= Dissociation constant for bound radiolabelled ligand i.e.
125[ I]-a-BgTx.
The concentration of receptor sites in the incubation medium can 
also influence the relationship between IC^^ and the true K^. Jacobs 
et al (1975) point out that the inter-relationship between IC^^, 
and and receptor site concentration at steady state is:
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= n(K^ + Ly + Rp - M.)
= + n(Lj + RL)
125where = Total concentration of radiolabelled ligand [ I]- a-BgTx.
= Total concentration of receptor sites,
RL = Concentration of receptor-radiolabelled ligand complex
formed in the absence of unlabelled ligand i.e. maximum
125specific binding of [ I]-a-BgTx.
and K. 1 = n Kjj
Therefore if (L^ + then the IC^^ will approximate to .
In practice the concentration of total receptor sites should thus
125not exceed approximately 10% of the K_̂  for [ I]-a-BgTx binding. Also
125the concentration of [ I]-a-BgTx present should be not more than a
quarter of the concentration of unlabelled ligand giving 50% displacement.
125The latter point was fulfilled ([ I]-a-BgTx was at 2nM) but carrying out
experiments at a receptor site concentration of less than 10% of the 
125for [ l]-aBgTx binding was not possible because at this concentration
125of receptor sites(<Q.2nM) the low amounts of [ I]-aBgTx bound would be
very difficult to detect. Therefore a compromise was made and a concentration
of 0.4nM of binding sites was chosen as the lowest at which acceptable
determination of binding could be made. This may have resulted in an
overestimâtion of K^. This point of standardising the IC^^ values is
important if one is to compare values quoted from different groups of workers.
X25The order of potency of ligands in inhibiting [ I] -a-BgTx binding
will be the same from studies carried out under differing conditions
provided that the conditions are the same within any one study. However,
the absolute values cannot be compared between different studies unless
125the previously mentioned conditions of [ I] -a-BgTx and of binding site
concentration are met or if corrections are made to the results.
125The most effective inhibitor of specific [ I] -a-BgTx binding 
to the membrane fragments were nicotinic in nature, a-bungarotoxin
f PÜ a o O > g > M  W  CM pp p p P rt P* o co p 1 1X o p X P O P P P H wp p CJ" p O O rt P N C cH B B p rt *3 rt p- c o" pp" p p B P P* P» p P X o OQ tr*h-* H* rt rt g B P P O P C o P H-1—' m P̂ P* p* P P p" (- c P OQO O >*■ a o p p O PH P P Ci p p c p rt Pt—' P" H* P* p" p* p p O CMVO (P C Ê o p t- p- X00 co B B p* p p p P*o H* P" B P Pen pp
ON P 00 CJN -P' pù) 00 00 O(jJ P VO CJN P  . "p OV t—' Ol NO 00 00 00 P  S3 VO p Oen N) p O nX X X X X X X X X X p O ao p O co1 p* p» p p p p p  p  p P rt H(D (jO O o o O O o o  o  o O XP 1 1 1 1 1 1 1 1 1 1
g* 4> On CJN ON ON -vl VO OQ
(P
n> 1-*rt IfpPi |rtl-* IP VO P CJN p C/JC 5ÜLn O K5 o On O1—' P O cpVO 1 1 1 X 1 X 1 1 X X P O co"J 1—: P M00 VO P P p p P X PS00 O O o O rt r*O 1 1 1 I P OQ K!P 00 00 00 VO P N>rt
UJ p Onp 00 CO P Pw VO VO O C On O00 c» VO CJN P ►O O O Onp cp O1 X 1 X 1 X X 1 X X p O COp O M Op> P P p P P p O Pj So O O o O O rt M1 1 1 1 1 1 P XUl On 00 ON VO p Pi-S o rt OQOp"
IPM
1 p1 •“* 00 (JN PJ PJ PION N3 CJN KO On 00 CJN C P fOp, P Ch-* 1 X X X X X X 1 X 1 H* rt HVO Hn H* H00 p* p* p p p p p H* P PJO o o O o O o o P P f1 1 1 1 1 1 1 CJu P k5Ln Ln On On 'M ON % ■rr
COOn 00 N3 ON to On C PIV V V V p) On PJX X X X X X p O Cp1-' h-* p> P p O Mo O O O p p p p p P p H1 1 1 1 O o o o o O p X 3.p- 4̂- 4>- 1 1 1 1 1 1 rt r*On On ON ON P P OQ MO P enrt
. .
e
sI—■ H*3
C/î
g-On>
H HP" >P WfP3 MP"PP OJco
Ui
OH*hhH-OH*
rt%
rtP"(D
mH-OQy
>l-ht-hH*PH*
QrOQ3i-JO
rtOXH*P
WH*
&H*POQ
0
1OP(DPrt
H*P
— 166 —
having an value very close to its measured from equilibrium
binding studies (8.89 x 10 and 1.38 x 10 respectively). Of the
ligands tested, d-tubocurarine was next to a-bungarotoxin in potency,
followed closely by benzoquinonium, eserine, acetylcholine and nicotine
in that order. The muscarinic ligands atropine and dexetimide were
-4not very strong inhibitors, having IC^^’s of > 10 M. Décaméthonium, 
the ligand used to identify the putative nm AChR was relatively 
ineffectual, thus lending credence to the hypothesis that there are at 
least two distinct cholinergic receptors in insects. Hexaméthonium, 
a potent ganglionic blocking agent in vertebrate CNS, also had little 
effect, as did carbamoylcholine. These results strongly suggest the 
presence of a binding component of nicotinic specificity and are in 
general agreement with those for membrane fragments or total homogenates 
from other insect species (Cattell, 1980a & b; Dudai, 1978; Gepner, 1979; 
Rudloff, 1978), although in some cases nicotine was found to be more 
potent an inhibitor than d-tubocurarine (Dudai, 1978; Gepner, 1979).
The absolute values of the IC^^'s quoted by different workers 
for different insect species are also comparable for any one ligand 
(see Table33). Any differences may be due to the preparations being 
at different stages of purity such that high levels of non-specific 
binding could lead to an overestimate of the concentration of ligand 
necessary to give 50% displacement. Alternatively, the conditions 
mentioned previously to ensure that IC^^ - K^, may not have been met. 
Unfortunately, the great majority of workers do not give sufficient 
experimental details to allow such an assessment of these data to be 
made.
Affinity reagents have been designed to specifically label the 
nAChR in vertebrate skeletal muscle and in electroplax (Karlin, 1969).
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These reagents combine the features of two molecules. One consists 
of a moiety resembling a cholinergic ligand, including a quaternary 
ammonium ion, which reacts at the negative subsite of the active site 
of the receptor and confers specificity on the reagent. The other 
portion of the molecule contains a reactive centre that alkylates 
sulphydryl groups. If the geometry of the reagent is such that the 
alkylating centre comes into juxaposition with a reduced sulphydryl 
on the receptor, when the quaternary ammonium group is bound at the 
negative subsite of the nAChR, the reagent will alkylate reduced 
nAChR’s with much higher specificity, and at a faster rate than it 
will react non-specifically with "non-receptor" reduced sulphydryls.
Such a reagent is maleimidobem.yltrimethylammonium (MBTA), which 
alkylates reduced electroplax nAChR’s with high affinity, antagonises 
the flux of ions through the receptor coupled channels and perturbs 
nicotinic-like neurotoxin binding (Karlin, 1977; Karlin et al., 1971).
If the a-BgTx binding component of insects is similar at the molecular 
level to the nAChR of electroplax, then [^h Im BTA would serve as a useful 
tool in its further characterisation and, if the a-BgTx binding component 
of insects reacts in the same way with MBTA as does the nAChR of the 
electroplax, this would suggest that they bear resemblances at the 
active site and would provide further supportive evidence for the 
identity of the a-BgTx binding component of insect CNS as a nAChR.
Affinity labelling also enables the identification of the
acetylcholine binding site by electrophoresis on polyacrylamide gels
under denaturing conditions of either membranes or the purified
3receptor, prelabelled with [ H]-MBTA. To date, there have been no 
reported attempts of using affinity labelling to identify the acetyl­
choline binding subunit from insect tissue or from mammalian CNS.
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In the case of the electroplax and vertebrate muscle nAChR [ H]MBTA
has been shown to label a single subunit of about M^ 40,000 (Sobel
£t al., 1977; Weill et̂  a1̂ ,, 1974; Rubs amen et al., 1978), similar
results were obtained for the nAChR from human skeletal muscle
(Stephenson, 1980). It has been reported that in the case of rat
denarvated (Froehner e^ a^., 1977) and innervated muscle (Nathanson
and Hall, 1979) two subunits are labelled.
In a preparation of membranes from locust supra-oesophageal 
3ganglia labelled with [ H]MBTA and subsequently examined by SDS-PAGE, 
only one major peak of radioactivity of M^ 58,000 was apparent. This 
peak was eliminated by preincubation of the membranes with unlabelled 
a-BgTx prior to the affinity labelling procedure, thereby indicating 
a common binding site for a-BgTx and MBTA. This apparent binding 
site however differs from both electroplax and vertebrate skeletal 
muscle, with respect to the size of the subunit.
The Solubilised Membranes (Detergent Extract):
A prerequisite for purification of a putative receptor is the 
presence of that receptor in a soluble form. This requirement would 
appear to present no problems to March el̂  al̂ . (1980) , who achieved 
solubilisation of the putative receptor from housefly heads upon homo­
genisation. Other workers (Dudai, 1978; Jimenez and Rudloff, 1980) 
reported problems with the solubilisation of particulate fractions 
of fruitfly heads enriched in a-BgTx binding activity. Dudai(1980) found 
that procedures which totally solubilised the nAChR of vertebrate CNS 
(Lowry et al., 1976) were inefficient when applied to fruitfly heads.
A combination of high ionic strength and non-ionic detergents released 
40% of the a-BgTx binding activity into a 100,000 x g supernatant but
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90% of this binding activity was sedimented after further centrifugation 
at 200,000 X g suggesting that it was in the form of small membrane 
fragments or supramolecular aggregates. The authors suggest that 
solubilisation is very sensitive to homogenisation procedures and 
appears to depend upon mechanical parameters involved in tissue dis­
ruption. Jimenez and Rudloff (1980) demonstrated complete solubilisation 
of 30 - 40% of a-BgTx binding activity by treatment of a particulate 
fraction of fruitfly heads with sodium deoxycholate at pH 9.0.
Inclusion of binding activity on a Sepharose 4B gel filtration column 
was used as a criterion of solubility.
Other workers have reported studies on Triton X-100 solubilised 
binding components from housefly heads (Eldefrawi and Eldefrawi, 1980) 
and from fruitfly heads (Hall, 1980). The latter group of workers used 
release of binding activity into a 30,000 x g supernatant as the 
criterion for solubilisation but neither study reports the percentage 
of total binding activity that is recovered in a soluble form.
It was found that approximately 90% of the a-BgTx binding activity 
from locust supra-oesophageal ganglion membrane fragments was released 
into either a 100,000 x g or 200,000 x g supernatant after treatment 
with 1% (v/v) Triton X-100, with approximately a 60% recovery of total 
binding activity. The amount of specific binding protein released was 
greater with 1% (v/v) Triton X-100 than with either 0.1% (v/v) or 0.5%
(v/v) Triton X-100.
125Specific [ I]-a-BgTx binding was proportional to tissue concent­
ration, providing that toxin was in excess. From equilibrium binding 
studies a Kjj of 5.6 nM and a B^^^ of 1.714 pmol/mg protein were 
calculated. The concentration of binding sites is in agreement with
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that for the membrane fragments (1.18 pmol/mg protein) and although 
of the same order of magnitude, there is a slight increase in the 
for the detergent extract compared to the membrane fragments. This 
could be due to the different methods of assay or to interference of 
the detergent with a-BgTx binding. It has been noted that both ionic 
and non-ionic detergents can have a marked effect on the affinity for 
a-BgTx of the nAChR from the electroplax (Sugiyama and Changeux, 1975). 
Nevertheless the decrease in affinity for a-BgTx of the membranes after 
solubilisation is relatively small and it is reasonable to assume that 
the binding kinetics of the membrane fragments are relatively unchanged 
after treatment with Triton X-100.
125Sedimentation in a continuous sucrose gradient of the [ I] -
a-BgTx detergent extract complex was attempted but no difference in the
distribution of radioactivity was found between the complex and free 
125[ I]-a-BgTx (Fig.30 )• The most likely explanation for this is
dissociation of the binding component-toxin complex occasioned by the
change in equilibrium when the complex enters the gradient, thus after
125the five hour centrifugation, undetectable amounts of [" I] -a-BgTx 
remain bound. This is plausible in view of the t^  ̂of approximately 
65 minutes calculated for dissociation of the membrane fragments 
- toxin complex.
The Partially Purified Binding Component;
Purification of the solubilised nAChR from electroplax and from 
vertebrate skeletal muscle entails adsorption onto an affinity column, 
washing to remove non-bound material and finally specific elution of 
the receptor. The most popular affinity columns for such preparations 
have been of Naja-naja a-toxin coupled to Sepharose 4B. Naja-naja
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a-toxin is used in preference to a-BgTx because the latter binds to
these receptors essentially irreversibly (t of days) and early studies0.5
using affinity columns of a-toxin from N.nigricollis venom, which has
a similar t^  ̂as a-bungarotoxin, failed to achieve any recovery of
the bound receptor (Meunier e^ a^., 1971 ). The acetylcholine
analogue carbomoylcholine in high concentrations (1 M) is usually
used as an elutant because it binds with relatively low affinity and
is therefore easily removed from the receptor by dialysis. However,
with membrane fragments from locust supra-oesophageal ganglia, it has
been shown firstly, that a-BgTx binds with a much lower affinity to
this preparation than to either electroplax or vertebrate skeletal
muscle receptors and secondly, that carbamoylcholine has an
-4value of greater than 10 M and therefore is relatively ineffectual in 
displacing bound a-BgTx. For these reasons an affinity column of 
a-BgTx coupled to Sepharose 4B was chosen for further purification of 
the a-BgTx binding component from the detergent extract of locust 
supra-oesophageal ganglia and the column was eluted with 1 M acetyl­
choline which, although it has a lower (6.68 x 10 ^M) than
carbamoylcholine, is still easily removed by dialysis. Using this 
method, the a-BgTx binding component from locust supra-oesophageal
ganglia, in the solubilised form, was further purified,
125The specific [ I]-a-BgTx binding of activity of the affinity- 
purified material ranged from 7 - 230 pmol/mg protein and the purification 
factor (taking the total homogenate as one) varied from 32 - 1100.
This figure may be compared with values of 0.19 - 12 nmol/mg protein 
for the purified nAChR from electroplax and vertebrate skeletal muscle 
(see Karlin, 1980). However, until more detailed experiments are made 
for the locust receptor, with respect to molecular weight, subunit
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composition and stoichiometry of binding subunits, no meaningful 
comparison can be made with these well characterised binding receptor 
proteins.
Although the experimental conditions were identical for every 
preparation of locust supra-oesophageal ganglia, a consistent specific 
binding activity and purification factor was not achieved. This may 
be due to a number of factors, some of which are outlined below, 
along with possible remedies:
1. To date no study has been made of the extent of proteolysis 
during purification of the a-BgTx binding component from insect 
CNS tissue. Although, in this thesis and in the partial 
purification of a preparation of fruitfly heads, (Hall, 1980) 
a range of anti-protease agents are included in the buffers 
used, it is not known whether they are sufficient to completely 
prevent proteolysis.
Shorr e_t (1981) made two major observations with respect to 
proteolysis when working with purified nAChR from denervated 
cat skeletal muscle. First, in addition to the 43,000 
polypeptide always demonstrated by SDS-PAGE of the purified 
receptor, a polypeptide of 39,000 was sometimes apparent. 
Rapid preparation of the receptor in the presence of a wide 
range of protease inhibitors eliminated this smaller polypeptide 
which was therefore assumed to be a degradation product of the
43.000 subunit. Secondly, sedimentation in a sucrose density 
gradient of the native purified receptor yielded two bands of 
^20 W 9S and 4S. Both were composed of the same subunits,
43.000 M^, when subjected to SDS-PAGE but the 4S oligomer 
disappeared if either the muscle protease inhibitor.
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iodoacetamide, was added early in the preparative stages or 
if fresh rather than frozen muscle was used. These two points 
exemplify the subtle effects of proteolysis on the behaviour 
of both the native protein and its constituent subunits. 
Questions therefore arise, with respect to both fruitfly and 
locust preparations, as to the extent of proteolysis during 
purification and whether the binding capacity and/or affinity 
of the putative receptor is impaired. Therefore, proteolysis 
could be partly responsible for the variability of specific 
binding activities from preparation to preparation of locust 
supra-oesophageal ganglia. A detailed systematic study, using 
such a preparation, of the effects of different combinations 
of anti-proteases and preparation times on binding capacity, 
sedimentation coefficient and subunit composition is necessary 
before any definite conclusions can be drawn about the effects 
of proteolysis. This problem seems to highlight yet again our 
almost total lack of knowledge of many aspects of the bio­
chemistry of insect tissues in that no information is available 
on the nature of the proteases presumed to be present in these 
tissues.
1252. The overall recovery of total specific [ I]-a-BgTx 
binding activity after the affinity column stage ranged from 
9% - 48%, which is equivalent to a recovery of 18% - 83% of 
the specific binding activity applied to the column. Therefore, 
a portion of the binding activity is lost in the affinity 
chromatography and subsequent dialysis steps, a loss which 
may be partly due to inefficient elution of the putative
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receptor from the affinity column and/or incomplete removal 
of the acetylcholine by dialysis. The former problem has 
been minimised in some cases (Shorr e_t a1 .̂, 1981) by eluting 
the affinity column with a combination of eluting ligand and 
anti-toxin immunoglobulin. The rationale for this procedure 
is that immunoglobulin will mask any unoccupied toxin and will 
therefore prevent reassociation of displaced receptor. 
Constraints are imposed by the difficulty and cost of raising 
sufficient anti-toxin antisera to routinely adopt this 
method.
In the case of preparations of AChR from Torpedo electroplax 
and vertebrate skeletal muscle extensive dialysis of the elutant 
appears to remove a large proportion but not all of the eluting 
ligand from the putative receptor. Thus, preparations that 
are subjected only to dialysis do not show such high specific 
activities as the preparations in which dialysis is followed 
by ion-exchange chromatography on DEAE cellulose (Fulpius, 1976; 
Stephenson, 1980). The eluting ligand not removed (in the case 
of the work reported in this thesis, acetylcholine) will 
consequently interfere with the binding assay, giving an 
underestimation of the concentration of binding sites. However, 
because the amount of protein was so small in the preparations 
described here an ion-exchange step was not included in the 
purification procedure.
3. The amount of protein recovered was low and just fell 
within the lower limits of detection by the Lowry method.
Ideally a more sensitive method of protein estimation or
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recovery of greater amounts of protein would eliminate any
errors in the calculation of specific activity which may
result from inaccuracies in protein determination.
An additional step in the purification procedure of the nAChR
from denervated vertebrate skeletal muscle (Shorr e_t a^., 1981) has
exploited the glycoprotein nature of the receptor. The eluate from
an a-toxin affinity column was chromatographed on lentil lectin
immobilised on Sepharose 4B. An increased specific activity resulted
but the yield was decreased by more than one half. Herein, lies the
problem of applying the partially purified a-bungarotoxin binding
component from locust supra-oesophageal ganglia to a lectin affinity
column but such procedures should be borne in mind for future use,
when the yield has been improved.
Specific binding to the partially purified a-BgTx binding
component from locust supra-oesophageal ganglia increased linearly
with protein concentration and showed the same binding kinetics as the
membrane fragments, K^’s 1.71 nM and 1.38 nM respectively, as
calculated from binding studies at equilibrium. Binding, as before,
was non-cooperative (Hill number = 1). These binding data suggest
that little change in the conformational structure of the a-BgTx
binding component has occurred during the purification procedure.
125However, the dissociation of [ I]-a-BgTx from this partially
purified preparation is monophasic and faster (t^ ^ < 1 min) than from
the membrane fragments (t^ ^ - 65 minutes). This suggests, perhaps,
125that the biphasic nature of dissociation of [ I]-a-BgTx from the 
membrane fragments could be an inherent property of the putative 
receptor situ, a characteristic which is lost on removal of the 
receptor from its membrane environment.
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The difference in  ̂for the partially purified preparation
and the membrane fragments is not so large when compared to the t^ ^
for electroplax and vertebrate skeletal muscle receptor-toxin complexes
which is of the order of days. Nonetheless, such a fast t^  ̂ imposes
1 25restrictions on using the [ I]-a-BgTx labelled binding component in
further characterisation. Vacuum filtration on DEAE cellulose discs
1 25was used to separate bound [ I ]-a-BgTx from free toxin and as
filtration and washing was complete within 6 seconds little dissociation
will have occurred in this time.
The Kjj calculated using k_^ was > 7.25 x 10 M, Cp. 148) which
is a factor of ten times higher than the .calculated in the same way
-10for the membrane fragments (2.78 x 10 M) but is in close agreement
with the calculated from equilibrium binding studies for either
-9 ”9preparation (1.38 x 10 M and 1.71 x 10 M for the membrane fragments
and the partially purified binding components respectively). For this
1 25reason the rate of dissociation of [ I ]-«-BgTx from the partially
purified receptor as opposed to the membrane fragments was taken as
the more reliable estimate of k_^.
Sedimentation in a . continuous secrose density gradient of the
paritally purified a-BgTx binding component was carried out without
125pre-incubation with f I ]-a-BgTx (see p.161). Instead, the unlabelled
a-BgTx binding component was sedimented and each fraction was assayed 
125for [ I ]-a-BgTx binding activity. A sedimentation coefficient of 
14.2s was obtained which is higher than the value measured for 
solubilised receptors from electroplax and from vertebrate skeletal 
muscle (98) (Shorr et al., 1981; Stephenson, 1980). However, 
sedimentation coefficients higher than 9s have also been reported for 
putative receptors from both mammalian CNS (11.4S - 12.9S)
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(Seto £t a]̂ ., 1977; Salvaterra and Mahler, 1976) and from preparations 
of fruitfly heads (11.4S) (Gepaer, 1979) and therefore similarities 
can be drawn between these putative receptors and the partially 
purified a-BgTx binding component from locust supra-oesophageal 
ganglia.
The solubilised Torpedo nAChR has been found to exist in both 
a 9S and 13S form and the 13S is apparently a dimer of the 9S form 
(Raftery ^  al.> 1979). A high sedimentation coefficient for the 
a-BgTx binding component prepared from locust supra-oesophageal ganglia 
could be due to the presence of a dimer. However, no smaller form 
of the a-BgTx binding component, which could be attributed to a possible 
monomer, was detected. Clearly, until further detailed characterisation 
of this binding component is made such questions must remain open.
A M  of 400,000 - 450,000 was estimated from the value of 14.2S for r
the a-BgTx binding component by the approximation of Schachman Cl959).
It is probable that this value is an under-approximation of the molecular 
weight of the binding species due to the presence of bound detergent. 
Tanford ^  £l (1974), have shown that there is a significant decrease 
in buoyant density of protein following the binding of either lipid 
material or detergents. Thus, it follows that there is an increase 
in partial specific volume of the protein, and as the molecular weight 
of a protein is related to the sedimentation coefficient by the formula:-
M =
D (1 - Y p)
Where y is the partial specific volume, it follows that an apparent 
increase in y would yield an erroneously low value for S and hence 
a low molecular ■ weight with respect to marker proteins that do not bind 
detergent. The problem can be circumvented with no knowledge of the
— 178 —
percentage detergent bound to a protein by adjusting the solvent 
density with D2O to blank out the contribution of bound detergent to 
the sedimentation coefficient (Reynolds and Tanford, 1976).
Polyacrylamide gel electrophoresis under denaturing conditions 
of the partially purified a-BgTx binding component from locust supra- 
oesophageal ganglia yielded three faint but distinct protein bands.
These bands corresponded to M^’s of 60,000, 41,000 and 25,000. The
60.000 subunit, allowing for experimental error, closely corresponds 
to the subunit that is labelled by the affinity reagent pH]-MBTA.
A recent report from Hall (1981) tentatively suggests that a 60,000 M^ 
subunit from-.a preparation of fruitfly heads carries the AChR binding 
site, on the basis of studies in which this subunit was photoaffinity 
labelled with a deri vative of a-BgTx. In electroplax and in vertebrate 
skeletal muscle preparations, however, it is the subunit of 40,000 M^ 
which binds both MBTA and a-BgTx. Herein lies a possible major 
difference between the nAChR from either electric fish electroplax or 
vertebrate skeletal muscle and the putative nAChR from insect CNS.
The 24,000 M^ subunit revealed by SDS-PACE of the partially 
purified a-BgTx binding component may be due to proteolytic degradation 
of one of the larger subunits. In the well-characterised receptor 
from electroplax and vertebrate skeletal muscle it is generally agreed 
that subunits with molecular weights lower than 40,000 are the results 
of proteolysis (Bartfeld and Fuchs, 1979; Lindstrom et al., 198Cb).
The purified nAChR from Torpedo electroplax is reported to have four 
different subunits of M^’s 40,000 (a); 50,000 (g); 57,000 (y);
64.000 (6), present in the ratio 2:1:1:1 (see Heidmann and Changeux, 1978) 
whereas the existence of only two subunits of 'v 40,000 and 60,000 M^’s 
has been reported for human (Stephenson, 1980) and rat (Kemp et al., 1980)
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skeletal muscle receptors. The latter observations are in general 
agreement with the subunit patterns reported here for the partially 
purified a-BgTx binding component from locust supra-oesophageal ganglia.
The subunit composition of the vertebrate muscle nAChR is however
still the subject of considerable debate. Thus the group of Barnard
and Dolly have produced compelling evidence that the nAChR from cat
muscle contains a single subunit of 40,000 (Shorr e^ a1̂ ., 1981)
whereas Lindstrom and co-workers find that foetal calf muscle has an
identical subunit pattern to Torpedo electroplax AChR (Lindstrom et al., 1980a)
It is possible that acetylcholine receptors from all sources have a
unique quaternary subunit structure and that the observed differences
simply reflect differing degrees of proteolysis and this is the view
expressed by Lindstrom and co-workers (Lindstrom ̂  al,, 1979; 1980a).
However may workers have taken stringent precautions to minimize such 
effects (Shorr e^ al^., 1981, Stephenson e^ , 1981) and it seems 
premature to reach such a conclusion. Our appreciation of exactly 
how the insect receptors fit into the patterns of structural composition 
of nAChR's must await further detailed studies of subunit composition.
Acetylcholine Esterase Activity;
A slight enrichment of acetylcholine esterase activity was apparent
in the particulate fractions of the preparation. The partially purified
a-BgTx binding component exhibited no enzyme activity thereby confirming
that the binding component for a-BgTx and the enzyme are distinct.
This is in agreement with the well established findings in the electroplax
(Meunier ^  a^., 1971).
In conclusion, an a-BgTx binding component has been partially
125purified from locust supra-oesophageal ganglia. Binding of [ I]-a-BgTx
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increased linearly with protein concentration in the particulate, 
in the solubilised and in a partially purified preparation. The 
binding was in each case of high affinity, specific and saturable.
The pharmacological characteristics of the membrane fragments were 
predominantly nicotinic. Taking all these points into consideration 
with respect to the criteria for defining a receptor (p.15 ), the 
a-BgTx binding component of locust supra-oesophageal ganglia can 
tentatively be termed a nicotinic acetylcholine receptôc. The 
partially purified nAChR from locust supra-oesophageal ganglia 
sediments as a single component S^Q ^ = 14.2S, from which an approximate 
value of 400,000 - 450,000 has been calculated. SDS-PAGE revealed 
two major subunits, 41,000 and 60,000, of which only the 60,000
3subunit was labelled with [ H]-MBTA.
Further work on this putative nAChR from locust supra-oesophageal 
ganglia should be primarily concerned with improvement of the 
purification procedure and with increasing the yield, thereby 
facilitating a more intensive and thorough characterisation.
The problem of detection and analysis of very small amounts of nAChR 
has been overcome by some workers by radioiodination of the purified 
receptor (Stephenson, 1980; Shorr et al., 1981). The same technique 
may also be applied to the partially purified nAChR from locust supra- 
oesophageal ganglia which may enable detection of not only small amounts 
of the native receptor but also small amounts of its constituent subunits.
Further characterisation and comparison with other nAChR's should 
include investigation of the immunological properties of this putative 
insect nAChR. A preliminary study by Eldefrawi and Eldefrawi (1980) 
demonstrated that there was no cross-reactivity between a detergent 
solubilised a-BgTx binding component from housefly heads and antibodies
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raised in sheep against purified Torpedo nAChR, The authors concluded 
that the a-BgTx binding components of Torpedo electroplax and housefly 
heads differed with regard to the antigenic site(s). However, it 
should be borne in mind that the cross reactivity between Torpedo and 
other nAChR from vertebrate muscle is very low (Lindstrom ^  £l_* > 1979;
Garlepp e_t a1̂ ., 1981). It would be interesting, therefore, to compare 
the cross-reactivity and hence antigenic similarities of putative 
insect AChR's with antibodies raised against receptors from 
vertebrate skeletal muscle and mammalian CNS. In addition a different 
antigenic pattern for the three putative acetylcholine receptors from 
insect CNS would be strong evidence for three distinct receptors.
A novel approach to producing the nAChR in large quantities 
would be the insertion of the gene responsible for acetylcholine receptor 
synthesis into the DNA of a prolific bacterium. The difficulty in 
such a study is the identification of the AChR gene. Hall (1978;Hall, 1980)
have approached the problem of gene identification by investigating 
drug resistant mutants of fruitfly on the premise that resistance to 
the cholinergic drug nicotine may be indicative of a change in AChR 
structure. This they found to be the case and observed a change in 
the isoelectric point of the solubilised a-BgTx binding component 
from the resistant strain compared to the wild type. Their conclusion 
was that the mutated gene of nicotine resistant fruitfly coded for 
a structural polypeptide in the a-BgTx binding complex, i.e. the putative 
nAChR. However, it is highly probable that more than one gene codes for 
the AChR, therefore considerably more work is necessary to identify 
all the genes required for a complete AChR. This study however serves 
to demonstrate the ease of genetic manipulation of fruitfly in comparison
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to higher organisms. In this respect, insects, especially the fruit­
fly, are an extremely useful tool in specific gene identification.
Recently Sumikawa e^ a^ (1981) have reported the extraction of 
AChR mRNA from Torpedo and have shown it to be translated in a cell- 
free reticulocyte system and also in Xenopus oocytes. The latter 
efficiently assembled intact, multi-subunit AChR molecules which showed 
properties characteristic of the native AChR, including the binding of 
a-BgTx. The suggested use of such a system is in the elucidation of 
mechanismsby which the receptor molecule is assembled and inserted 
into the membrane. Such an investigation could provide evidence in 
support of the "signal hypothesis" of orientation of proteins in the 
membrane (see Lodish and Rothman, 1979; Harrison and Lunt, 1980). It 
is thought that the N-terminal section of the nascent peptide carries 
a "signal"sequence which directs the insertion of the peptide into the 
endoplasmic reticulum whereupon the signal sequence is removed, 
initial sugar residues are added and the C-terminal section of the 
polypeptide is completed. The membrane glycoprotein is now transferred 
to the Golgi apparatus, where carbohydrate incorporation is largely 
completed. Finally, the glycoprotein, still membrane bound, migrates 
to and fuses with the plasma membrane. Throughout the entire process 
the asymmetric orientation of the glycoprotein, with respect to the 
cytoplasm, is maintained. In the Xenopus oocyte system (Sumikawa et al., 
1981) the AChR is both synthesised and inserted into the membrane and 
may therefore prove to be a particularly appropriate system in which 
to investigate the possible functions of carbohydrate residues of the 
receptor. Wonnacott e^ a^ (1980a) have shown that removal of the 
carbohydrate from the purified Torpedo nAChR has no effect on the 
binding of a-BgTx. Further work by Wonnacott et al (1980b) suggests
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that the carbohydrate residues may have only a minor role as anti­
genic determinants. It is possible therefore that the major function 
of the glycosyl residues is to maintain the orientation of the receptor 
in the membrane during assembly of the synaptic membrane.
The major problem in the study ^  vitro of AChR synthesis is 
identification of the AChR, mRNA. Sumikawa e_t a]̂  (1981) identified 
the specific mRNA by screening of all the proteins produced by the 
cell-free reticulocyte system; this is very laborious work but these 
same techniques could be applied to the mRNA from insects.
If the AChR from insect CNS could be produced in large quantities, 
from cloning studies, this would greatly accelerate its characterisation 
and may also provide a novel system for the screening of potential 
insecticides.
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